<!DOCTYPE HTML PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<title>
        Nasal Type Extranodal Nk/t-Cell Lymphoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials
    </title>
<link href="/favicon.ico" type="image/x-icon" rel="icon" />
<link href="/favicon.ico" type="image/x-icon" rel="shortcut icon" />
<link rel="canonical" href="https://www.malacards.org/card/nasal_type_extranodal_nk_t_cell_lymphoma" />
<link href="/styles/main?v=4ibYhrTKhtFkLb0eOKJyI76F8l4oz0xxD-Ee5OvEFUg1" rel="stylesheet" />
<script type="text/javascript">
        var baseUrl = '/';
        var slug = '';
        var status = 'guest';
    </script>

<script async src="https://www.googletagmanager.com/gtag/js?id=G-CPGXGV3Z40"></script>
<script>
      window.dataLayer = window.dataLayer || [];
        function gtag(){dataLayer.push(arguments);}
        gtag('js', new Date());
        gtag('set', 'user_properties', {
            OrgType: 'Unknown',
            OrgName: 'Unknown'
        });
        gtag('set', 'custom_map', {
          'dimension2': 'OrgType',
          'dimension3': 'OrgName'
        });
        // Track GA4
        gtag('config', 'G-CPGXGV3Z40');
        // Track Universal Analytics
        gtag('config', 'UA-33531077-1', {
            'OrgType': 'Unknown',
            'OrgName': 'Unknown'
        });
    </script>
</head>
<body itemscope="itemscope" itemtype="http://schema.org/MedicalWebPage" class="eupopup eupopup-bottom">
<link itemprop="audience" href="https://schema.org/Patient" />
<link itemprop="audience" href="https://schema.org/MedicalResearcher" />
<link itemprop="audience" href="https://schema.org/Clinician" />
<div itemscope="itemscope" itemtype="http://schema.org/MedicalCondition">
<div id="container">
<div id="header">
<a href="/" id="home" title="MalaCards - human disease database"><img src="/img/malacards_logo.png" alt /></a>
<div>
<a href="http://www.weizmann.ac.il" id="weizmann" title="Weizmann Institute of Science" target="_blank"><img src="/img/weizmann_logo.png" alt /></a>
<a href="http://www.lifemapsc.com" id="lifemap" title="LifeMap Sciences, Inc." target="_blank"><img src="/img/lm_logo.png" alt /></a>
</div>
<div id="user-area">
<div class="search-box">
<form action="/search/results" class="search-box-form" id="HeaderSearchForm" method="get" accept-charset="utf-8">
<div class="search-box-content">
<div class="content1" id="the-basics2">
<div style="margin-top:6px;">
<span class="search_button">Search</span>
</div>
<div>
<input type="text" name="query" id="search-box-input" autocomplete="off" class="search-box-input typeahead" />
</div>
<div class="search-submit">
<input name value type="submit" style="background-image:url('/img/magnifying_glass.png');background-repeat:no-repeat;background-color: #eea904;border: 0;width:23px;height:26px;cursor: pointer;" />
<input type="hidden" id="pageSizeInput" name="pageSize" value="25" />
</div>
<div style="margin-top:5px;">
<a href="/search/">Advanced</a>
</div>
</div>
</div>
</form>
</div>
</div>
</div>
<div class="nav-container">
<div>
<a href="/" title="MalaCards Home">Home</a>
<div class="dropdown">
<span class="dropbtn">User Guide</span>
<div class="dropdown-content">
<a href="/pages/info#whats_in_a_malacard">What's in a MalaCard</a>
<a href="/pages/searchguide">Search Guide</a>
<a href="/pages/info/#sources">Our Sources</a>
</div>
</div>
<div class="dropdown">
<span class="dropbtn">Analysis Tools</span>
<div class="dropdown-content">
<a href="https://www.genecards.org" target="_blank">GeneCards</a>
<a href="https://ga.genecards.org/gene-set-analysis/?utm_source=malacards&amp;utm_campaign=malacards&amp;utm_medium=logo_link&amp;utm_content=plus_panel" target="_blank">GeneAnalytics</a>
<a href="http://pathcards.genecards.org/?utm_source=malacards&amp;utm_campaign=malacards&amp;utm_medium=logo_link&amp;utm_content=plus_panel" target="_blank">PathCards</a>
<a href="http://varelect.genecards.org/?utm_source=malacards&amp;utm_campaign=malacards&amp;utm_medium=logo_link&amp;utm_content=plus_panel" target="_blank">VarElect</a>
</div>
</div>
<a href="/pages/whatsnew" target="_blank">Release Notes</a>
<a href="/categories" target="_blank">Disease Lists/Categories</a>
<div class="dropdown">
<span class="dropbtn">About</span>
<div class="dropdown-content">
<a href="/pages/info">About MalaCards</a>
<a href="https://www.genecards.org/Guide/Datasets" target="_blank">Datasets</a>
<a href="/pages/ourpublications">Our Publications</a>
<a href="http://www.weizmann.ac.il/" target="_blank" rel="nofollow">Weizmann Institute</a>
<a href="https://discovery.lifemapsc.com" target="_blank" rel="nofollow">LifeMap Discovery&reg;</a>
<a href="https://auth.lifemapsc.com/TermsOfUse" target="_blank">Terms of Use</a>
<a href="https://www.genecards.org/Guide/GeneCardsTeam">MalaCards Team</a>
</div>
</div>
<div class="sign-in-menu">
<a href="/Account/LogOn?moduleName=MC" rel="nofollow" target="_self">Log In</a> <span>&nbsp;</span>
<a href="/Account/Register?moduleName=MC" rel="nofollow" target="_self">Sign Up</a> </div>
</div>
</div>
<div id="content">
<script type="text/javascript">
    var slug = 'nasal_type_extranodal_nk_t_cell_lymphoma';
</script>
<div class="card" id="top-card">
<div class="card-header">
<table cellpadding="0" cellspacing="0">
<tr>
<td width="160px">
<div class="symbol-section">
<div class="acronym">
<div class="acronym">
NKTCL <div class="symbol">MCID: NSL029</div>
<div class="symbol" title="MalaCards InFormaTion Score. Annotation strength of this MalaCard (max 100)">
<a href="/pages/info/#mift" target="_blank"><span class="header_mift">MIFTS</span></a>: 43
</div>
</div>
</div>
</div>
</td>
<td>
<div class="card-description">
<h1>
<span itemprop="name">Nasal Type Extranodal Nk/t-Cell Lymphoma</span>
(<span itemprop="alternateName">NKTCL</span>)
</h1>
<div>
<a href="/categories/" title="See all disease categories">Categories</a>:
Blood diseases, Cancer diseases, Immune diseases, Rare diseases, Respiratory diseases, Skin diseases, Smell/Taste diseases
</div>
</div>
</td>
<td width="160px">
<div class="data-licensing-section">
<div class="acronym">
<div class="acronym">
Data Licensing
</div>
<div class="symbol">For inquiries, contact:</div>
<div class="symbol">
<a href="/cdn-cgi/l/email-protection#fb889a979e88bb97929d9e969a8b8898d5989496" target="_blank"><span class="__cf_email__" data-cfemail="deadbfb2bbad9eb2b7b8bbb3bfaeadbdf0bdb1b3">[email&#160;protected]</span></a>
</div>
</div>
</div>
</td>
</tr>
<tr>
<td colspan="3">
<div class="stats">
<a href="#related_genes" title="8 Genes associated with Nasal Type Extranodal Nk/t-Cell Lymphoma">Genes</a>
<a href="#anatomical_context" title="7 Tissues associated with Nasal Type Extranodal Nk/t-Cell Lymphoma">Tissues</a>
<a href="#disorders" title="339 Related diseases associated with Nasal Type Extranodal Nk/t-Cell Lymphoma">Related diseases</a>
<a href="#publications" title="2137 Publications associated with Nasal Type Extranodal Nk/t-Cell Lymphoma">Publications</a>
<a href="#clinical_features" title="2 Symptoms &amp; Phenotypes associated with Nasal Type Extranodal Nk/t-Cell Lymphoma">Symptoms &amp; Phenotypes</a>
<a href="#therapeutics" title="166 Drugs associated with Nasal Type Extranodal Nk/t-Cell Lymphoma">Drugs</a>
</div>
<div style="float:right;">
<div class="stats_button">
<a href="/card/nasal_type_extranodal_nk_t_cell_lymphoma?search%3dRare+diseases&amp;showAll=True" target="_self">Expand all tables</a>
</div>
</div>
</td>
</tr>
</table>
</div>
<div class="section" id="aliases_descriptions">
<div class="section-header">
<div class="jump-to-section">
<select onchange="jumpToSection(this);">
<option selected="selected" value>Jump to section</option>
<option value="#aliases_descriptions">Aliases &amp; Classifications</option>
<option value="#anatomical_context">Anatomical Context</option>
<option value="#therapeutics">Drugs &amp; Therapeutics</option>
<option value="#expression_profiles">Expression</option>
<option value="#related_genes">Genes</option>
<option value="#genetic_testing">Genetic Tests</option>
<option value="#goterms">GO Terms</option>
<option value="#pathways">Pathways</option>
<option value="#publications">Publications</option>
<option value="#disorders">Related Diseases</option>
<option value="#sources">Sources</option>
<option value="#summaries">Summaries</option>
<option value="#clinical_features">Symptoms &amp; Phenotypes</option>
<option value="#genetic_variations">Variations</option>
<option value="#container">Top</option>
<option value="#footer">Bottom</option>
</select>
</div>
<div class="section-header-sources">
<a href="#sources">Sources</a>
</div>
<h2 class="title">
<span itemprop="aspect">Aliases &amp; Classifications<small> for Nasal Type Extranodal Nk/t-Cell Lymphoma</small></span>
</h2>
<div class="about-section">
<a href="/pages/info#aliases_descriptions">
<img src="/img/menu/help_icon.png" alt="About this section" title="About this section" style="width:20px;margin:0px;" />
</a>
</div>
</div>
<table class="section-table">
<tr>
<td class="rhs">
<div class="section-data">
<h3>MalaCards integrated aliases for Nasal Type Extranodal Nk/t-Cell Lymphoma:</h3>
<div class="main-name">
Name: <b>Nasal Type Extranodal Nk/t-Cell Lymphoma</b>
<sup title="Disease Ontology"> <a href="https://disease-ontology.org/?id=DOID:0080797" title="Disease Ontology" target="_blank">11</a></sup>
<sup title="The University of Copenhagen DISEASES"> <a href="http://diseases.jensenlab.org/Entity?textmining=12&amp;type1=-26&amp;type2=9606&amp;id1=DOID:0080797" title="The University of Copenhagen DISEASES" target="_blank">14</a></sup>
<sup title="Unified Medical Language System"><span title="Unified Medical Language System">71</span> </sup>
</div>
<table class="borderless aliases">
<tbody>
<tr>
<td width="390">
<div>
Nasal T/natural Killer-Cell Lymphoma
<sup title="Genetic and Rare Diseases Information Center"> <a href="https://rarediseases.info.nih.gov/diseases/7041/index" title="Genetic and Rare Diseases Information Center" target="_blank">19</a></sup>
<sup title="Orphanet"> <a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=86879" title="Orphanet" target="_blank">58</a></sup>
</div>
<div>
Extranodal Nasal Nk/t Cell Lymphoma
<sup title="Genetic and Rare Diseases Information Center"> <a href="https://rarediseases.info.nih.gov/diseases/7041/index" title="Genetic and Rare Diseases Information Center" target="_blank">19</a></sup>
<sup title="Orphanet"> <a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=86879" title="Orphanet" target="_blank">58</a></sup>
</div>
<div>
Angiocentric T-Cell Lymphoma
<sup title="Genetic and Rare Diseases Information Center"> <a href="https://rarediseases.info.nih.gov/diseases/7041/index" title="Genetic and Rare Diseases Information Center" target="_blank">19</a></sup>
<sup title="Orphanet"> <a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=86879" title="Orphanet" target="_blank">58</a></sup>
</div>
<div>
Lethal Midline Granuloma
<sup title="Genetic and Rare Diseases Information Center"> <a href="https://rarediseases.info.nih.gov/diseases/7041/index" title="Genetic and Rare Diseases Information Center" target="_blank">19</a></sup>
<sup title="Orphanet"> <a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=86879" title="Orphanet" target="_blank">58</a></sup>
</div>
</td>
<td width="390">
<div>
Nk/t-Cell Lymphoma
<sup title="Genetic and Rare Diseases Information Center"> <a href="https://rarediseases.info.nih.gov/diseases/7041/index" title="Genetic and Rare Diseases Information Center" target="_blank">19</a></sup>
<sup title="Orphanet"> <a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=86879" title="Orphanet" target="_blank">58</a></sup>
</div>
<div>
Nktcl
<sup title="Genetic and Rare Diseases Information Center"> <a href="https://rarediseases.info.nih.gov/diseases/7041/index" title="Genetic and Rare Diseases Information Center" target="_blank">19</a></sup>
<sup title="Orphanet"> <a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=86879" title="Orphanet" target="_blank">58</a></sup>
</div>
<div>
Nasal and Nasal-Type Nk/t-Cell Lymphoma
<sup title="Unified Medical Language System"><span title="Unified Medical Language System">71</span> </sup>
</div>
<div>
Granuloma, Lethal Midline
<sup title="Unified Medical Language System"><span title="Unified Medical Language System">71</span> </sup>
</div>
</td>
</tr>
</tbody>
</table>
<br/>
<h3>Characteristics:</h3>
<br/>
<h3>Inheritance:</h3>
<div class="tab">
<b>Extranodal Nasal Nk/t Cell Lymphoma:</b>
Multigenic/multifactorial <sup title="Orphanet"> <a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=86879" target="_blank">58</a></sup>
</div>
<br/>
<div class="tab">
<h3>Prevelance:</h3>
<div class="tab">
<b>Extranodal Nasal Nk/t Cell Lymphoma:</b>
1-9/100000 (France) <sup title="Orphanet"> <a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=86879" target="_blank">58</a></sup>
</div>
<br/>
<h3>Age Of Onset:</h3>
<div class="tab">
<b>Extranodal Nasal Nk/t Cell Lymphoma:</b>
Adult <sup title="Orphanet"> <a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=86879" target="_blank">58</a></sup>
</div>
<br/>
</div>
<div id="classifications"></div>
<h3>Classifications:</h3>
<div class="tab">
<b>MalaCards categories: </b>
<br/>
<span>Global:</span>
<a href="https://www.malacards.org/categories/rare_diseases" target="_blank">Rare diseases</a> <a href="https://www.malacards.org/categories/cancer_disease_list" target="_blank">Cancer diseases</a> <br/>
<span>Anatomical:</span>
<a href="https://www.malacards.org/categories/skin_disease_list" target="_blank">Skin diseases</a> <a href="https://www.malacards.org/categories/blood_disease_list" target="_blank">Blood diseases</a> <a href="https://www.malacards.org/categories/immune_disease_list" target="_blank">Immune diseases</a> <a href="https://www.malacards.org/categories/respiratory_disease_list" target="_blank">Respiratory diseases</a> <a href="https://www.malacards.org/categories/smell_taste_disease_list" target="_blank">Smell/Taste diseases</a> <br/>
<div class="padding_left">
<a href="/categories/" class target="_blank">See all MalaCards categories (disease lists)</a>
</div>
</div>
<div class="tab">
<b>ICD10:</b>
<sup title="International Classification of Diseases, 10th Revision">31</sup>
<sup title="ICD10 via Orphanet">32</sup>
<br/>
<div style="padding-left: 0px;">
<img src="/img/grey_arrow.png" alt title width="20" style />
<a href="http://apps.who.int/classifications/icd10/browse/2019/en#/II" title="II" target="_blank">Neoplasms</a>
</div>
<div style="padding-left: 30px;">
<img src="/img/grey_arrow.png" alt title width="20" style />
<a href="http://apps.who.int/classifications/icd10/browse/2019/en#/C81-C96" title="C81-C96" target="_blank">Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue</a>
</div>
<div style="padding-left: 60px;">
<img src="/img/grey_arrow.png" alt title width="20" style />
<a href="http://apps.who.int/classifications/icd10/browse/2019/en#/C86" title="C86" target="_blank">Other specified types of T/NK-cell lymphoma</a>
</div>
<div style="padding-left: 90px;">
<img src="/img/grey_arrow.png" alt title width="20" style />
<a href="http://apps.who.int/classifications/icd10/browse/2019/en#/C86.0" title="C86.0" target="_blank">Extranodal NK/T-cell lymphoma, nasal type</a>
</div>
</div>
<div class="tab">
<b>ICD11:</b>
<sup title="International Classification of Diseases, 11th Revision">33</sup>
<br/>
<div style="padding-left: 0px;">
<img src="/img/grey_arrow.png" alt title width="20" style />
<a href="https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/release/11/beta/mms/1630407678" title="1630407678" target="_blank">Neoplasms</a>
</div>
<div style="padding-left: 30px;">
<img src="/img/grey_arrow.png" alt title width="20" style />
<a href="https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/release/11/beta/mms/944754984" title="944754984" target="_blank">Neoplasms of haematopoietic or lymphoid tissues</a>
</div>
<div style="padding-left: 60px;">
<img src="/img/grey_arrow.png" alt title width="20" style />
<a href="https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/release/11/beta/mms/450630526" title="450630526" target="_blank">Mature T-cell or NK-cell neoplasms</a>
</div>
<div style="padding-left: 90px;">
<img src="/img/grey_arrow.png" alt title width="20" style />
<a href="https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/release/11/beta/mms/1327154972" title="1327154972" target="_blank">Mature T-cell lymphoma, specified types, nodal or systemic</a>
</div>
<div style="padding-left: 120px;">
<img src="/img/grey_arrow.png" alt title width="20" style />
<a href="https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/release/11/beta/mms/684005900" title="684005900" target="_blank">Extranodal NK/T-cell lymphoma, nasal type</a>
</div>
</div>
<div class="tab">
<b>Orphanet: </b> <sup title="Orphanet">58</sup>
&nbsp;<br/>
<img src="/img/grey_arrow.png" alt title width="20" style />
Rare skin diseases <br/>
<img src="/img/grey_arrow.png" alt title width="20" style />
Rare haematological diseases <br/>
</div>
<br/>
<br/>
<div id="ExternalId">
<h3>External Ids:</h3>
<table class="borderless">
<tr>
<td width="390">
<div id="ExternalId_item_1">
<b title="Disease Ontology">Disease Ontology</b>
<sup title="Disease Ontology"> <a href="https://disease-ontology.org/?id=DOID:0080797" target="_blank">11</a></sup>
<a href="https://disease-ontology.org/?id=DOID:0080797" target="_blank">DOID:0080797</a>
</div>
<div id="ExternalId_item_2">
<b title="National Cancer Institute Thesaurus">NCIt</b>
<sup title="National Cancer Institute Thesaurus"> <a href="http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&amp;code=C4684" target="_blank">49</a></sup>
<a href="http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&amp;code=C4684" target="_blank">C4684</a>
</div>
<div id="ExternalId_item_3">
<b title="International Classification of Diseases, 10th Revision">ICD10</b>
<sup title="International Classification of Diseases, 10th Revision"> <a href="http://apps.who.int/classifications/icd10/browse/2019/en#/C86.0" target="_blank">31</a></sup>
<a href="http://apps.who.int/classifications/icd10/browse/2019/en#/C86.0" target="_blank">C86.0</a>
</div>
<div id="ExternalId_item_4">
<b title="MESH via Orphanet">MESH via Orphanet</b>
<sup title="MESH via Orphanet"><span>44</span> </sup>
<span>D054391</span>
</div>
<div id="ExternalId_item_5">
<b title="ICD10 via Orphanet">ICD10 via Orphanet</b>
<sup title="ICD10 via Orphanet"> <a href="http://apps.who.int/classifications/icd10/browse/2019/en#/C86.0" target="_blank">32</a></sup>
<a href="http://apps.who.int/classifications/icd10/browse/2019/en#/C86.0" target="_blank">C86.0</a>
</div>
</td>
<td width="390">
<div id="ExternalId_item_6">
<b title="UMLS via Orphanet">UMLS via Orphanet</b>
<sup title="UMLS via Orphanet"><span>72</span> </sup>
<span>C0392788</span>
</div>
<div id="ExternalId_item_7">
<b title="Orphanet">Orphanet</b>
<sup title="Orphanet"> <a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=86879" target="_blank">58</a></sup>
<a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=86879" target="_blank">ORPHA86879</a>
</div>
<div id="ExternalId_item_8">
<b title="International Classification of Diseases, 11th Revision">ICD11</b>
<sup title="International Classification of Diseases, 11th Revision"> <a href="https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/release/11/beta/mms/684005900" target="_blank">33</a></sup>
<a href="https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/release/11/beta/mms/684005900" target="_blank">684005900</a>
</div>
<div id="ExternalId_item_9">
<b title="Unified Medical Language System">UMLS</b>
<sup title="Unified Medical Language System"><span>71</span> </sup>
<span>C0018197</span> <span>C0392788</span> <span>C0558916</span>
</div>
</td>
</tr>
</table>
</div>
</div>
</td>
</tr>
</table>
</div>
<div class="section" id="summaries">
<div class="section-header">
<div class="jump-to-section">
<select onchange="jumpToSection(this);">
<option selected="selected" value>Jump to section</option>
<option value="#aliases_descriptions">Aliases &amp; Classifications</option>
<option value="#anatomical_context">Anatomical Context</option>
<option value="#therapeutics">Drugs &amp; Therapeutics</option>
<option value="#expression_profiles">Expression</option>
<option value="#related_genes">Genes</option>
<option value="#genetic_testing">Genetic Tests</option>
<option value="#goterms">GO Terms</option>
<option value="#pathways">Pathways</option>
<option value="#publications">Publications</option>
<option value="#disorders">Related Diseases</option>
<option value="#sources">Sources</option>
<option value="#summaries">Summaries</option>
<option value="#clinical_features">Symptoms &amp; Phenotypes</option>
<option value="#genetic_variations">Variations</option>
<option value="#container">Top</option>
<option value="#footer">Bottom</option>
</select>
</div>
<div class="section-header-sources">
<a href="#sources">Sources</a>
</div>
<h2 class="title">
<span itemprop="aspect">Summaries<small> for Nasal Type Extranodal Nk/t-Cell Lymphoma</small></span>
</h2>
<div class="about-section">
<a href="/pages/info#summaries">
<img src="/img/menu/help_icon.png" alt="About this section" title="About this section" style="width:20px;margin:0px;" />
</a>
</div>
</div>
<table class="section-table">
<tr>
<td class="rhs">
<div class="section-data">
<div id="Summary">
<p> <b> <a href="https://rarediseases.info.nih.gov/diseases/7041/index" target="_blank">GARD</a>:</b>
<sup title="Genetic and Rare Diseases Information Center"> <a href="https://rarediseases.info.nih.gov/diseases/7041/index" target="_blank">19</a></sup>
Extranodal nasal NK/T cell lymphoma (NKTCL) is a rare, malignant neoplasm mainly affecting men in the fifth decade of life, that usually arises in the nose, paranasal sinuses, orbits or upper airway, and that can present with a nasal mass, nasal bleeding, nasal obstruction, palate perforation (i.e. midline perforation of the hard palate), and mid-facial and/or upper airway destructive lesions. In advanced disease stages, which are associated with a poor prognosis, NKTCL may disseminate to other organs. A few cases of NKTCL presenting primarily in the lymph nodes have also been described.</p>
<p> <b> <a href="https://www.malacards.org/pages/info#summaries" target="_blank">MalaCards based summary</a>:</b>
Nasal Type Extranodal Nk/t-Cell Lymphoma, also known as <i>nasal t/natural killer-cell lymphoma</i>, is related to <i><a href="/card/lethal_midline_granuloma" target="_blank">lethal midline granuloma</a></i> and <i><a href="/card/hemophagocytic_lymphohistiocytosis" target="_blank">hemophagocytic lymphohistiocytosis</a></i>, and has symptoms including <i>fever</i> and <i>malaise</i>. An important gene associated with Nasal Type Extranodal Nk/t-Cell Lymphoma is <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDM4C" target="_blank">KDM4C</a> (Lysine Demethylase 4C), and among its related pathways/superpathways are <i><a href="https://pathcards.genecards.org/card/nf-kappab_signaling" target="_blank">NF-kappaB Signaling</a></i> and <i><a href="https://pathcards.genecards.org/card/innate_lymphoid_cells_differentiation" target="_blank">Innate Lymphoid Cells Differentiation</a></i>. The drugs <i>Aspartic acid</i> and <i>N-Methylaspartate</i> have been mentioned in the context of this disorder. Affiliated tissues include <i>t cells</i> and <i>skin</i>.</p>
<p> <b> <a href="https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=86879" target="_blank">Orphanet</a>:</b>
<sup title="Orphanet"> <a href="https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=86879" target="_blank">58</a></sup>
Extranodal nasal NK/T cell lymphoma (NKTCL) is a rare, malignant neoplasm mainly affecting men in the fifth decade of life, that usually arises in the nose, paranasal sinuses, orbits or upper airway, and that can present with a nasal mass, nasal bleeding, nasal obstruction, palate perforation (i.e. midline perforation of the hard palate), and mid-facial and/or upper airway destructive lesions. In advanced disease stages, which are associated with a poor prognosis, NKTCL may disseminate to other organs. A few cases of NKTCL presenting primarily in the lymph nodes have also been described.</p><p> <b> <a href="https://disease-ontology.org/?id=DOID:0080797" target="_blank">Disease Ontology</a>:</b>
<sup title="Disease Ontology"> <a href="https://disease-ontology.org/?id=DOID:0080797" target="_blank">11</a></sup>
A mature T-cell and NK-cell lymphoma that is characterized by an often angiocentric and angiodestructive cellular infiltrate composed of EBV positive NK/T cells.</p>
</div>
</div>
</td>
</tr>
</table>
</div>
<div class="section" id="disorders">
<div class="section-header">
<div class="jump-to-section">
<select onchange="jumpToSection(this);">
<option selected="selected" value>Jump to section</option>
<option value="#aliases_descriptions">Aliases &amp; Classifications</option>
<option value="#anatomical_context">Anatomical Context</option>
<option value="#therapeutics">Drugs &amp; Therapeutics</option>
<option value="#expression_profiles">Expression</option>
<option value="#related_genes">Genes</option>
<option value="#genetic_testing">Genetic Tests</option>
<option value="#goterms">GO Terms</option>
<option value="#pathways">Pathways</option>
<option value="#publications">Publications</option>
<option value="#disorders">Related Diseases</option>
<option value="#sources">Sources</option>
<option value="#summaries">Summaries</option>
<option value="#clinical_features">Symptoms &amp; Phenotypes</option>
<option value="#genetic_variations">Variations</option>
<option value="#container">Top</option>
<option value="#footer">Bottom</option>
</select>
</div>
<div class="section-header-sources">
<a href="#sources">Sources</a>
</div>
<h2 class="title">
<span itemprop="aspect">Related Diseases<small> for Nasal Type Extranodal Nk/t-Cell Lymphoma</small></span>
</h2>
<div class="about-section">
<a href="/pages/info#disorders">
<img src="/img/menu/help_icon.png" alt="About this section" title="About this section" style="width:20px;margin:0px;" />
</a>
</div>
</div>
<table class="section-table">
<tr>
<td class="rhs">
<div class="section-data">
<h3>Diseases related to Nasal Type Extranodal Nk/t-Cell Lymphoma via text searches within MalaCards or GeneCards Suite gene sharing:</h3>
<span class="showmore">
(<a id="RelatedDiseases-table_SeeMore" href="javascript:showMoreTable('RelatedDiseases-table','RelatedDiseases-table_SeeMore', 'show top 50', 'showing 50, show less','collapsable')">show top 50</a>)
</span>
<span class="showmore">
(<a href="#" class="showAll" onclick="javascript: return showAll('RelatedDiseases', '339', 'RelatedDiseases-table');">show all 339</a>)
</span>
<table id="RelatedDiseases-table">
<thead>
<tr>
<th width="12">#</th>
<th>Related Disease</th>
<th width="40" title="Solr Relevance Score">Score</th>
<th>Top Affiliating Genes</th>
</tr>
</thead>
<tbody>
<tr>
<td>1</td>
<td> <a href="/card/lethal_midline_granuloma" target="_blank">lethal midline granuloma</a></td>
<td>31.8</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=lethal+midline+granuloma&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIA1&amp;keywords=lethal+midline+granuloma&amp;prefilter=diseases#diseases" title="TIA1 gene information at GeneCards" target="_blank">TIA1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=lethal+midline+granuloma&amp;prefilter=diseases#diseases" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=lethal+midline+granuloma&amp;prefilter=diseases#diseases" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD2&amp;keywords=lethal+midline+granuloma&amp;prefilter=diseases#diseases" title="CD2 gene information at GeneCards" target="_blank">CD2</a> </td>
</tr>
<tr>
<td>2</td>
<td> <a href="/card/hemophagocytic_lymphohistiocytosis" target="_blank">hemophagocytic lymphohistiocytosis</a></td>
<td>30.6</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=hemophagocytic+lymphohistiocytosis&amp;prefilter=diseases#diseases" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=hemophagocytic+lymphohistiocytosis&amp;prefilter=diseases#diseases" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> </td>
</tr>
<tr>
<td>3</td>
<td> <a href="/card/lymphomatoid_granulomatosis" target="_blank">lymphomatoid granulomatosis</a></td>
<td>30.5</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIA1&amp;keywords=lymphomatoid+granulomatosis&amp;prefilter=diseases#diseases" title="TIA1 gene information at GeneCards" target="_blank">TIA1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=lymphomatoid+granulomatosis&amp;prefilter=diseases#diseases" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> </td>
</tr>
<tr>
<td>4</td>
<td> <a href="/card/orbit_lymphoma" target="_blank">orbit lymphoma</a></td>
<td>30.4</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIA1&amp;keywords=orbit+lymphoma&amp;prefilter=diseases#diseases" title="TIA1 gene information at GeneCards" target="_blank">TIA1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=orbit+lymphoma&amp;prefilter=diseases#diseases" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> </td>
</tr>
<tr>
<td>5</td>
<td> <a href="/card/lymphoproliferative_syndrome" target="_blank">lymphoproliferative syndrome</a></td>
<td>30.3</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=lymphoproliferative+syndrome&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIA1&amp;keywords=lymphoproliferative+syndrome&amp;prefilter=diseases#diseases" title="TIA1 gene information at GeneCards" target="_blank">TIA1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=lymphoproliferative+syndrome&amp;prefilter=diseases#diseases" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> </td>
</tr>
<tr>
<td>6</td>
<td> <a href="/card/composite_lymphoma" target="_blank">composite lymphoma</a></td>
<td>30.2</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=composite+lymphoma&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDM4C&amp;keywords=composite+lymphoma&amp;prefilter=diseases#diseases" title="KDM4C gene information at GeneCards" target="_blank">KDM4C</a> </td>
</tr>
<tr>
<td>7</td>
<td> <a href="/card/lymphoma_hodgkin_classic" target="_blank">lymphoma, hodgkin, classic</a></td>
<td>30.2</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=lymphoma%2c+hodgkin%2c+classic&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIA1&amp;keywords=lymphoma%2c+hodgkin%2c+classic&amp;prefilter=diseases#diseases" title="TIA1 gene information at GeneCards" target="_blank">TIA1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDM4C&amp;keywords=lymphoma%2c+hodgkin%2c+classic&amp;prefilter=diseases#diseases" title="KDM4C gene information at GeneCards" target="_blank">KDM4C</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=lymphoma%2c+hodgkin%2c+classic&amp;prefilter=diseases#diseases" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> </td>
</tr>
<tr>
<td>8</td>
<td> <a href="/card/lymphoma_non_hodgkin_familial" target="_blank">lymphoma, non-hodgkin, familial</a></td>
<td>30.2</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=lymphoma%2c+non-hodgkin%2c+familial&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=lymphoma%2c+non-hodgkin%2c+familial&amp;prefilter=diseases#diseases" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDM4C&amp;keywords=lymphoma%2c+non-hodgkin%2c+familial&amp;prefilter=diseases#diseases" title="KDM4C gene information at GeneCards" target="_blank">KDM4C</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=lymphoma%2c+non-hodgkin%2c+familial&amp;prefilter=diseases#diseases" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> </td>
</tr>
<tr>
<td>9</td>
<td> <a href="/card/extranodal_marginal_zone_lymphoma_of_mucosa_associated_lymphoid_tissue" target="_blank">extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue</a></td>
<td>30.1</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=extranodal+marginal+zone+lymphoma+of+mucosa-associated+lymphoid+tissue&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDM4C&amp;keywords=extranodal+marginal+zone+lymphoma+of+mucosa-associated+lymphoid+tissue&amp;prefilter=diseases#diseases" title="KDM4C gene information at GeneCards" target="_blank">KDM4C</a> </td>
</tr>
<tr>
<td>10</td>
<td> <a href="/card/mature_t_cell_and_nk_cell_lymphoma" target="_blank">mature t-cell and nk-cell lymphoma</a></td>
<td>30.0</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=mature+t-cell+and+nk-cell+lymphoma&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIA1&amp;keywords=mature+t-cell+and+nk-cell+lymphoma&amp;prefilter=diseases#diseases" title="TIA1 gene information at GeneCards" target="_blank">TIA1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=mature+t-cell+and+nk-cell+lymphoma&amp;prefilter=diseases#diseases" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDM4C&amp;keywords=mature+t-cell+and+nk-cell+lymphoma&amp;prefilter=diseases#diseases" title="KDM4C gene information at GeneCards" target="_blank">KDM4C</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=mature+t-cell+and+nk-cell+lymphoma&amp;prefilter=diseases#diseases" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD2&amp;keywords=mature+t-cell+and+nk-cell+lymphoma&amp;prefilter=diseases#diseases" title="CD2 gene information at GeneCards" target="_blank">CD2</a> </td>
</tr>
<tr class="collapsable">
<td>11</td>
<td> <a href="/card/reticulosarcoma" target="_blank">reticulosarcoma</a></td>
<td>29.9</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=reticulosarcoma&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIA1&amp;keywords=reticulosarcoma&amp;prefilter=diseases#diseases" title="TIA1 gene information at GeneCards" target="_blank">TIA1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=reticulosarcoma&amp;prefilter=diseases#diseases" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> </td>
</tr>
<tr class="collapsable">
<td>12</td>
<td> <a href="/card/peripheral_nervous_system_disease" target="_blank">peripheral nervous system disease</a></td>
<td>29.9</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=peripheral+nervous+system+disease&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=peripheral+nervous+system+disease&amp;prefilter=diseases#diseases" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDM4C&amp;keywords=peripheral+nervous+system+disease&amp;prefilter=diseases#diseases" title="KDM4C gene information at GeneCards" target="_blank">KDM4C</a> </td>
</tr>
<tr class="collapsable">
<td>13</td>
<td> <a href="/card/appendix_lymphoma" target="_blank">appendix lymphoma</a></td>
<td>29.9</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=appendix+lymphoma&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIA1&amp;keywords=appendix+lymphoma&amp;prefilter=diseases#diseases" title="TIA1 gene information at GeneCards" target="_blank">TIA1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=appendix+lymphoma&amp;prefilter=diseases#diseases" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> </td>
</tr>
<tr class="collapsable">
<td>14</td>
<td> <a href="/card/mycosis_fungoides" target="_blank">mycosis fungoides</a></td>
<td>29.8</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=mycosis+fungoides&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIA1&amp;keywords=mycosis+fungoides&amp;prefilter=diseases#diseases" title="TIA1 gene information at GeneCards" target="_blank">TIA1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=mycosis+fungoides&amp;prefilter=diseases#diseases" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> </td>
</tr>
<tr class="collapsable">
<td>15</td>
<td> <a href="/card/panniculitis" target="_blank">panniculitis</a></td>
<td>29.8</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIA1&amp;keywords=panniculitis&amp;prefilter=diseases#diseases" title="TIA1 gene information at GeneCards" target="_blank">TIA1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=panniculitis&amp;prefilter=diseases#diseases" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=panniculitis&amp;prefilter=diseases#diseases" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> </td>
</tr>
<tr class="collapsable">
<td>16</td>
<td> <a href="/card/primary_cutaneous_t_cell_non_hodgkin_lymphoma" target="_blank">primary cutaneous t-cell non-hodgkin lymphoma</a></td>
<td>29.8</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=primary+cutaneous+t-cell+non-hodgkin+lymphoma&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIA1&amp;keywords=primary+cutaneous+t-cell+non-hodgkin+lymphoma&amp;prefilter=diseases#diseases" title="TIA1 gene information at GeneCards" target="_blank">TIA1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDM4C&amp;keywords=primary+cutaneous+t-cell+non-hodgkin+lymphoma&amp;prefilter=diseases#diseases" title="KDM4C gene information at GeneCards" target="_blank">KDM4C</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=primary+cutaneous+t-cell+non-hodgkin+lymphoma&amp;prefilter=diseases#diseases" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> </td>
</tr>
<tr class="collapsable">
<td>17</td>
<td> <a href="/card/pfeiffer_syndrome" target="_blank">pfeiffer syndrome</a></td>
<td>29.8</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=pfeiffer+syndrome&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=pfeiffer+syndrome&amp;prefilter=diseases#diseases" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> </td>
</tr>
<tr class="collapsable">
<td>18</td>
<td> <a href="/card/t_cell_acute_lymphoblastic_leukemia" target="_blank">t-cell acute lymphoblastic leukemia</a></td>
<td>29.8</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=t-cell+acute+lymphoblastic+leukemia&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDM4C&amp;keywords=t-cell+acute+lymphoblastic+leukemia&amp;prefilter=diseases#diseases" title="KDM4C gene information at GeneCards" target="_blank">KDM4C</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD2&amp;keywords=t-cell+acute+lymphoblastic+leukemia&amp;prefilter=diseases#diseases" title="CD2 gene information at GeneCards" target="_blank">CD2</a> </td>
</tr>
<tr class="collapsable">
<td>19</td>
<td> <a href="/card/lymphoproliferative_syndrome_x_linked_1" target="_blank">lymphoproliferative syndrome, x-linked, 1</a></td>
<td>29.7</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=lymphoproliferative+syndrome%2c+x-linked%2c+1&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIA1&amp;keywords=lymphoproliferative+syndrome%2c+x-linked%2c+1&amp;prefilter=diseases#diseases" title="TIA1 gene information at GeneCards" target="_blank">TIA1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=lymphoproliferative+syndrome%2c+x-linked%2c+1&amp;prefilter=diseases#diseases" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> </td>
</tr>
<tr class="collapsable">
<td>20</td>
<td> <a href="/card/adult_t_cell_leukemia_lymphoma" target="_blank">adult t-cell leukemia/lymphoma</a></td>
<td>29.7</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=adult+t-cell+leukemia%2flymphoma&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDM4C&amp;keywords=adult+t-cell+leukemia%2flymphoma&amp;prefilter=diseases#diseases" title="KDM4C gene information at GeneCards" target="_blank">KDM4C</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD2&amp;keywords=adult+t-cell+leukemia%2flymphoma&amp;prefilter=diseases#diseases" title="CD2 gene information at GeneCards" target="_blank">CD2</a> </td>
</tr>
<tr class="collapsable">
<td>21</td>
<td> <a href="/card/angioimmunoblastic_t_cell_lymphoma" target="_blank">angioimmunoblastic t-cell lymphoma</a></td>
<td>29.6</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=angioimmunoblastic+t-cell+lymphoma&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIA1&amp;keywords=angioimmunoblastic+t-cell+lymphoma&amp;prefilter=diseases#diseases" title="TIA1 gene information at GeneCards" target="_blank">TIA1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDM4C&amp;keywords=angioimmunoblastic+t-cell+lymphoma&amp;prefilter=diseases#diseases" title="KDM4C gene information at GeneCards" target="_blank">KDM4C</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD2&amp;keywords=angioimmunoblastic+t-cell+lymphoma&amp;prefilter=diseases#diseases" title="CD2 gene information at GeneCards" target="_blank">CD2</a> </td>
</tr>
<tr class="collapsable">
<td>22</td>
<td> <a href="/card/myeloma_multiple" target="_blank">myeloma, multiple</a></td>
<td>29.5</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=myeloma%2c+multiple&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=myeloma%2c+multiple&amp;prefilter=diseases#diseases" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDM4C&amp;keywords=myeloma%2c+multiple&amp;prefilter=diseases#diseases" title="KDM4C gene information at GeneCards" target="_blank">KDM4C</a> </td>
</tr>
<tr class="collapsable">
<td>23</td>
<td> <a href="/card/myelodysplastic_syndrome" target="_blank">myelodysplastic syndrome</a></td>
<td>29.5</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=myelodysplastic+syndrome&amp;prefilter=diseases#diseases" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDM4C&amp;keywords=myelodysplastic+syndrome&amp;prefilter=diseases#diseases" title="KDM4C gene information at GeneCards" target="_blank">KDM4C</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=myelodysplastic+syndrome&amp;prefilter=diseases#diseases" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> </td>
</tr>
<tr class="collapsable">
<td>24</td>
<td> <a href="/card/skin_disease" target="_blank">skin disease</a></td>
<td>29.4</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=skin+disease&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=skin+disease&amp;prefilter=diseases#diseases" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDM4C&amp;keywords=skin+disease&amp;prefilter=diseases#diseases" title="KDM4C gene information at GeneCards" target="_blank">KDM4C</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=skin+disease&amp;prefilter=diseases#diseases" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> </td>
</tr>
<tr class="collapsable">
<td>25</td>
<td> <a href="/card/celiac_disease_1" target="_blank">celiac disease 1</a></td>
<td>29.4</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=celiac+disease+1&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIA1&amp;keywords=celiac+disease+1&amp;prefilter=diseases#diseases" title="TIA1 gene information at GeneCards" target="_blank">TIA1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=celiac+disease+1&amp;prefilter=diseases#diseases" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=celiac+disease+1&amp;prefilter=diseases#diseases" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> </td>
</tr>
<tr class="collapsable">
<td>26</td>
<td> <a href="/card/sezarys_disease" target="_blank">sezary&#39;s disease</a></td>
<td>29.4</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=sezary%27s+disease&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIA1&amp;keywords=sezary%27s+disease&amp;prefilter=diseases#diseases" title="TIA1 gene information at GeneCards" target="_blank">TIA1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=sezary%27s+disease&amp;prefilter=diseases#diseases" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD2&amp;keywords=sezary%27s+disease&amp;prefilter=diseases#diseases" title="CD2 gene information at GeneCards" target="_blank">CD2</a> </td>
</tr>
<tr class="collapsable">
<td>27</td>
<td> <a href="/card/leukemia_chronic_lymphocytic" target="_blank">leukemia, chronic lymphocytic</a></td>
<td>29.4</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=leukemia%2c+chronic+lymphocytic&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=leukemia%2c+chronic+lymphocytic&amp;prefilter=diseases#diseases" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDM4C&amp;keywords=leukemia%2c+chronic+lymphocytic&amp;prefilter=diseases#diseases" title="KDM4C gene information at GeneCards" target="_blank">KDM4C</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=leukemia%2c+chronic+lymphocytic&amp;prefilter=diseases#diseases" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD2&amp;keywords=leukemia%2c+chronic+lymphocytic&amp;prefilter=diseases#diseases" title="CD2 gene information at GeneCards" target="_blank">CD2</a> </td>
</tr>
<tr class="collapsable">
<td>28</td>
<td> <a href="/card/peripheral_t_cell_lymphoma" target="_blank">peripheral t-cell lymphoma</a></td>
<td>29.1</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=peripheral+t-cell+lymphoma&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIA1&amp;keywords=peripheral+t-cell+lymphoma&amp;prefilter=diseases#diseases" title="TIA1 gene information at GeneCards" target="_blank">TIA1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=peripheral+t-cell+lymphoma&amp;prefilter=diseases#diseases" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDM4C&amp;keywords=peripheral+t-cell+lymphoma&amp;prefilter=diseases#diseases" title="KDM4C gene information at GeneCards" target="_blank">KDM4C</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=peripheral+t-cell+lymphoma&amp;prefilter=diseases#diseases" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD2&amp;keywords=peripheral+t-cell+lymphoma&amp;prefilter=diseases#diseases" title="CD2 gene information at GeneCards" target="_blank">CD2</a> </td>
</tr>
<tr class="collapsable">
<td>29</td>
<td> <a href="/card/primary_cutaneous_gamma_delta_t_cell_lymphoma" target="_blank">primary cutaneous gamma-delta t-cell lymphoma</a></td>
<td>29.0</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=primary+cutaneous+gamma-delta+t-cell+lymphoma&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIA1&amp;keywords=primary+cutaneous+gamma-delta+t-cell+lymphoma&amp;prefilter=diseases#diseases" title="TIA1 gene information at GeneCards" target="_blank">TIA1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=primary+cutaneous+gamma-delta+t-cell+lymphoma&amp;prefilter=diseases#diseases" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=primary+cutaneous+gamma-delta+t-cell+lymphoma&amp;prefilter=diseases#diseases" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD2&amp;keywords=primary+cutaneous+gamma-delta+t-cell+lymphoma&amp;prefilter=diseases#diseases" title="CD2 gene information at GeneCards" target="_blank">CD2</a> </td>
</tr>
<tr class="collapsable">
<td>30</td>
<td> <a href="/card/leukemia_acute_lymphoblastic" target="_blank">leukemia, acute lymphoblastic</a></td>
<td>28.8</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=leukemia%2c+acute+lymphoblastic&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=leukemia%2c+acute+lymphoblastic&amp;prefilter=diseases#diseases" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDM4C&amp;keywords=leukemia%2c+acute+lymphoblastic&amp;prefilter=diseases#diseases" title="KDM4C gene information at GeneCards" target="_blank">KDM4C</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD2&amp;keywords=leukemia%2c+acute+lymphoblastic&amp;prefilter=diseases#diseases" title="CD2 gene information at GeneCards" target="_blank">CD2</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=ASPG&amp;keywords=leukemia%2c+acute+lymphoblastic&amp;prefilter=diseases#diseases" title="ASPG gene information at GeneCards" target="_blank">ASPG</a> </td>
</tr>
<tr class="collapsable">
<td>31</td>
<td> <a href="/card/aggressive_nk_cell_leukemia_2" target="_blank">aggressive nk-cell leukemia</a></td>
<td>28.3</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=aggressive+nk-cell+leukemia&amp;prefilter=diseases#diseases" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIA1&amp;keywords=aggressive+nk-cell+leukemia&amp;prefilter=diseases#diseases" title="TIA1 gene information at GeneCards" target="_blank">TIA1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=aggressive+nk-cell+leukemia&amp;prefilter=diseases#diseases" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=aggressive+nk-cell+leukemia&amp;prefilter=diseases#diseases" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD2&amp;keywords=aggressive+nk-cell+leukemia&amp;prefilter=diseases#diseases" title="CD2 gene information at GeneCards" target="_blank">CD2</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=ASPG&amp;keywords=aggressive+nk-cell+leukemia&amp;prefilter=diseases#diseases" title="ASPG gene information at GeneCards" target="_blank">ASPG</a> </td>
</tr>
<tr class="collapsable">
<td>32</td>
<td> <a href="/card/fibrosarcoma_of_bone" target="_blank">fibrosarcoma of bone</a></td>
<td>11.6</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=&amp;keywords=fibrosarcoma+of+bone&amp;prefilter=diseases#diseases" title=" gene information at GeneCards" target="_blank"></a> </td>
</tr>
<tr class="collapsable">
<td>33</td>
<td> <a href="/card/lymphoma" target="_blank">lymphoma</a></td>
<td>10.7</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=&amp;keywords=lymphoma&amp;prefilter=diseases#diseases" title=" gene information at GeneCards" target="_blank"></a> </td>
</tr>
<tr class="collapsable">
<td>34</td>
<td> <a href="/card/burkitt_lymphoma" target="_blank">burkitt lymphoma</a></td>
<td>10.7</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=&amp;keywords=burkitt+lymphoma&amp;prefilter=diseases#diseases" title=" gene information at GeneCards" target="_blank"></a> </td>
</tr>
<tr class="collapsable">
<td>35</td>
<td> <a href="/card/polymorphic_reticulosis" target="_blank">polymorphic reticulosis</a></td>
<td>10.6</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=&amp;keywords=polymorphic+reticulosis&amp;prefilter=diseases#diseases" title=" gene information at GeneCards" target="_blank"></a> </td>
</tr>
<tr class="collapsable">
<td>36</td>
<td> <a href="/card/rare_tumor" target="_blank">rare tumor</a></td>
<td>10.5</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=&amp;keywords=rare+tumor&amp;prefilter=diseases#diseases" title=" gene information at GeneCards" target="_blank"></a> </td>
</tr>
<tr class="collapsable">
<td>37</td>
<td> <a href="/card/aplastic_anemia" target="_blank">aplastic anemia</a></td>
<td>10.5</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=&amp;keywords=aplastic+anemia&amp;prefilter=diseases#diseases" title=" gene information at GeneCards" target="_blank"></a> </td>
</tr>
<tr class="collapsable">
<td>38</td>
<td> <a href="/card/pancytopenia" target="_blank">pancytopenia</a></td>
<td>10.5</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=&amp;keywords=pancytopenia&amp;prefilter=diseases#diseases" title=" gene information at GeneCards" target="_blank"></a> </td>
</tr>
<tr class="collapsable">
<td>39</td>
<td> <a href="/card/neuromyelitis_optica" target="_blank">neuromyelitis optica</a></td>
<td>10.5</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=&amp;keywords=neuromyelitis+optica&amp;prefilter=diseases#diseases" title=" gene information at GeneCards" target="_blank"></a> </td>
</tr>
<tr class="collapsable">
<td>40</td>
<td> <a href="/card/common_cold" target="_blank">common cold</a></td>
<td>10.5</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=&amp;keywords=common+cold&amp;prefilter=diseases#diseases" title=" gene information at GeneCards" target="_blank"></a> </td>
</tr>
<tr class="collapsable">
<td>41</td>
<td> <a href="/card/splenomegaly" target="_blank">splenomegaly</a></td>
<td>10.5</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=&amp;keywords=splenomegaly&amp;prefilter=diseases#diseases" title=" gene information at GeneCards" target="_blank"></a> </td>
</tr>
<tr class="collapsable">
<td>42</td>
<td> <a href="/card/malaria" target="_blank">malaria</a></td>
<td>10.4</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=&amp;keywords=malaria&amp;prefilter=diseases#diseases" title=" gene information at GeneCards" target="_blank"></a> </td>
</tr>
<tr class="collapsable">
<td>43</td>
<td> <a href="/card/nasal_cavity_lymphoma" target="_blank">nasal cavity lymphoma</a></td>
<td>10.4</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=&amp;keywords=nasal+cavity+lymphoma&amp;prefilter=diseases#diseases" title=" gene information at GeneCards" target="_blank"></a> </td>
</tr>
<tr class="collapsable">
<td>44</td>
<td> <a href="/card/loose_anagen_hair_syndrome" target="_blank">loose anagen hair syndrome</a></td>
<td>10.4</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=&amp;keywords=loose+anagen+hair+syndrome&amp;prefilter=diseases#diseases" title=" gene information at GeneCards" target="_blank"></a> </td>
</tr>
<tr class="collapsable">
<td>45</td>
<td> <a href="/card/tatton_brown_rahman_syndrome" target="_blank">tatton-brown-rahman syndrome</a></td>
<td>10.4</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=&amp;keywords=tatton-brown-rahman+syndrome&amp;prefilter=diseases#diseases" title=" gene information at GeneCards" target="_blank"></a> </td>
</tr>
<tr class="collapsable">
<td>46</td>
<td> <a href="/card/trisomy_x" target="_blank">trisomy x</a></td>
<td>10.4</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=&amp;keywords=trisomy+x&amp;prefilter=diseases#diseases" title=" gene information at GeneCards" target="_blank"></a> </td>
</tr>
<tr class="collapsable">
<td>47</td>
<td> <a href="/card/histiocytosis" target="_blank">histiocytosis</a></td>
<td>10.4</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=&amp;keywords=histiocytosis&amp;prefilter=diseases#diseases" title=" gene information at GeneCards" target="_blank"></a> </td>
</tr>
<tr class="collapsable">
<td>48</td>
<td> <a href="/card/factor_vii_deficiency" target="_blank">factor vii deficiency</a></td>
<td>10.4</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=&amp;keywords=factor+vii+deficiency&amp;prefilter=diseases#diseases" title=" gene information at GeneCards" target="_blank"></a> </td>
</tr>
<tr class="collapsable">
<td>49</td>
<td> <a href="/card/graft_versus_host_disease_2" target="_blank">graft-versus-host disease</a></td>
<td>10.4</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=&amp;keywords=graft-versus-host+disease&amp;prefilter=diseases#diseases" title=" gene information at GeneCards" target="_blank"></a> </td>
</tr>
<tr class="collapsable">
<td>50</td>
<td> <a href="/card/allergic_disease" target="_blank">allergic disease</a></td>
<td>10.4</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=&amp;keywords=allergic+disease&amp;prefilter=diseases#diseases" title=" gene information at GeneCards" target="_blank"></a> </td>
</tr>
</tbody>
</table>
<br/>
</div>
<div class="section-data">
<div class="expression-images" id="network-image">
<h3 title="Line thickness- association strength&#013;Red lines - direct connections of current disease&#013;Grey lines - indirect connections">
Graphical network of the top 20 diseases related to Nasal Type Extranodal Nk/t-Cell Lymphoma:
</h3>
<br/>
<br/>
<img src="http://malacards.blob.core.windows.net/network-images-v5-17-5/nasal_type_extranodal_nk_t_cell_lymphoma_related_diseases.jpg" width="100%" alt="Diseases related to Nasal Type Extranodal Nk/t-Cell Lymphoma" title="Diseases related to Nasal Type Extranodal Nk/t-Cell Lymphoma" />
</div>
</div>
</td>
</tr>
</table>
</div>
<div class="section" id="clinical_features">
<div class="section-header">
<div class="jump-to-section">
<select onchange="jumpToSection(this);">
<option selected="selected" value>Jump to section</option>
<option value="#aliases_descriptions">Aliases &amp; Classifications</option>
<option value="#anatomical_context">Anatomical Context</option>
<option value="#therapeutics">Drugs &amp; Therapeutics</option>
<option value="#expression_profiles">Expression</option>
<option value="#related_genes">Genes</option>
<option value="#genetic_testing">Genetic Tests</option>
<option value="#goterms">GO Terms</option>
<option value="#pathways">Pathways</option>
<option value="#publications">Publications</option>
<option value="#disorders">Related Diseases</option>
<option value="#sources">Sources</option>
<option value="#summaries">Summaries</option>
<option value="#clinical_features">Symptoms &amp; Phenotypes</option>
<option value="#genetic_variations">Variations</option>
<option value="#container">Top</option>
<option value="#footer">Bottom</option>
</select>
</div>
<div class="section-header-sources">
<a href="#sources">Sources</a>
</div>
<h2 class="title">
<span itemprop="aspect">Symptoms &amp; Phenotypes<small> for Nasal Type Extranodal Nk/t-Cell Lymphoma</small></span>
</h2>
<div class="about-section">
<a href="/pages/info#clinical_features">
<img src="/img/menu/help_icon.png" alt="About this section" title="About this section" style="width:20px;margin:0px;" />
</a>
</div>
</div>
<table class="section-table">
<tr>
<td class="rhs">
<div class="section-data">
<div id="Symptoms">
</div>
<div>
<div class="symptoms_div">
<h3>UMLS symptoms related to Nasal Type Extranodal Nk/t-Cell Lymphoma:</h3>
<br/>
<span itemprop="signOrSymptom" itemscope="itemscope" itemtype="http://schema.org/MedicalSymptom">
<span itemprop="name">
<span>fever;</span>
</span>
</span>
<span itemprop="signOrSymptom" itemscope="itemscope" itemtype="http://schema.org/MedicalSymptom">
<span itemprop="name">
<span>malaise</span>
</span>
</span>
</div>
</div>
</div>
</td>
</tr>
</table>
</div>
<div class="section" id="therapeutics">
<div class="section-header">
<div class="jump-to-section">
<select onchange="jumpToSection(this);">
<option selected="selected" value>Jump to section</option>
<option value="#aliases_descriptions">Aliases &amp; Classifications</option>
<option value="#anatomical_context">Anatomical Context</option>
<option value="#therapeutics">Drugs &amp; Therapeutics</option>
<option value="#expression_profiles">Expression</option>
<option value="#related_genes">Genes</option>
<option value="#genetic_testing">Genetic Tests</option>
<option value="#goterms">GO Terms</option>
<option value="#pathways">Pathways</option>
<option value="#publications">Publications</option>
<option value="#disorders">Related Diseases</option>
<option value="#sources">Sources</option>
<option value="#summaries">Summaries</option>
<option value="#clinical_features">Symptoms &amp; Phenotypes</option>
<option value="#genetic_variations">Variations</option>
<option value="#container">Top</option>
<option value="#footer">Bottom</option>
</select>
</div>
<div class="section-header-sources">
<a href="#sources">Sources</a>
</div>
<h2 class="title">
<span itemprop="aspect">Drugs &amp; Therapeutics<small> for Nasal Type Extranodal Nk/t-Cell Lymphoma</small></span>
</h2>
<div class="about-section">
<a href="/pages/info#therapeutics">
<img src="/img/menu/help_icon.png" alt="About this section" title="About this section" style="width:20px;margin:0px;" />
</a>
</div>
</div>
<table class="section-table">
<tr>
<td class="rhs">
<div class="section-data">
<h3>Drugs for Nasal Type Extranodal Nk/t-Cell Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):</h3>
<span class="showmore">
(<a id="MaladiesUnifiedCompounds-table_SeeMore" href="javascript:showMoreTable('MaladiesUnifiedCompounds-table','MaladiesUnifiedCompounds-table_SeeMore', 'show top 50', 'showing 50, show less','collapsable')">show top 50</a>)
</span>
<span class="showmore">
(<a href="#" class="showAll" onclick="javascript: return showAll('MaladiesUnifiedCompounds', '166', 'MaladiesUnifiedCompounds-table');">show all 166</a>)
</span>
<br/>
<table id="MaladiesUnifiedCompounds-table" style="table-layout:fixed;">
<thead>
<tr>
<th width="12">#</th>
<td width="18" class="unified_drug_open_all" title="Expand to show all"></td>
<th width="150">Name</th>
<th width="100">Status</th>
<th width="90">Phase</th>
<th width="30">Clinical Trials</th>
<th width="60">Cas Number</th>
<th width="60">PubChem Id</th>
</tr>
</thead>
<tbody>
<tr>
<td>1</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Unknown status">Aspartic acid</td>
<td>Approved, Nutraceutical</td>
<td>Phase 4</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Aspartic+acid%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>56-84-8</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/5960" target="_blank">5960</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>(+)-Aspartate</div>
<div>(+)-Aspartic acid</div>
<div>(+-)-Aspartic acid</div>
<div>(2S)-2-AMINOBUTANEDIOIC ACID</div>
<div>(2S)-2-AMINOSUCCINIC ACID</div>
<div>(2S)-Aspartate</div>
<div>(2S)-Aspartic acid</div>
<div>(L)-Aspartate</div>
<div>(L)-Aspartic acid</div>
<div>(R)-2-Aminosuccinate</div>
<div>(R,S)-Aspartic acid</div>
<div>(S)-(+)-Aspartate</div>
<div>(S)-(+)-Aspartic acid</div>
<div>(S)-2-Aminobutanedioate</div>
<div>(S)-2-Aminobutanedioic acid</div>
<div>(S)-2-Aminosuccinate</div>
<div>(S)-2-Aminosuccinic acid</div>
<div>(S)-Aminobutanedioate</div>
<div>(S)-Amino-butanedioate</div>
<div>(S)-Aminobutanedioic acid</div>
<div>(S)-Amino-butanedioic acid</div>
<div>(S)-Aspartate</div>
<div>(S)-Aspartic acid</div>
<div>[&lt;sup&gt;3&lt;/sup&gt;H]-L-aspartate</div>
<div>[&lt;sup&gt;3&lt;/sup&gt;H]-L-aspartic acid</div>
<div>2-Amino-3-methylsuccinate</div>
<div>2-Amino-3-methylsuccinic acid</div>
<div>2-Aminosuccinate</div>
<div>2-Aminosuccinic acid</div>
<div>&#225;cido asp&#225;rtico</div>
<div>Acidum asparticum</div>
<div>alpha-Aminosuccinate</div>
<div>alpha-Aminosuccinic acid</div>
<div>Aminosuccinate</div>
<div>Ammonium aspartate</div>
<div>Asp</div>
<div>Asparagate</div>
<div>Asparagic acid</div>
<div>Asparaginate</div>
<div>Asparaginic acid</div>
<div>Asparatate</div>
<div>ASPARTate</div>
<div>Aspartate magnesium hydrochloride</div>
<div>Aspartate, ammonium</div>
<div>Aspartate, calcium</div>
<div>Aspartate, dipotassium</div>
<div>Aspartate, disodium</div>
<div>Aspartate, magnesium</div>
<div>Aspartate, monopotassium</div>
<div>Aspartate, monosodium</div>
<div>Aspartate, potassium</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Aspartate, sodium</div>
<div>ASPARTIC ACID</div>
<div>Aspartic acid, ammonium salt</div>
<div>Aspartic acid, calcium salt</div>
<div>Aspartic acid, dipotassium salt</div>
<div>Aspartic acid, disodium salt</div>
<div>Aspartic acid, hydrobromide</div>
<div>Aspartic acid, hydrochloride</div>
<div>Aspartic acid, magnesium (1:1) salt, hydrochloride, trihydrate</div>
<div>Aspartic acid, magnesium (2:1) salt</div>
<div>Aspartic acid, magnesium-potassium (2:1:2) salt</div>
<div>Aspartic acid, monopotassium salt</div>
<div>Aspartic acid, monosodium salt</div>
<div>Aspartic acid, potassium salt</div>
<div>Aspartic acid, sodium salt</div>
<div>Calcium aspartate</div>
<div>D</div>
<div>Dipotassium aspartate</div>
<div>Disodium aspartate</div>
<div>FEMA NO. 3656</div>
<div>H-Asp-OH</div>
<div>Hydrobromide aspartic acid</div>
<div>Hydrochloride aspartic acid</div>
<div>Hydrochloride, aspartate magnesium</div>
<div>L Aspartate</div>
<div>L Aspartic acid</div>
<div>L-(+)-Aspartate</div>
<div>L-(+)-Aspartic acid</div>
<div>L-Aminosuccinate</div>
<div>L-Aminosuccinic acid</div>
<div>L-Asp</div>
<div>L-Asparagate</div>
<div>L-Asparagic acid</div>
<div>L-Asparaginate</div>
<div>L-Asparaginic acid</div>
<div>L-Asparaginsaeure</div>
<div>L-ASPARAGINS&#196;URE</div>
<div>L-Aspartate</div>
<div>L-ASPARTIC ACID</div>
<div>Magnesiocard</div>
<div>Magnesium aspartate</div>
<div>MG 5 Longoral</div>
<div>MG5Longoral</div>
<div>MG-5-Longoral</div>
<div>Monopotassium aspartate</div>
<div>Monosodium aspartate</div>
<div>NSC-3973</div>
<div>Poly-DL-succinimide</div>
<div>Polysuccinimide</div>
<div>Potassium aspartate</div>
<div>Sodium aspartate</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td>2</td>
<td>
</td>
<td title="Unknown status">N-Methylaspartate</td>
<td></td>
<td>Phase 4</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22N-Methylaspartate%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td></td>
<td>
</td>
</tr>
<tr>
<td>3</td>
<td>
</td>
<td title="Unknown status">Antibodies, Blocking</td>
<td></td>
<td>Phase 4</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Antibodies%2c+Blocking%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td></td>
<td>
</td>
</tr>
<tr>
<td>4</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Unknown status">protease inhibitors</td>
<td></td>
<td>Phase 4</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22protease+inhibitors%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td></td>
<td>
</td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>protease inhibitors</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td>5</td>
<td>
</td>
<td title="Unknown status">Dexamethasone 21-phosphate</td>
<td></td>
<td>Phase 4</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Dexamethasone+21-phosphate%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td></td>
<td>
</td>
</tr>
<tr class="collapsable">
<td>6</td>
<td>
</td>
<td title="Unknown status">Radiation-Protective Agents</td>
<td></td>
<td>Phase 4</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Radiation-Protective+Agents%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td></td>
<td>
</td>
</tr>
<tr class="collapsable">
<td>7</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Unknown status">Thalidomide</td>
<td>Approved, Investigational, Withdrawn</td>
<td>Phase 3</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Thalidomide%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>50-35-1</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/5426" target="_blank">5426</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>(+-)-N-(2,6-DIOXO-3-PIPERIDYL)PHTHALIMIDE</div>
<div>(+-)-THALIDOMIDE</div>
<div>(&#177;)-N-(2,6-DIOXO-3-PIPERIDYL)PHTHALIMIDE</div>
<div>(&#177;)-THALIDOMIDE</div>
<div>1,3-DIOXO-2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE</div>
<div>2,6-DIOXO-3-PHTHALIMIDOPIPERIDINE</div>
<div>3-PHTHALIMIDOGLUTARIMIDE</div>
<div>Algosediv</div>
<div>ALPHA-(N-PHTHALIMIDO)GLUTARIMIDE</div>
<div>ALPHA-N-PHTHALYLGLUTARAMIDE</div>
<div>alpha-Phthalimidoglutarimide</div>
<div>Asidon 3</div>
<div>Asmadion</div>
<div>Asmaval</div>
<div>Bonbrain</div>
<div>Bonbrrin</div>
<div>Calmore</div>
<div>Calmorex</div>
<div>Celgene brand OF thalidomide</div>
<div>Contergan</div>
<div>Corronarobetin</div>
<div>Distaval</div>
<div>Distaxal</div>
<div>Distoval</div>
<div>Ectiluran</div>
<div>Enterosediv</div>
<div>Gastrinide</div>
<div>Glupan</div>
<div>Glutanon</div>
<div>Grippex</div>
<div>Hippuzon</div>
<div>Imida-Lab</div>
<div>Imidan</div>
<div>Imidene</div>
<div>Isomin</div>
<div>K-17</div>
<div>Kedavon</div>
<div>Kevadon</div>
<div>Lulamin</div>
<div>N-(2,6-DIOXO-3-PIPERIDYL)PHTHALIMIDE</div>
<div>Neaufatin</div>
<div>Neo</div>
<div>Neosedyn</div>
<div>Neosydyn</div>
<div>Nerosedyn</div>
<div>Neufatin</div>
<div>Neurodyn</div>
<div>Neurosedin</div>
<div>Neurosedym</div>
<div>Neurosedyn</div>
<div>Nevrodyn</div>
<div>Nibrol</div>
<div>Noctosediv</div>
<div>Noxodyn</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>N-Phthalimidoglutamic acid imide</div>
<div>N-Phthaloylglutamimide</div>
<div>N-Phthalylglutamic acid imide</div>
<div>N-PHTHALYL-GLUTAMINSAEURE-IMID</div>
<div>NSC-527179</div>
<div>NSC-66847</div>
<div>Pangul</div>
<div>Pantosediv</div>
<div>Poly-Giron</div>
<div>Polygripan</div>
<div>Predni-Sediv</div>
<div>Pro-ban M</div>
<div>Profarmil</div>
<div>Psycholiquid</div>
<div>Psychotablets</div>
<div>Quetimid</div>
<div>Quietoplex</div>
<div>Sandormin</div>
<div>Sedalis</div>
<div>Sedalis sedi-lab</div>
<div>Sedimide</div>
<div>Sedin</div>
<div>Sedisperil</div>
<div>Sedoval</div>
<div>Shin-naito S</div>
<div>Shinnibrol</div>
<div>Sleepan</div>
<div>Slipro</div>
<div>Softenil</div>
<div>Softenon</div>
<div>Talargan</div>
<div>TALIDEX</div>
<div>TALIDOMIDA</div>
<div>Talimol</div>
<div>Talismol</div>
<div>Telagan</div>
<div>Telargan</div>
<div>Telargean</div>
<div>Tensival</div>
<div>Thaled</div>
<div>Thalidomide</div>
<div>THALIDOMIDUM</div>
<div>Thalidomine usp26</div>
<div>Thalin</div>
<div>Thalinette</div>
<div>Thalomid</div>
<div>Theophilcholine</div>
<div>Valgis</div>
<div>Valgraine</div>
<div>Yodomin</div>
<div>-(N-PHTHALIMIDO)GLUTARIMIDE</div>
<div>-N-PHTHALYLGLUTARAMIDE</div>
<div>-PHTHALIMIDOGLUTARIMIDE</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>8</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Active, not recruiting">Methotrexate</td>
<td>Approved</td>
<td>Phase 3</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Methotrexate%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>1959-05-2, 59-05-2</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/4112" target="_blank">4112</a> <a href="https://pubchem.ncbi.nlm.nih.gov/compound/126941" target="_blank">126941</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>[&lt;sup&gt;3&lt;/sup&gt;H]-methotrexate</div>
<div>2-[(4-{[(4-amino-2-imino-2,3-dihydropteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioate</div>
<div>4-Amino-10-methylfolate</div>
<div>4-Amino-10-methylfolic acid</div>
<div>4-Amino-N(10)-methylpteroylglutamate</div>
<div>4-Amino-N(10)-methylpteroylglutamic acid</div>
<div>ABITREXATE</div>
<div>Abitrexate&amp;reg;</div>
<div>Amethopterin</div>
<div>Amethopterine</div>
<div>Antifolan</div>
<div>Arbitrexate</div>
<div>CL-14377</div>
<div>Dicesium salt methotrexate</div>
<div>EBETREX</div>
<div>EMT-25299</div>
<div>Emtexate</div>
<div>EMTEXATE HIGH-POT</div>
<div>EMTEXATE PF</div>
<div>Emtexic acid</div>
<div>FOLEX</div>
<div>HDMTX</div>
<div>Hydrate, methotrexate</div>
<div>L-Amethopterin</div>
<div>Ledertrexate</div>
<div>Ledertrexic acid</div>
<div>MAXTREX</div>
<div>Metatrexan</div>
<div>Methopterin</div>
<div>Methotextrate</div>
<div>Methotrate</div>
<div>Methotrexat</div>
<div>Methotrexate</div>
<div>M&#201;THOTREXATE</div>
<div>Methotrexate hydrate</div>
<div>Methotrexate sodium</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Methotrexate, (D)-isomer</div>
<div>Methotrexate, (DL)-isomer</div>
<div>Methotrexate, dicesium salt</div>
<div>Methotrexate, disodium salt</div>
<div>Methotrexate, sodium salt</div>
<div>Methotrexatum</div>
<div>Methotrexic acid</div>
<div>Methylaminopterin</div>
<div>Methylaminopterinum</div>
<div>METOJECT</div>
<div>Metotrexato</div>
<div>Mexate</div>
<div>MEXATE-AQ</div>
<div>MTX</div>
<div>N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamate</div>
<div>N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid</div>
<div>N-Bismethylpteroylglutamic acid</div>
<div>Nordimet&amp;reg;</div>
<div>NSC-740</div>
<div>Otrexup</div>
<div>OTREXUP PFS</div>
<div>R-9985</div>
<div>RASUVO</div>
<div>Rasuvo&amp;reg;</div>
<div>Rheumatrex</div>
<div>R-METHOTREXATE</div>
<div>Sodium, methotrexate</div>
<div>TCMDC-123832</div>
<div>TCMDC-125488</div>
<div>TCMDC-125858</div>
<div>TCMDC-125858TCMDC-125488TCMDC-123832Methotrexate</div>
<div>TCMDC-125858TCMDC-125488TCMDC-123832Methotrexic acid</div>
<div>Trexall</div>
<div>Xatmep</div>
<div>ZLATAL</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>9</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Active, not recruiting">Asparaginase Escherichia coli</td>
<td>Approved, Investigational</td>
<td>Phase 3</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Asparaginase+Escherichia+coli%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>9015-68-3</td>
<td>
</td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>ASPARAGINASE</div>
<div>Asparaginase (E. coli)</div>
<div>COLASPASE</div>
<div>CRASNITIN</div>
<div>ELSPAR</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Escherichia coli L-asparaginase</div>
<div>L-ASPARAGINASE</div>
<div>L-asparagine amidohydrolase</div>
<div>NSC-109229</div>
<div>Putative L-asparaginase precursor</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>10</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Active, not recruiting">Levoleucovorin</td>
<td>Approved, Experimental, Investigational, Nutraceutical</td>
<td>Phase 3</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Levoleucovorin%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>58-05-9, 68538-85-2, 73951-54-9</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/135403648" target="_blank">135403648</a> <a href="https://pubchem.ncbi.nlm.nih.gov/compound/149436" target="_blank">149436</a> <a href="https://pubchem.ncbi.nlm.nih.gov/compound/6006" target="_blank">6006</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate</div>
<div>(6R)-Leucovorin</div>
<div>(6R,2&#39;S)-Folinic acid</div>
<div>(6R,S)-5-Formyltetrahydrofolate</div>
<div>(6S)-5-Formyl-5,6,7,8-tetrahydrofolate</div>
<div>(6S)-5-Formyl-5,6,7,8-tetrahydrofolic acid</div>
<div>(6S)-5-Formyltetrahydrofolate</div>
<div>(6S)-5-Formyltetrahydrofolic acid</div>
<div>(6S)-Folinate</div>
<div>(6S)-Folinic acid</div>
<div>(6S)-Leucovorin</div>
<div>(S)-Leucovorin</div>
<div>[6R]-5-formyl-5,6,7,8-tetrahydrofolate</div>
<div>10-Formyl-7,8-dihydrofolate</div>
<div>10-Formyl-7,8-dihydrofolic acid</div>
<div>5 Formyltetrahydrofolate</div>
<div>5 Formyltetrahydropteroylglutamate</div>
<div>5-Formlyl-5,6,7,8-tetrahydrofolate,calcium salt</div>
<div>5-Formyl-(6S)-tetrahydrofolic acid</div>
<div>5-Formyl-5,6,7,8-tetrahydrofolate</div>
<div>5-Formyl-5,6,7,8-tetrahydrofolic acid</div>
<div>5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid</div>
<div>5-Formyltetrahydrofolate</div>
<div>5-Formyltetrahydrofolic acid</div>
<div>5-Formyltetrahydropteroylglutamate</div>
<div>5-Formyltetrahydropteroylglutamic acid</div>
<div>5-formylTHF</div>
<div>6 S Leucovorin</div>
<div>6R-Leucovorin</div>
<div>6S Leucovorin</div>
<div>6S-Leucovorin</div>
<div>6-S-Leucovorin</div>
<div>Acid, folinic</div>
<div>Acide folinique</div>
<div>Acido folinico</div>
<div>&#225;cido levofol&#237;nico</div>
<div>Calcium citrovorum factor</div>
<div>Calcium folinate</div>
<div>Calcium leucovorin</div>
<div>CF</div>
<div>Citrovorum factor</div>
<div>Dextrofolinic acid</div>
<div>Factor, citrovorum</div>
<div>Folinate</div>
<div>Folinate, calcium</div>
<div>Folinic acid</div>
<div>Folinic acid calcium salt</div>
<div>Folinic acid calcium salt USP27</div>
<div>Folinic acid SF</div>
<div>Folinic acid-SF</div>
<div>Fusilev</div>
<div>KHAPZORY</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Kunyrin</div>
<div>L(-)-5-Formyl-5,6,7,8-tetrahydrofolate</div>
<div>L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid</div>
<div>Leucal</div>
<div>Leucoverin</div>
<div>Leucovorin</div>
<div>Leucovorin calcium</div>
<div>Leucovorin folinic acid</div>
<div>Leucovorin, (D)-isomer</div>
<div>Leucovorin, (DL)-isomer</div>
<div>Leucovorin, (R)-isomer</div>
<div>Leucovorin, (S)-isomer</div>
<div>Leucovorin, calcium</div>
<div>Leucovorin, calcium (1:1) salt</div>
<div>Leucovorin, calcium (1:1) salt, (DL)-isomer</div>
<div>Leucovorin, calcium (1:1) salt, (S)-isomer</div>
<div>Leucovorin, calcium (1:1) salt, pentahydrate</div>
<div>Leucovorin, monopotassium salt, (S)-isomer</div>
<div>Leucovorin, monosodium salt</div>
<div>Leucovorin, monosodium salt, (S)-isomer</div>
<div>Leucovorinum</div>
<div>Leukovorin</div>
<div>Leukovorum</div>
<div>Levo leucovorin</div>
<div>Levofolene</div>
<div>Levofolinate</div>
<div>Levofolinic acid</div>
<div>Levoleucovorin</div>
<div>Levo-leucovorin</div>
<div>L-Folinate</div>
<div>L-Folinic acid</div>
<div>LFP-754</div>
<div>L-Leucovorin</div>
<div>L-N-[P-[[(2-amino-5-Formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-glutamic acid</div>
<div>Monosodium salt leucovorin</div>
<div>N(5)-Formyltetrahydrofolate</div>
<div>N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid</div>
<div>N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamate</div>
<div>N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid</div>
<div>N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid</div>
<div>N5-Formyl-5,6,7,8-tetrahydrofolate</div>
<div>N5-Formyl-5,6,7,8-tetrahydrofolic acid</div>
<div>N5-Formyltetrahydrofolate</div>
<div>N5-Formyltetrahydrofolic acid</div>
<div>N5-Formyl-THF</div>
<div>Pteroyl-D-glutamate</div>
<div>Rescuvolin</div>
<div>S Leucovorin</div>
<div>S-Leucovorin</div>
<div>Welcovorin</div>
<div>Wellcovorin</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>11</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Active, not recruiting">Folic acid</td>
<td>Approved, Nutraceutical, Vet_approved</td>
<td>Phase 3</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Folic+acid%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>59-30-3</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/6037" target="_blank">6037</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>(2S)-2-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)FORMAMIDO]PENTANEDIOIC ACID</div>
<div>(2S)-2-[[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]-OXO-METHYL]AMINO]PENTANEDIOIC ACID</div>
<div>(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]GLUTARIC ACID</div>
<div>(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]PENTANEDIOIC ACID</div>
<div>(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]CARBONYLAMINO]PENTANEDIOIC ACID</div>
<div>[&lt;sup&gt;3&lt;/sup&gt;H]-folic acid</div>
<div>Acide folique</div>
<div>&#225;cido f&#243;lico</div>
<div>Acidum folicum</div>
<div>Acifolic</div>
<div>Apo-Folic</div>
<div>B03BB01</div>
<div>b9, Vitamin</div>
<div>BIO SCIENCE</div>
<div>Cytofol</div>
<div>Dosfolat b activ</div>
<div>Folacid</div>
<div>Folacin</div>
<div>Folate</div>
<div>Folbal</div>
<div>Folcidin</div>
<div>Foldine</div>
<div>Folettes</div>
<div>Foliamin</div>
<div>FOLIC ACID</div>
<div>Folic acid, (D)-isomer</div>
<div>Folic acid, (DL)-isomer</div>
<div>Folic acid, calcium salt (1:1)</div>
<div>Folic acid, monopotassium salt</div>
<div>Folic acid, monosodium salt</div>
<div>Folic acid, potassium salt</div>
<div>Folic acid, sodium salt</div>
<div>FOLICARE</div>
<div>Folicet</div>
<div>Folipac</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Folsaeure</div>
<div>Folsan</div>
<div>Folsaure</div>
<div>Fols&#228;ure</div>
<div>Folsav</div>
<div>Folvite</div>
<div>Folvron</div>
<div>Incafolic</div>
<div>LEXPEC</div>
<div>Liver lactobacillus casei factor</div>
<div>Millafol</div>
<div>N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid</div>
<div>N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate</div>
<div>N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid</div>
<div>N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid</div>
<div>NATUR FLOW</div>
<div>N-Pteroyl-L-glutamate</div>
<div>N-Pteroyl-L-glutamic acid</div>
<div>NSC-3073</div>
<div>PGA</div>
<div>PRECONCEIVE</div>
<div>PteGlu</div>
<div>Pteroylglutamate</div>
<div>Pteroylglutamic acid</div>
<div>Pteroyl-L-glutamate</div>
<div>Pteroyl-L-glutamic acid</div>
<div>Pteroyl-L-monoglutamate</div>
<div>Pteroyl-L-monoglutamic acid</div>
<div>Pteroylmonoglutamic acid</div>
<div>ROCHE</div>
<div>Vitamin b9</div>
<div>Vitamin BC</div>
<div>Vitamin be</div>
<div>Vitamin m</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>12</td>
<td>
</td>
<td title="Active, not recruiting">Vitamin B Complex</td>
<td></td>
<td>Phase 3</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Vitamin+B+Complex%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td></td>
<td>
</td>
</tr>
<tr class="collapsable">
<td>13</td>
<td>
</td>
<td title="Active, not recruiting">Dermatologic Agents</td>
<td></td>
<td>Phase 3</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Dermatologic+Agents%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td></td>
<td>
</td>
</tr>
<tr class="collapsable">
<td>14</td>
<td>
</td>
<td title="Active, not recruiting">Folic Acid Antagonists</td>
<td></td>
<td>Phase 3</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Folic+Acid+Antagonists%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td></td>
<td>
</td>
</tr>
<tr class="collapsable">
<td>15</td>
<td>
</td>
<td title="Active, not recruiting">Vitamin B9</td>
<td>Nutraceutical</td>
<td>Phase 3</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Vitamin+B9%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td></td>
<td>
</td>
</tr>
<tr class="collapsable">
<td>16</td>
<td>
</td>
<td title="Active, not recruiting">Folate</td>
<td>Nutraceutical</td>
<td>Phase 3</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Folate%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td></td>
<td>
</td>
</tr>
<tr class="collapsable">
<td>17</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Unknown status">Durvalumab</td>
<td>Approved, Investigational</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Durvalumab%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>1428935-60-7</td>
<td>
</td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>DURVALUMAB</div>
<div>IMFINZI</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>MEDI4736</div>
<div>MEDI-4736</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>18</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Unknown status">Erlotinib</td>
<td>Approved, Investigational</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Erlotinib%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>183319-69-9, 183321-74-6</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/176870" target="_blank">176870</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine</div>
<div>[6,7-Bis(2-methoxy-ethoxy)quinazoline-4-yl]-(3-ethynylphenyl)amine</div>
<div>11C Erlotinib</div>
<div>11C-Erlotinib</div>
<div>CP-358</div>
<div>CP-358,774</div>
<div>CP-358774</div>
<div>CP-35877401</div>
<div>CP-358774-01</div>
<div>ERLOTINIB</div>
<div>Erlotinib HCL</div>
<div>Erlotinib hydrochloride</div>
<div>Erlotinibum</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>HCL, Erlotinib</div>
<div>Hydrochloride, erlotinib</div>
<div>N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine</div>
<div>NSC 718781</div>
<div>OSI 744</div>
<div>OSI 774</div>
<div>OSI-774</div>
<div>R 1415</div>
<div>R-1415</div>
<div>RG-1415</div>
<div>RO-508231</div>
<div>Tarceva</div>
<div>Tarceva&amp;reg;</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>19</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Unknown status">Tofacitinib</td>
<td>Approved, Investigational</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Tofacitinib%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>477600-75-2</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/9926791" target="_blank">9926791</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>550</div>
<div>CP- 690 550</div>
<div>CP 690550</div>
<div>CP-690</div>
<div>CP690,550</div>
<div>CP-690,550</div>
<div>CP-690,550 FREE BASE</div>
<div>CP690550</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>CP-690550</div>
<div>CP-690-550</div>
<div>CP-690550 FREE BASE</div>
<div>Tasocitinib</div>
<div>Tofacitinib</div>
<div>Tofacitinibum</div>
<div>XELJANZ</div>
<div>Xeljanz&amp;reg;</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>20</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Unknown status">Basiliximab</td>
<td>Approved, Investigational</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Basiliximab%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>179045-86-4</td>
<td>
</td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>BASILIXIMAB</div>
<div>CHI621</div>
<div>CHI-621</div>
<div>CHIMERIC MOUSE-HUMAN ANTICD25</div>
<div>IG GAMMA-1 CHAIN C REGION</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>L04AC02</div>
<div>SDZ-CHI-621</div>
<div>SIMULECT</div>
<div>Simulect&amp;reg;</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>21</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Unknown status">Decitabine</td>
<td>Approved, Investigational</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Decitabine%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>2353-33-5</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/451668" target="_blank">451668</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>2&#39; Deoxy 5 azacytidine</div>
<div>2&#39;-Deoxy-5-azacytidine</div>
<div>4-Amino-1-(2-deoxy-b-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one</div>
<div>4-Amino-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-S-triazin-2(1H)-one</div>
<div>4-Amino-1-(2-deoxy--D-erythro-pentofuranosyl)-S-triazin-2(1H)-one</div>
<div>5 Aza 2&#39; deoxycytidine</div>
<div>5 Azadeoxycytidine</div>
<div>5 Deoxyazacytidine</div>
<div>5-Aza-2&#39;-deoxycytidine</div>
<div>5AzadC</div>
<div>5-AzadC</div>
<div>5-Azadeoxycytidine</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>5-Deoxyazacytidine</div>
<div>Azadc</div>
<div>AzadC compound</div>
<div>Compound, azadc</div>
<div>DAC</div>
<div>Dacogen</div>
<div>Decitabina</div>
<div>Decitabine</div>
<div>Decitabine mesylate</div>
<div>Dezocitidine</div>
<div>Mesylate, decitabine</div>
<div>NSC-127716</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>22</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Completed">Melphalan</td>
<td>Approved</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Melphalan%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>148-82-3</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/4053" target="_blank">4053</a> <a href="https://pubchem.ncbi.nlm.nih.gov/compound/460612" target="_blank">460612</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>2-Amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoate</div>
<div>2-Amino-3-{4-[bis(2-chloroethyl)amino]phenyl}propanoate</div>
<div>3-(p-(Bis(2-chloroethyl)amino)phenyl)-L-alanine</div>
<div>3-p-(Di(2-chloroethyl)amino)-phenyl-L-alanine</div>
<div>4-(Bis(2-chloroethyl)amino)-L-phenylalanine</div>
<div>4-(Bis(2-chloroethyl)amino)phenylalanine</div>
<div>AIKERAN</div>
<div>ALANINE NITROGEN MUSTARD</div>
<div>Alkeran</div>
<div>CB-3025</div>
<div>L-3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine</div>
<div>Levofalan</div>
<div>L-PAM</div>
<div>L-Phenylalanine mustard</div>
<div>L-PHENYLALANINE MUSTARD (L-PAM)</div>
<div>L-SARCOLYSIN</div>
<div>L-Sarcolysine</div>
<div>L-Sarkolysin</div>
<div>Medphalan</div>
<div>MELFALAN</div>
<div>Melfalano</div>
<div>Melphalan</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Melphalanum</div>
<div>Mephalan</div>
<div>Merphalan</div>
<div>MLP673</div>
<div>Mustard, phenylalanine</div>
<div>NCI-C04853</div>
<div>NSC-241286</div>
<div>NSC-8806</div>
<div>p-Bis(b-chloroethyl)aminophenylalanine</div>
<div>p-Bis(beta-chloroethyl)aminophenylalanine</div>
<div>p-Bis(-chloroethyl)aminophenylalanine</div>
<div>p-Di-(2-chloroethyl)amino-L-phenylalanine</div>
<div>Phenylalanine mustard</div>
<div>Phenylalanine nitrogen mustard</div>
<div>p-L-Sarcolysin</div>
<div>p-N,N-Bis(2-chloroethyl)amino-L-phenylalanine</div>
<div>p-N-Bis(2-chloroethyl)amino-L-phenylalanine</div>
<div>Sarcolysin</div>
<div>Sarcolysine</div>
<div>Sarkolysin</div>
<div>SK 15673</div>
<div>SK-15673</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>23</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Completed">Mechlorethamine</td>
<td>Approved, Investigational</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Mechlorethamine%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>51-75-2</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/4033" target="_blank">4033</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>2,2&#39;-Dichloro-N-methyldiethylamine</div>
<div>b,Beta&#39;-dichlorodiethyl-N-methylamine</div>
<div>beta,Beta&#39;-dichlorodiethyl-N-methylamine</div>
<div>BIS (2-CHLOROETHYL) METHYLAMINE</div>
<div>Bis(2-chloroethyl)methylamine</div>
<div>Bis(b-chloroethyl)methylamine</div>
<div>Bis(beta-chloroethyl)methylamine</div>
<div>Bis(-chloroethyl)methylamine</div>
<div>Caryolysine</div>
<div>Chlorethazine</div>
<div>Chlormethine</div>
<div>Chlormethinum</div>
<div>Cloramin</div>
<div>Clormetina</div>
<div>Embichin</div>
<div>HN2</div>
<div>HN-2</div>
<div>Hydrochloride N-oxide, mechlorethamine</div>
<div>Hydrochloride, mechlorethamine</div>
<div>MBA</div>
<div>MECHLORETHAMINE</div>
<div>Mechlorethamine hydrochloride</div>
<div>Mechlorethamine hydrochloride N oxide</div>
<div>Mechlorethamine hydrochloride N-oxide</div>
<div>Mechlorethamine N oxide</div>
<div>Mechlorethamine N-oxide</div>
<div>Mechlorethamine oxide</div>
<div>Mechloroethamine</div>
<div>Mecloretamina</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Merck brand OF mechlorethamine hydrochloride</div>
<div>Merck frosst brand OF mechlorethamine hydrochloride</div>
<div>Methylbis(2-chloroethyl)amine</div>
<div>Methylbis(b-chloroethyl)amine</div>
<div>Methylbis(beta-chloroethyl)amine</div>
<div>Methylbis(-chloroethyl)amine</div>
<div>Methylchlorethamine</div>
<div>Mitomen</div>
<div>Mustargen</div>
<div>Mustine</div>
<div>Nitrogen mustard</div>
<div>Nitrogen mustard N oxide</div>
<div>Nitrogen mustard N-oxide</div>
<div>NITROGEN MUSTARD N-OXIDE HYDROCHLORIDE</div>
<div>Nitrogranulogen</div>
<div>Nitromin</div>
<div>N-Methyl-bis(2-chloroethyl)amine</div>
<div>N-Methyl-bis(b-chloroethyl)amine</div>
<div>N-Methyl-bis(beta-chloroethyl)amine</div>
<div>N-Methyl-bis(-chloroethyl)amine</div>
<div>N-Oxide, mechlorethamine hydrochloride</div>
<div>N-Oxide, nitrogen mustard</div>
<div>NSC 762</div>
<div>NSC-10107</div>
<div>NSC-128663</div>
<div>NSC-762</div>
<div>,beta&#39;-dichlorodiethyl-N-methylamine</div>
<div>,&#39;-DICHLORODIETHYL-N-METHYLAMINE</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>24</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Completed">Panobinostat</td>
<td>Approved, Investigational</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Panobinostat%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>404950-80-7</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/6918837" target="_blank">6918837</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>(2E)-N-HYDROXY-3-[4-({[2-(2-METHYL-1H-INDOL-3-YL)ETHYL]AMINO}METHYL)PHENYL]ACRYLAMIDE</div>
<div>FARYDAK</div>
<div>Farydak&amp;reg;</div>
<div>LBH 589</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>LBH589</div>
<div>LBH-589</div>
<div>PANOBINOSTAT</div>
<div>Panobinostatum</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>25</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Completed">Alemtuzumab</td>
<td>Approved, Investigational</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Alemtuzumab%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>216503-57-0</td>
<td>
</td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>ALEMTUZUMAB</div>
<div>ALEMTUZUMAB (GENETICAL RECOMBINATION)</div>
<div>CAMPATH</div>
<div>campath 1H</div>
<div>CAMPATH MABCAMPATH</div>
<div>CAMPATH MABCAMPATH, LEMTRADA</div>
<div>Campath&amp;reg;</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>CAMPATH-1H</div>
<div>GZ402673</div>
<div>GZ-402673</div>
<div>LDP-03</div>
<div>LEMTRADA</div>
<div>Lemtrada&amp;reg;</div>
<div>MABCAMPATH</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>26</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Completed">Methylprednisolone</td>
<td>Approved, Vet_approved</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Methylprednisolone%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>83-43-2</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/4159" target="_blank">4159</a> <a href="https://pubchem.ncbi.nlm.nih.gov/compound/6741" target="_blank">6741</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione</div>
<div>(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione</div>
<div>(6,11)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione</div>
<div>1-Dehydro-6alpha-methylhydrocortisone</div>
<div>1-Dehydro-6a-methylhydrocortisone</div>
<div>1-Dehydro-6-methylhydrocortisone</div>
<div>6 Methylprednisolone</div>
<div>6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione</div>
<div>6alpha-Methylprednisolone</div>
<div>6a-Methyl-11b,17a,21-triol-1,4-pregnadiene-3,20-dione</div>
<div>6a-Methylprednisolone</div>
<div>6-Methylprednisolone</div>
<div>6-methyl-11,17,21-triol-1,4-pregnadiene-3,20-dione</div>
<div>6-methylprednisolone</div>
<div>Artisone-Wyeth</div>
<div>Besonia</div>
<div>Delta(1)-6alpha-Methylhydrocortisone</div>
<div>delta(1)-6a-Methylhydrocortisone</div>
<div>Dopomedrol</div>
<div>Esametone</div>
<div>Firmacort</div>
<div>J3.872E</div>
<div>Lemod</div>
<div>Medesone</div>
<div>Medixon</div>
<div>Medlone 21</div>
<div>Medrate</div>
<div>Medric acid</div>
<div>Medrol</div>
<div>Medrol Adt Pak</div>
<div>Medrol Dosepak</div>
<div>Medrol&amp;reg;</div>
<div>Medrone</div>
<div>Mesopren</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Metastab</div>
<div>Methyleneprednisolone</div>
<div>Methylprednisolon</div>
<div>Methylprednisolone</div>
<div>Methylprednisolonum</div>
<div>Methylprednisolonum [INN-Latin]</div>
<div>Metilbetasone</div>
<div>Metilprednisolona</div>
<div>Metilprednisolona [INN-Spanish]</div>
<div>Metilprednisolone</div>
<div>Metilprednisolone [Dcit]</div>
<div>Metipred</div>
<div>Metrisone</div>
<div>Metrocort</div>
<div>Metysolon</div>
<div>Moderin</div>
<div>Nirypan</div>
<div>Noretona</div>
<div>NSC-19987</div>
<div>Predni N Tablinen</div>
<div>Promacortine</div>
<div>Reactenol</div>
<div>Sieropresol</div>
<div>Solomet</div>
<div>SOLU-MEDROL</div>
<div>Summicort</div>
<div>Suprametil</div>
<div>U-67590A</div>
<div>Urbason</div>
<div>Urbasone</div>
<div>Wyacort</div>
<div>(1)-6a-methylhydrocortisone</div>
<div>(1)-6-methylhydrocortisone</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>27</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Completed">Methylprednisolone hemisuccinate</td>
<td>Approved</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Methylprednisolone+hemisuccinate%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>2921-57-5</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/1875" target="_blank">1875</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Methylprednisolone hemisuccinate</div>
<div>Methylprednisolone hemisuccinic acid</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Methylprednisolone hydrogen succinate</div>
<div>Methylprednisolone succinate</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>28</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Completed">Prednisolone</td>
<td>Approved, Vet_approved</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Prednisolone%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>50-24-8</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/4894" target="_blank">4894</a> <a href="https://pubchem.ncbi.nlm.nih.gov/compound/5755" target="_blank">5755</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>(11b)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione</div>
<div>(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione</div>
<div>(11)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione</div>
<div>1,4-Pregnadiene-11b,17a,21-triol-3,20-dione</div>
<div>1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione</div>
<div>1,4-Pregnadiene-11,17,21-triol-3,20-dione</div>
<div>1,4-Pregnadiene-3,20-dione-11b,17a,21-triol</div>
<div>1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol</div>
<div>1,4-Pregnadiene-3,20-dione-11,17,21-triol</div>
<div>3,20-Dioxo-11b,17a,21-trihydroxy-1,4-pregnadiene</div>
<div>3,20-Dioxo-11beta,17alpha,21-trihydroxy-1,4-pregnadiene</div>
<div>3,20-Dioxo-11,17,21-trihydroxy-1,4-pregnadiene</div>
<div>Ak-Pred</div>
<div>Ak-Tate</div>
<div>Alphadrol</div>
<div>Articulose-50</div>
<div>Codelcortone</div>
<div>Co-Hydeltra</div>
<div>Cordrol</div>
<div>CORTALONE</div>
<div>Cotogesic</div>
<div>Cotolone</div>
<div>Decaprednil</div>
<div>Decortin H</div>
<div>DEKOTIL</div>
<div>Delcortol</div>
<div>Delta F</div>
<div>Delta(1)-Dehydrocortisol</div>
<div>Delta(1)-Dehydrohydrocortisone</div>
<div>Delta(1)-Hydrocortisone</div>
<div>DELTA.1-CORTISOL</div>
<div>Delta-Cortef</div>
<div>Deltacortenol</div>
<div>DELTACORTRIL</div>
<div>Deltacortril Enteric</div>
<div>DELTA-DEHYDROCORTISOL</div>
<div>DELTA-DEHYDROHYDROCORTISONE</div>
<div>Deltahydrocortisone</div>
<div>DELTA-HYDROCORTISONE</div>
<div>DELTALONE</div>
<div>Deltasolone</div>
<div>Delta-Stab</div>
<div>Deltisilone</div>
<div>Depo-Medrol</div>
<div>Derpo Pd</div>
<div>DESOWEN</div>
<div>Dexa-Cortidelt Hostacortin H</div>
<div>Di adreson F</div>
<div>Di-Adreson F</div>
<div>Di-adreson-F</div>
<div>DiAdresonF</div>
<div>Dicortol</div>
<div>DILACORT</div>
<div>Donisolone</div>
<div>Dydeltrone</div>
<div>Eazolin D</div>
<div>Econopred</div>
<div>Econopred Plus</div>
<div>Erbacort</div>
<div>Erbasona</div>
<div>Estilsona</div>
<div>Fernisolone</div>
<div>Fernisolone P</div>
<div>FERNISOLONE-P</div>
<div>Flamasone</div>
<div>Hostacortin H</div>
<div>HYDELTRA</div>
<div>Hydeltrasol</div>
<div>HYDELTRA-TBA</div>
<div>Hydeltrone</div>
<div>Hydrodeltalone</div>
<div>Hydrodeltisone</div>
<div>Hydroretrocortin</div>
<div>Hydroretrocortine</div>
<div>IMS904</div>
<div>Inflamase Forte</div>
<div>Inflamase Mild</div>
<div>I-Pred</div>
<div>Key-Pred</div>
<div>Klismacort</div>
<div>Lentosone</div>
<div>Lite Pred</div>
<div>Medrol</div>
<div>Medrol Acetate</div>
<div>Metacortandralone</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Methylprednisolone acetate</div>
<div>METICORTELONE</div>
<div>METI-DERM</div>
<div>Metreton</div>
<div>M-Predrol</div>
<div>NEO-DELTA-CORTEF</div>
<div>Nisolone</div>
<div>Nor-Pred T.B.A.</div>
<div>NSC-9120</div>
<div>NSC-9900</div>
<div>Ocu-Pred</div>
<div>Ocu-Pred Forte</div>
<div>Ophtho-Tate</div>
<div>ORAPRED</div>
<div>Orapred&amp;reg;</div>
<div>Panafcortelone</div>
<div>Paracortol</div>
<div>Paracotol</div>
<div>PEDIAPRED</div>
<div>Pediapred&amp;reg;</div>
<div>PEVANTI</div>
<div>POLY-PRED</div>
<div>PRDL</div>
<div>Precortalon</div>
<div>Precortancyl</div>
<div>Precortilon</div>
<div>PRECORTISYL</div>
<div>PRECORTISYL FTE</div>
<div>Pred Forte</div>
<div>Pred Mild</div>
<div>Predair</div>
<div>Predair A</div>
<div>Predair Forte</div>
<div>Predalone 50</div>
<div>Predalone T.B.A.</div>
<div>Predate</div>
<div>Predate Tba</div>
<div>Predate-50</div>
<div>Predcor-25</div>
<div>Predcor-50</div>
<div>Predcor-Tba</div>
<div>PRED-G</div>
<div>Predisolone sodium phosphate</div>
<div>PREDL</div>
<div>Predne-Dome</div>
<div>Prednelan</div>
<div>Prednicen</div>
<div>Predni-Dome</div>
<div>Predniliderm</div>
<div>Predniretard</div>
<div>Prednis</div>
<div>Prednisolona</div>
<div>Prednisolona [INN-Spanish]</div>
<div>PREDNISOLONE</div>
<div>Prednisolone acetate</div>
<div>Prednisolone sodium phosphate</div>
<div>Prednisolone tebutate</div>
<div>Prednisolonum</div>
<div>Prednisolonum [INN-Latin]</div>
<div>Predonin</div>
<div>Predonine</div>
<div>PRELONE</div>
<div>Prenolone</div>
<div>Rolisone</div>
<div>SCHERIPROCT</div>
<div>Scherisolon</div>
<div>SERVISONE</div>
<div>Solone</div>
<div>Steran</div>
<div>STERANE</div>
<div>Sterolone</div>
<div>Supercortisol</div>
<div>TRIDESILON</div>
<div>Ulacort</div>
<div>Ultra Pred</div>
<div>Ultracorten H</div>
<div>Ultracortene H</div>
<div>Ultracortene-H</div>
<div>Ultracortene-Hydrogen</div>
<div>VERDESO</div>
<div>(1)-dehydrocortisol</div>
<div>(1)-dehydrohydrocortisone</div>
<div>(1)-hydrocortisone</div>
<div>-cortef</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>29</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Completed">Prednisolone acetate</td>
<td>Approved, Vet_approved</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Prednisolone+acetate%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>52-21-1</td>
<td>
</td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>ECONOPRED</div>
<div>FLO-PRED</div>
<div>METICORTELONE</div>
<div>NSC-10966</div>
<div>OMNIPRED</div>
<div>PRED FORTE</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>PRED FTE</div>
<div>PRED MILD</div>
<div>PREDNISOLONE 21-ACETATE</div>
<div>Prednisolone acetate</div>
<div>STERANE</div>
<div>ULTRACORTENOL</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>30</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Completed">Prednisolone phosphate</td>
<td>Approved, Vet_approved</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Prednisolone+phosphate%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>302-25-0</td>
<td>
</td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Prednisolone 21-(dihydrogen phosphate)</div>
<div>Prednisolone 21-monophosphate</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Prednisolone 21-phosphate</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>31</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Completed">Everolimus</td>
<td>Approved</td>
<td>Phase 1, Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Everolimus%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>159351-69-6</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/70789204" target="_blank">70789204</a> <a href="https://pubchem.ncbi.nlm.nih.gov/compound/6442177" target="_blank">6442177</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>001, RAD</div>
<div>40-O-(2-Hydroxyethyl)-rapamycin</div>
<div>42-O-(2-HYDROXYETHYL)RAPAMYCIN</div>
<div>Afinitor</div>
<div>AFINITOR DISPERZ</div>
<div>Afinitor&amp;reg;</div>
<div>Certican</div>
<div>Certican&amp;reg;</div>
<div>EVEROLIMUS</div>
<div>&#233;v&#233;rolimus</div>
<div>RAD 001</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>RAD 666</div>
<div>RAD, SDZ</div>
<div>RAD001</div>
<div>RAD-001</div>
<div>RAD-666</div>
<div>rapamycin, 42-O-(2-hydroxyethyl)-</div>
<div>SDZ RAD</div>
<div>SDZ-RAD</div>
<div>VOTUBIA</div>
<div>ZORTRESS</div>
<div>Zortress&amp;reg;</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>32</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Completed">Sirolimus</td>
<td>Approved, Investigational</td>
<td>Phase 1, Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Sirolimus%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>53123-88-9</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/5284616" target="_blank">5284616</a> <a href="https://pubchem.ncbi.nlm.nih.gov/compound/6436030" target="_blank">6436030</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>(-)-Rapamycin</div>
<div>(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone</div>
<div>Antibiotic ay 22989</div>
<div>AY-22989</div>
<div>Fyarro&amp;reg; (sirolimus albumin-bound particles)</div>
<div>L04AA10</div>
<div>NSC-226080</div>
<div>Perceiva</div>
<div>RAPA</div>
<div>Rapammune</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Rapamune</div>
<div>Rapamune&amp;reg;</div>
<div>Rapamycin</div>
<div>Rapamysin</div>
<div>RPM</div>
<div>Sirolimus</div>
<div>Sirolim&#250;s</div>
<div>Sirolimusum</div>
<div>SM-88 COMPONENT SIROLIMUS</div>
<div>WY-090217</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>33</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Completed">Temsirolimus</td>
<td>Approved</td>
<td>Phase 1, Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Temsirolimus%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>162635-04-3</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/6918289" target="_blank">6918289</a> <a href="https://pubchem.ncbi.nlm.nih.gov/compound/23724530" target="_blank">23724530</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]rapamycin</div>
<div>42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoic acid]rapamycin</div>
<div>CCI 779</div>
<div>CCI-779</div>
<div>Rapamycin, 42-(3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate)</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>TEMSIROLIMUS</div>
<div>Torisel</div>
<div>Torisel&amp;reg;</div>
<div>Wyeth brand OF temsirolimus</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>34</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Completed">Vorinostat</td>
<td>Approved, Investigational</td>
<td>Phase 1, Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Vorinostat%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>149647-78-9</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/5311" target="_blank">5311</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>18F Suberoylanilide hydroxamic acid</div>
<div>18F-SAHA</div>
<div>18F-Suberoylanilide hydroxamic acid</div>
<div>Merck brand OF vorinostat</div>
<div>MK0683</div>
<div>MK-0683</div>
<div>N Hydroxy n&#39; phenyloctanediamide</div>
<div>N1 Hydroxy N8 phenyloctanediamide</div>
<div>N1-Hydroxy-N8-phenyloctanediamide</div>
<div>NHNPODA</div>
<div>N-Hydroxy-n&#39;-phenyloctanediamide</div>
<div>N-Hyrdroxy-n&#39;-phenyloctanediamide</div>
<div>Octanedioate hydroxyamide phenylamide</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Octanedioic acid hydroxyamide phenylamide</div>
<div>SAHA</div>
<div>SHH</div>
<div>Suberanilohydroxamate</div>
<div>Suberanilohydroxamic acid</div>
<div>Suberoyl anilide hydroxamic acid</div>
<div>Suberoylanilide hydroxamate</div>
<div>Suberoylanilide hydroxamic acid</div>
<div>Vorinostat</div>
<div>Vorinostatum</div>
<div>Zolinza</div>
<div>Zolinza&amp;reg;</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>35</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Completed">Deferasirox</td>
<td>Approved, Investigational</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Deferasirox%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>201530-41-8</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/214348" target="_blank">214348</a> <a href="https://pubchem.ncbi.nlm.nih.gov/compound/5493381" target="_blank">5493381</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>4-(3,5-Bis-(2-hydroxyphenyl)-(1,2,4)-triazol-1-yl)benzoic acid</div>
<div>DEFERASIROX</div>
<div>Deferasiroxum</div>
<div>Deferasiroxum [inn-latin]</div>
<div>Exjade</div>
<div>ICL 670</div>
<div>ICL 670a</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>ICL670</div>
<div>ICL-670</div>
<div>ICL670a</div>
<div>ICL-670a</div>
<div>Jadenu</div>
<div>JADENU SPRINKLE</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>36</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Completed">Iron</td>
<td>Approved</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Iron%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>7439-89-6</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/29936" target="_blank">29936</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Carbonyl iron</div>
<div>Eisen</div>
<div>Electrolytic iron</div>
<div>Fe</div>
<div>FE (III) ion</div>
<div>Fe(3+)</div>
<div>Fe(III)</div>
<div>fer</div>
<div>Ferric ion</div>
<div>Ferric iron</div>
<div>Ferrum</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Ferrum metallicum</div>
<div>Hierro</div>
<div>Iron powder</div>
<div>Iron(3+)</div>
<div>Iron, carbonyl</div>
<div>Iron, electrolytic</div>
<div>Iron, elemental</div>
<div>Iron, ion (fe(3+))</div>
<div>Iron, reduced</div>
<div>Reduced iron</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>37</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Recruiting">Prednisone</td>
<td>Approved, Vet_approved</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Prednisone%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>53-03-2</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/5865" target="_blank">5865</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>1,2-Dehydrocortisone</div>
<div>1,4-Pregnadiene-17a,21-diol-3,11,20-trione</div>
<div>1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione</div>
<div>1,4-Pregnadiene-17,21-diol-3,11,20-trione</div>
<div>17,21-Dihydroxypregna-1,4-diene-3,11,20-trione</div>
<div>Acis brand OF prednisone</div>
<div>Acsis, prednison</div>
<div>Adasone</div>
<div>Ancortone</div>
<div>Apo-prednisone</div>
<div>Apotex brand OF prednisone</div>
<div>Aventis brand OF prednisone</div>
<div>Betapar</div>
<div>Bicortone</div>
<div>Cartancyl</div>
<div>Colisone</div>
<div>Cortan</div>
<div>Cortancyl</div>
<div>Cortidelt</div>
<div>Cotone</div>
<div>Cutason</div>
<div>Dacorten</div>
<div>Dacortin</div>
<div>Decortancyl</div>
<div>Decortin</div>
<div>Decortisyl</div>
<div>Dehydrocortisone</div>
<div>Dekortin</div>
<div>Delcortin</div>
<div>Dellacort</div>
<div>Dellacort A</div>
<div>Delta Cortelan</div>
<div>Delta E</div>
<div>Delta-cortelan</div>
<div>Deltacortene</div>
<div>delta-Cortisone</div>
<div>Deltacortisone</div>
<div>Deltacortone</div>
<div>Delta-cortone</div>
<div>DELTA-DOME</div>
<div>Deltasone</div>
<div>Deltison</div>
<div>Deltisona</div>
<div>Deltisone</div>
<div>Deltra</div>
<div>Diadreson</div>
<div>Di-Adreson</div>
<div>Diba brand OF prednisone</div>
<div>Econosone</div>
<div>Encorton</div>
<div>Encortone</div>
<div>Enkortolon</div>
<div>Enkorton</div>
<div>Fawns and mcallan brand OF prednisone</div>
<div>FERNISONE</div>
<div>Ferring brand OF prednisone</div>
<div>Fiasone</div>
<div>GALENpharma brand OF prednisone</div>
<div>Halsey drug brand OF prednisone</div>
<div>Hexal brand OF prednisone</div>
<div>Hoechst brand OF prednisone</div>
<div>Hostacortin</div>
<div>ICN brand OF prednisone</div>
<div>Incocortyl</div>
<div>In-Sone</div>
<div>Juvason</div>
<div>Kortancyl</div>
<div>Lichtenstein brand OF prednisone</div>
<div>Liquid pred</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Lisacort</div>
<div>LODOTRA</div>
<div>Lodotra&amp;reg;</div>
<div>Me-Korti</div>
<div>Merck brand OF prednisone</div>
<div>Merz brand OF prednisone</div>
<div>Metacortandracin</div>
<div>Meticorten</div>
<div>Mibe brand OF prednisone</div>
<div>Nisona</div>
<div>Nizon</div>
<div>Novoprednisone</div>
<div>NSC-10023</div>
<div>Nurison</div>
<div>Orasone</div>
<div>Origen Prednisone</div>
<div>Panafcort</div>
<div>Panasol</div>
<div>PARACORT</div>
<div>Parmenison</div>
<div>Pehacort</div>
<div>Pharmacia brand OF prednisone</div>
<div>PRD</div>
<div>Precort</div>
<div>Predeltin</div>
<div>PREDN</div>
<div>Predni tablinen</div>
<div>PREDNICEN-M</div>
<div>Prednicorm</div>
<div>Prednicort</div>
<div>Prednicot</div>
<div>Prednidib</div>
<div>Prednilonga</div>
<div>Predniment</div>
<div>Prednison</div>
<div>Prednison acsis</div>
<div>Prednison galen</div>
<div>Prednison hexal</div>
<div>Prednisona</div>
<div>Prednisona [INN-Spanish]</div>
<div>PREDNISONE</div>
<div>PREDNISONE INTENSOL</div>
<div>PREDNISONE TABLETS</div>
<div>Prednisonum</div>
<div>Prednisonum [INN-Latin]</div>
<div>Prednitone</div>
<div>Prednizon</div>
<div>Prednovister</div>
<div>Presone</div>
<div>Pronison</div>
<div>Pronisone</div>
<div>RAYOS</div>
<div>Rectodelt</div>
<div>Retrocortine</div>
<div>Schering-plough brand OF prednisone</div>
<div>Seatrace brand OF prednisone</div>
<div>SERVISONE</div>
<div>Solvay brand OF prednisone</div>
<div>Sone</div>
<div>Sterapred</div>
<div>Sterapred&amp;reg;</div>
<div>Supercortil</div>
<div>Trommsdorff brand OF prednisone</div>
<div>Ultracorten</div>
<div>Ultracortene</div>
<div>Winpred</div>
<div>Wojtab</div>
<div>Zenadrid</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>38</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Recruiting">Coenzyme M</td>
<td>Approved, Investigational</td>
<td>Phase 1, Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Coenzyme+M%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>19767-45-4, 3375-50-6</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/23662354" target="_blank">23662354</a> <a href="https://pubchem.ncbi.nlm.nih.gov/compound/598" target="_blank">598</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>1-THIOETHANEsulfonate</div>
<div>1-THIOETHANEsulfonIC ACID</div>
<div>1-THIOETHANEsulphonate</div>
<div>1-THIOETHANEsulphonic acid</div>
<div>2 Mercaptoethanesulfonate</div>
<div>2-Mercaptoethane</div>
<div>2-Mercaptoethanesulfonate</div>
<div>2-mercaptoethanesulfonic acid</div>
<div>2-Mercaptoethanesulphonate</div>
<div>2-Mercaptoethanesulphonate, sodium</div>
<div>2-mercaptoethanesulphonic acid</div>
<div>2-mercaptoethylsulfonate</div>
<div>2-Mercaptoethylsulfonic acid</div>
<div>2-Mercaptoethylsulphonate</div>
<div>2-Mercaptoethylsulphonic acid</div>
<div>2-sulfanylethylsulfonate</div>
<div>2-Sulfanylethylsulfonic acid</div>
<div>2-Sulphanylethylsulphonate</div>
<div>2-Sulphanylethylsulphonic acid</div>
<div>ASTA D 7093</div>
<div>ASTA medica brand OF mesna</div>
<div>ASTAD 7093</div>
<div>ASTA-D 7093</div>
<div>beta-Mercaptoethanesulfonate</div>
<div>beta-Mercaptoethanesulfonic acid</div>
<div>beta-Mercaptoethanesulphonate</div>
<div>beta-Mercaptoethanesulphonic acid</div>
<div>b-Mercaptoethanesulfonate</div>
<div>b-Mercaptoethanesulfonic acid</div>
<div>b-Mercaptoethanesulphonate</div>
<div>b-Mercaptoethanesulphonic acid</div>
<div>Bristol myers squibb brand OF mesna</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Bristol-myers squibb brand OF mesna</div>
<div>Cell pharm brand OF mesna</div>
<div>Coenzima M</div>
<div>Coenzym M</div>
<div>Coenzyme m</div>
<div>CoM</div>
<div>D-7093</div>
<div>HS-CoM</div>
<div>Kendrick brand OF mesna</div>
<div>MESNA</div>
<div>MESNA cell</div>
<div>Mesna kendrick brand</div>
<div>Mesna sanfer brand</div>
<div>MESNA-cell</div>
<div>MESNEX</div>
<div>Mesnum</div>
<div>MISTABRON</div>
<div>Mistabronco</div>
<div>Mitexan</div>
<div>Mucofluid</div>
<div>NSC-113891</div>
<div>reduced coenzyme M</div>
<div>reduced CoM</div>
<div>Sanfer brand OF mesna</div>
<div>Sodium 2-mercaptoethanesulphonate</div>
<div>UCB brand OF mesna</div>
<div>UROMITEXAN</div>
<div>Ziken</div>
<div>-mercaptoethanesulfonate</div>
<div>-mercaptoethanesulfonic acid</div>
<div>-mercaptoethanesulphonate</div>
<div>-mercaptoethanesulphonic acid</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>39</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Recruiting">Carboplatin</td>
<td>Approved</td>
<td>Phase 1, Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Carboplatin%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>41575-94-4</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/10339178" target="_blank">10339178</a> <a href="https://pubchem.ncbi.nlm.nih.gov/compound/38904" target="_blank">38904</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Blastocarb</div>
<div>Carboplat</div>
<div>CARBOPLATIN</div>
<div>Carboplatine</div>
<div>Carboplatino</div>
<div>Carbosin</div>
<div>Carbotec</div>
<div>Cbdca</div>
<div>CIS-(1,1-CYCLOBUTANEDICARBOXYLATO)DIAMMINEPLATINUM(II)</div>
<div>CIS-DIAMMINE(1,1-CYCLOBUTANEDICARBOXYLATO)PLATINUM</div>
<div>CIS-DIAMMINE(1,1-CYCLOBUTANEDICARBOXYLATO)PLATINUM(II)</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Ercar</div>
<div>JM 8</div>
<div>JM8</div>
<div>JM-8</div>
<div>Nealorin</div>
<div>Neocarbo</div>
<div>NSC-201345</div>
<div>NSC-241240</div>
<div>PARAPLATIN</div>
<div>Paraplatin-AQ</div>
<div>Ribocarbo</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>40</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Recruiting">Acetaminophen</td>
<td>Approved</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Acetaminophen%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>103-90-2</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/1983" target="_blank">1983</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>4-(Acetylamino)phenol</div>
<div>4-Acetamidophenol</div>
<div>4-Acetaminophenol</div>
<div>4&#39;-Hydroxyacetanilide</div>
<div>4-Hydroxyacetanilide</div>
<div>4-Hydroxyanilid kyseliny octove</div>
<div>A.F. anacin</div>
<div>ABDINE</div>
<div>Abenol</div>
<div>Abensanil</div>
<div>Abrol</div>
<div>Abrolet</div>
<div>Acamol</div>
<div>Accu-tap</div>
<div>Acenol</div>
<div>Acephen</div>
<div>Acertol</div>
<div>Aceta elixir</div>
<div>Aceta tablets</div>
<div>Acetaco</div>
<div>Acetagesic</div>
<div>Acetalgin</div>
<div>Acetamidophenol</div>
<div>Acetaminofen</div>
<div>ACETAMINOF&#201;N</div>
<div>acetaminophen</div>
<div>Acetaminophen uniserts</div>
<div>Acetaminophene</div>
<div>AC&#201;TAMINOPH&#200;NE</div>
<div>Acetamol</div>
<div>Acetofen</div>
<div>Acetominophen</div>
<div>Actamin</div>
<div>Actamin extra</div>
<div>Actamin super</div>
<div>Actifed plus</div>
<div>Actimol</div>
<div>Actimol chewable tablets</div>
<div>Actimol children&#39;s suspension</div>
<div>Actimol infants&#39; suspension</div>
<div>Actimol junior strength caplets</div>
<div>Actron</div>
<div>Afebrin</div>
<div>Afebryl</div>
<div>Aferadol</div>
<div>Algesidal</div>
<div>Algina</div>
<div>Algomol</div>
<div>Algotropyl</div>
<div>Allay</div>
<div>alpha-Per</div>
<div>Alpiny</div>
<div>Alpinyl</div>
<div>Alvedon</div>
<div>Amadil</div>
<div>Aminofen</div>
<div>Aminofen max</div>
<div>Anacin</div>
<div>Anacin 3</div>
<div>Anacin3</div>
<div>Anacin-3</div>
<div>Anacin-3 extra strength</div>
<div>Anadin dla dzieci</div>
<div>Anaflon</div>
<div>Analter</div>
<div>Anapap</div>
<div>Andox</div>
<div>Anelix</div>
<div>Anexsia</div>
<div>Anexsia 10/660</div>
<div>Anexsia 5/325</div>
<div>Anexsia 7.5/325</div>
<div>Anexsia 7.5/650</div>
<div>ANGIERS</div>
<div>Anhiba</div>
<div>Anoquan</div>
<div>Anti-algos</div>
<div>Antidol</div>
<div>Apacet</div>
<div>Apacet capsules</div>
<div>Apacet elixir</div>
<div>Apacet extra strength caplets</div>
<div>Apacet extra strength tablets</div>
<div>Apacet regular strength tablets</div>
<div>Apadon</div>
<div>Apamid</div>
<div>Apamide</div>
<div>APAP</div>
<div>a-Per</div>
<div>Apitrelal</div>
<div>Apo-acetaminophen</div>
<div>Arfen</div>
<div>Asetam</div>
<div>Asomal</div>
<div>Aspac</div>
<div>Aspirin free anacin maximum strength caplets</div>
<div>Aspirin free anacin maximum strength gel caplets</div>
<div>Aspirin free anacin maximum strength tablets</div>
<div>Aspirin-free anacin</div>
<div>Aspirin-free excedrin caplets</div>
<div>Asplin</div>
<div>Atasol</div>
<div>Atasol caplets</div>
<div>Atasol drops</div>
<div>Atasol forte caplets</div>
<div>Atasol forte tablets</div>
<div>Atasol oral solution</div>
<div>Atasol tablets</div>
<div>Atralidon</div>
<div>Babikan</div>
<div>Bacetamol</div>
<div>Bancap</div>
<div>Bancap HC</div>
<div>Banesin</div>
<div>Bayer Select</div>
<div>Bayer select allergy-sinus</div>
<div>Bayer select head cold</div>
<div>Bayer select headache pain</div>
<div>Bayer select maximum strength headache pain relief formula</div>
<div>Bayer select menstrual multi-symptom</div>
<div>Bayer select sinus pain relief</div>
<div>Benmyo</div>
<div>Ben-u-ron</div>
<div>Bickie-mol</div>
<div>Biocetamol</div>
<div>Bucet</div>
<div>Butalbital</div>
<div>Butapap</div>
<div>Cadafen</div>
<div>Calapol</div>
<div>Calmanticold</div>
<div>Calpol</div>
<div>CALPOL SIX PLUS</div>
<div>CALPOL SIX PLUS FASTMELTS</div>
<div>Capital with codeine</div>
<div>Captin</div>
<div>Causalon</div>
<div>Cefalex</div>
<div>Cetadol</div>
<div>CHILD LEMSIP</div>
<div>Children&#39;S acetaminophen elixir drops</div>
<div>Children&#39;S acetaminophen oral solution</div>
<div>Children&#39;S tylenol chewable</div>
<div>Claradol codeine</div>
<div>Clixodyne</div>
<div>Codabrol</div>
<div>COD-Acamol forte</div>
<div>Codalgin</div>
<div>Codapane</div>
<div>Codicet</div>
<div>Codisal</div>
<div>Codisal forte</div>
<div>Codoliprane</div>
<div>Codral pain relief</div>
<div>Cofamol</div>
<div>CO-Gesic</div>
<div>Conacetol</div>
<div>Contac cough &amp; sore throat formula</div>
<div>Contra-schmerz p</div>
<div>Coricidin</div>
<div>Coricidin D</div>
<div>Coricidin sinus</div>
<div>Cosutone</div>
<div>Croix blanche</div>
<div>CUPANOL</div>
<div>Cuponol</div>
<div>Curadon</div>
<div>Curpol</div>
<div>Custodial</div>
<div>DAFALGAN</div>
<div>Dapa</div>
<div>Dapa X-S</div>
<div>Darocet</div>
<div>Darvocet</div>
<div>Darvocet-N 50</div>
<div>Datril</div>
<div>Datril extra-strength</div>
<div>Daygrip</div>
<div>Demilets</div>
<div>Deminofen</div>
<div>Democyl</div>
<div>Demogripal</div>
<div>Desfebre</div>
<div>Dhamol</div>
<div>DHC Plus</div>
<div>Dial-a-gesic</div>
<div>Dial-alpha-gesic</div>
<div>Dimindol</div>
<div>Dirox</div>
<div>Disprol</div>
<div>DISPROL INFANT</div>
<div>DISPROL JNR</div>
<div>DISPROL PAED</div>
<div>Dolcor</div>
<div>Dolefin</div>
<div>Dolegrippin</div>
<div>Dolene ap-65</div>
<div>Dolgesic</div>
<div>Doliprane</div>
<div>Dolko</div>
<div>Dolofugin</div>
<div>Doloreduct</div>
<div>Dolorfug</div>
<div>Dolorol forte</div>
<div>Dolorstop</div>
<div>Dolotec</div>
<div>Dolprone</div>
<div>Dol-stop</div>
<div>Dorocoff</div>
<div>Dresan</div>
<div>Dristan cold no drowsiness</div>
<div>Dristancito</div>
<div>Drixoral Plus</div>
<div>Dularin</div>
<div>Duracetamol</div>
<div>Duradyne DHC</div>
<div>Durapan</div>
<div>Dymadon</div>
<div>Dymadon co</div>
<div>Dymadon forte</div>
<div>Dypap</div>
<div>Ecosetol</div>
<div>Elixodyne</div>
<div>Empracet</div>
<div>Endecon</div>
<div>Enelfa</div>
<div>Eneril</div>
<div>Esgic</div>
<div>Esgic-plus</div>
<div>Eu-med</div>
<div>Excedrin</div>
<div>Excedrin caplets</div>
<div>Excedrin extra strength caplets</div>
<div>Excipain</div>
<div>Exdol</div>
<div>Exdol strong</div>
<div>Fanalgic</div>
<div>Farmadol</div>
<div>Febranine</div>
<div>Febrectal</div>
<div>Febrectol</div>
<div>Febrex</div>
<div>Febricet</div>
<div>Febridol</div>
<div>Febrilix</div>
<div>Febrin</div>
<div>Febrinol</div>
<div>Febro-gesic</div>
<div>Febrolin</div>
<div>Femcet</div>
<div>Fendon</div>
<div>FENNINGS</div>
<div>Fensum</div>
<div>Fepanil</div>
<div>Feverall</div>
<div>Feverall junior strength</div>
<div>Feverall sprinkle caps junior strength</div>
<div>Fevor</div>
<div>Finimal</div>
<div>Finiweh</div>
<div>Fioricet</div>
<div>Fluparmol</div>
<div>Fortalidon p</div>
<div>Freka-cetamol</div>
<div>GALPAMOL</div>
<div>Gattaphen T</div>
<div>Gelocatil</div>
<div>Geluprane</div>
<div>Genapap</div>
<div>Genapap children&#39;s elixir</div>
<div>Genapap children&#39;s tablets</div>
<div>Genapap extra strength caplets</div>
<div>Genapap extra strength tablets</div>
<div>Genapap regular strength tablets</div>
<div>Genebs</div>
<div>Genebs extra strength caplets</div>
<div>Genebs regular strength tablets</div>
<div>Genebs X-tra</div>
<div>Geralgine-p</div>
<div>Gripin bebe</div>
<div>Grippostad</div>
<div>Gynospasmine</div>
<div>Hedex</div>
<div>Helon N</div>
<div>Homoolan</div>
<div>Hycomine compound</div>
<div>Hydrocet</div>
<div>Hydroxyacetanilide</div>
<div>Hy-phen</div>
<div>Ildamol</div>
<div>Inalgex</div>
<div>Infadrops</div>
<div>Infants&#39; feverall</div>
<div>Influbene N</div>
<div>Injectapap</div>
<div>Intensin</div>
<div>Janupap</div>
<div>Junior disprol</div>
<div>JUNIOR PARAPAED</div>
<div>Kataprin</div>
<div>Kinder finimal</div>
<div>Korum</div>
<div>Kratofin simplex</div>
<div>Labamol</div>
<div>Lekadol</div>
<div>Lemgrip</div>
<div>Lemsip</div>
<div>Lestemp</div>
<div>Liquagesic</div>
<div>Liquigesic co</div>
<div>Liquiprin</div>
<div>Liquiprin children&#39;s elixir</div>
<div>Liquiprin infants&quot; drops</div>
<div>Lonarid</div>
<div>Lonarid mono</div>
<div>Lorcet-HD</div>
<div>Lortab</div>
<div>Lupocet</div>
<div>Lyteca</div>
<div>Lyteca syrup</div>
<div>Magnidol</div>
<div>Malex N</div>
<div>Malgis</div>
<div>Malidens</div>
<div>MANDANOL</div>
<div>Maxadol</div>
<div>Medigesic plus</div>
<div>MEDINOL</div>
<div>MEDINOL FOR CHILDREN</div>
<div>MEDINOL OVER 6</div>
<div>Medinol paediatric</div>
<div>MEDINOL UNDER 6</div>
<div>MEDISED PLAIN</div>
<div>Medocodene</div>
<div>Melabon infantil</div>
<div>Mexalen</div>
<div>Midol maximum strength</div>
<div>Midol PM night time formula</div>
<div>Midol regular strength</div>
<div>Midol teen formula</div>
<div>Migraleve yellow</div>
<div>Minafen</div>
<div>Minoset</div>
<div>MIRADOL</div>
<div>Miralgin</div>
<div>Momentum</div>
<div>mono Praecimed</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Multin</div>
<div>N-(4-Hydroxyphenyl)acetamide</div>
<div>N-(4-Hydroxyphenyl)acetanilide</div>
<div>N-Acetyl-4-aminophenol</div>
<div>N-Acetyl-p-aminophenol</div>
<div>Naldegesic</div>
<div>NAPA</div>
<div>Napafen</div>
<div>Napap</div>
<div>Naprinol</div>
<div>Nealgyl</div>
<div>Nebs</div>
<div>NeoCitran</div>
<div>Neodol</div>
<div>Neodolito</div>
<div>Neo-fepramol</div>
<div>Neopap</div>
<div>Neotrend</div>
<div>Neuridon</div>
<div>New cortal for children</div>
<div>NilnOcen</div>
<div>Nina</div>
<div>Nobedon</div>
<div>Nodolex</div>
<div>NO-Febril</div>
<div>Noral</div>
<div>Norcet</div>
<div>Norco</div>
<div>NSC-109028</div>
<div>NSC-3991</div>
<div>O-Acetaminophenol</div>
<div>OFIRMEV</div>
<div>Oltyl</div>
<div>Oralgan</div>
<div>Oraphen-PD</div>
<div>Ortensan</div>
<div>Oxycet</div>
<div>Oxycocet</div>
<div>Oxycodone 2.5/apap 500</div>
<div>Oxycodone 5/apap 500</div>
<div>p-(Acetylamino)phenol</div>
<div>Paceco</div>
<div>Pacemo</div>
<div>Pacemol</div>
<div>Pacet</div>
<div>p-Acetamidophenol</div>
<div>p-Acetaminophenol</div>
<div>p-Acetylaminophenol</div>
<div>Pacimol</div>
<div>Paedialgon</div>
<div>Paedol</div>
<div>Painex</div>
<div>Paldesic</div>
<div>Pamol</div>
<div>Panacete</div>
<div>Panadeine</div>
<div>Panadeine co</div>
<div>Panadiene</div>
<div>PANADO</div>
<div>Panado-co</div>
<div>Panado-co caplets</div>
<div>Panadol</div>
<div>PANADOL ACTIFAST</div>
<div>PANADOL ACTIFAST SOLB</div>
<div>PANADOL ADVAN</div>
<div>Panadol extra strength</div>
<div>PANADOL JNR</div>
<div>Panadol junior strength caplets</div>
<div>Panadol maximum strength caplets</div>
<div>Panadol maximum strength tablets</div>
<div>PANADOL OA</div>
<div>Panadol&amp;reg;</div>
<div>Panaleve</div>
<div>PANALEVE 6 PLUS</div>
<div>Panamax</div>
<div>Panasorb</div>
<div>Panasorbe</div>
<div>Panets</div>
<div>Panex</div>
<div>Panodil</div>
<div>Panofen</div>
<div>Pantalgin</div>
<div>Papa-Deine</div>
<div>Papa-deine #3</div>
<div>Papa-deine #4</div>
<div>Paracemol</div>
<div>Paracenol</div>
<div>Paracet</div>
<div>Paracetamol</div>
<div>PARAC&#201;TAMOL</div>
<div>Paracetamol al</div>
<div>Paracetamol antipanin p</div>
<div>Paracetamol basics</div>
<div>Paracetamol BC</div>
<div>Paracetamol DC</div>
<div>Paracetamol dr. schmidgall</div>
<div>Paracetamol fecofar</div>
<div>Paracetamol genericon</div>
<div>Paracetamol hanseler</div>
<div>Paracetamol harkley</div>
<div>Paracetamol heumann</div>
<div>Paracetamol hexal</div>
<div>Paracetamol italfarmaco</div>
<div>Paracetamol nycomed</div>
<div>Paracetamol PB</div>
<div>Paracetamol raffo</div>
<div>Paracetamol ratiopharm</div>
<div>Paracetamol rosch</div>
<div>Paracetamol saar</div>
<div>Paracetamol smithkline beecham</div>
<div>Paracetamol stada</div>
<div>Paracetamol von CT</div>
<div>Paracetamol winthrop</div>
<div>Paracetamole</div>
<div>Paracetamolo</div>
<div>Paracetamolum</div>
<div>Paracetanol</div>
<div>Paracetol</div>
<div>Paracin</div>
<div>Paracod</div>
<div>Paracodol</div>
<div>Parador</div>
<div>Paradrops</div>
<div>Parakapton</div>
<div>Parake</div>
<div>Paralen</div>
<div>Paralief</div>
<div>Paralink</div>
<div>Paralyoc</div>
<div>PARAMIN</div>
<div>Paramol</div>
<div>Paramolan</div>
<div>Paranox</div>
<div>PARAPAED JNR</div>
<div>PARAPAED SIX PLUS</div>
<div>Parapan</div>
<div>Parasedol</div>
<div>Parasin</div>
<div>Paraspen</div>
<div>Para-suppo</div>
<div>Para-tabs</div>
<div>PARAVICT</div>
<div>Parcetol</div>
<div>Parelan</div>
<div>Parmol</div>
<div>Parogal</div>
<div>Paroma</div>
<div>Pasolind</div>
<div>Pasolind N</div>
<div>PCM Paracetamol lichtenstein</div>
<div>Pediapirin</div>
<div>Pediatrix</div>
<div>Pedric</div>
<div>Percocet</div>
<div>Percocet-5</div>
<div>Percocet-demi</div>
<div>Percogesic with codeine</div>
<div>Perdolan mono</div>
<div>PERFALGAN</div>
<div>Pe-tam</div>
<div>Phenaphen</div>
<div>Phenaphen caplets</div>
<div>Phenaphen w/codeine</div>
<div>Phendon</div>
<div>Phenipirin</div>
<div>Phogoglandin</div>
<div>Phrenilin</div>
<div>Phrenilin forte</div>
<div>P-HYDROXY-ACETANILID</div>
<div>p-Hydroxyacetanilide</div>
<div>p-Hydroxyphenolacetamide</div>
<div>Pinex</div>
<div>Piramin</div>
<div>Pirinasol</div>
<div>PLACIDEX</div>
<div>Plicet</div>
<div>Polmofen</div>
<div>Predimol</div>
<div>Predualito</div>
<div>Prestwick_13</div>
<div>Prodol</div>
<div>Prompt</div>
<div>Prontina</div>
<div>Propacet</div>
<div>Propacet 100</div>
<div>Proval #3</div>
<div>Puernol</div>
<div>Pulmofen</div>
<div>Pyregesic-C</div>
<div>Pyrigesic</div>
<div>Pyrinazine</div>
<div>Pyromed</div>
<div>Quiet world</div>
<div>Redutemp</div>
<div>Reliv</div>
<div>Remedol</div>
<div>Rhinex D-lay tablets</div>
<div>RIMADOL</div>
<div>Rivalgyl</div>
<div>Robigesic</div>
<div>Robitussin night relief</div>
<div>Rockamol plus</div>
<div>Rounox</div>
<div>Roxicet</div>
<div>Roxicet 5/500</div>
<div>Roxilox</div>
<div>RubieMol</div>
<div>Rubophen</div>
<div>Rupemol</div>
<div>Salzone</div>
<div>Sanicet</div>
<div>Sanicopyrine</div>
<div>Scanol</div>
<div>Scentalgyl</div>
<div>Scherzatabletten rezeptur 534</div>
<div>Schmerzex</div>
<div>Sedalito</div>
<div>Sedapap</div>
<div>Semolacin</div>
<div>Servigesic</div>
<div>Seskamol</div>
<div>Setakop</div>
<div>Setamol</div>
<div>Setol</div>
<div>Sifenol</div>
<div>Sinaspril</div>
<div>Sinedol</div>
<div>Sine-OFF sinus medicine caplets</div>
<div>Sinmol</div>
<div>Sinubid</div>
<div>SK-Apap</div>
<div>Snaplets-FR</div>
<div>Spalt fur die nacht</div>
<div>Spalt N</div>
<div>ST Joseph aspirin-free</div>
<div>ST Joseph aspirin-free for children</div>
<div>St. joseph cold tablets for children</div>
<div>St. joseph fever reducer</div>
<div>Stanback</div>
<div>Stopain</div>
<div>Sudafed severe cold formula</div>
<div>Sudafed sinus</div>
<div>Sunetheton</div>
<div>Supac</div>
<div>Supadol mono</div>
<div>Supofen</div>
<div>Suppap</div>
<div>Suppap-120</div>
<div>Suppap-325</div>
<div>Suppap-650</div>
<div>Supramol-m</div>
<div>Synalgos-DC-a</div>
<div>Tabalgin</div>
<div>Tachiprina</div>
<div>Talacen</div>
<div>Tapanol</div>
<div>Tapanol extra strength caplets</div>
<div>Tapanol extra strength tablets</div>
<div>Tapar</div>
<div>Tavist allergy/sinus/headache</div>
<div>Tazamol</div>
<div>Temlo</div>
<div>Tempanal</div>
<div>Tempra</div>
<div>Tempra caplets</div>
<div>Tempra chewable tablets</div>
<div>Tempra d.s</div>
<div>Tempra drops</div>
<div>Tempra syrup</div>
<div>Tencon</div>
<div>Termacet</div>
<div>Termalgin</div>
<div>Termalgine</div>
<div>Termofren</div>
<div>TheraFlu</div>
<div>Tibinide</div>
<div>Tibizide</div>
<div>Tiffy</div>
<div>Tisin</div>
<div>Tisiodrazida</div>
<div>Titralgan</div>
<div>TIXYMOL</div>
<div>Tizide</div>
<div>Tocris-1706</div>
<div>Toximer p</div>
<div>Tralgon</div>
<div>TRAMIL 500</div>
<div>Treupel mon</div>
<div>Treupel N</div>
<div>Treuphadol</div>
<div>Triad</div>
<div>Triaminic sore throat formula</div>
<div>Triaprin</div>
<div>Tricoton</div>
<div>Tussapap</div>
<div>Tycolet</div>
<div>TYL</div>
<div>Tylenol</div>
<div>Tylenol allergy sinus</div>
<div>Tylenol arthritis extended relief</div>
<div>Tylenol caplets</div>
<div>Tylenol children&#39;s chewable tablets</div>
<div>Tylenol children&#39;s elixir</div>
<div>Tylenol children&#39;s suspension liquid</div>
<div>Tylenol drops</div>
<div>Tylenol elixir</div>
<div>Tylenol extra strength adult liquid pain reliever</div>
<div>Tylenol extra strength caplets</div>
<div>Tylenol extra strength gelcaps</div>
<div>Tylenol extra strength tablets</div>
<div>Tylenol gelcaps</div>
<div>Tylenol infants drops</div>
<div>Tylenol infants&quot; suspension drops</div>
<div>Tylenol junior strength caplets</div>
<div>Tylenol junior strength chewable tablets</div>
<div>Tylenol regular strength caplets</div>
<div>Tylenol regular strength tablets</div>
<div>Tylenol tablets</div>
<div>Tylenol&amp;reg;</div>
<div>Tylex</div>
<div>Tylex CD</div>
<div>Tylol</div>
<div>Tylox</div>
<div>Tylox-325</div>
<div>Tymol</div>
<div>Ultracet</div>
<div>Upsanol</div>
<div>Utragin</div>
<div>Valadol</div>
<div>Valgesic</div>
<div>Valorin</div>
<div>Valorin extra</div>
<div>Vanquish</div>
<div>Veralgina</div>
<div>Vermidon</div>
<div>Verpol</div>
<div>Viclor richet</div>
<div>Vicodin</div>
<div>Vicodin es</div>
<div>Vicodin HP</div>
<div>Vips</div>
<div>Viruflu</div>
<div>Vivimed</div>
<div>Volpan</div>
<div>Wygesic</div>
<div>Zatinol</div>
<div>Zolben</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>41</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Recruiting">Valganciclovir</td>
<td>Approved, Investigational</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Valganciclovir%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>175865-60-8</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/64147" target="_blank">64147</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Cymeval</div>
<div>ester with ganciclovir</div>
<div>Ganciclovir L-valyl ester</div>
<div>L-valine</div>
<div>L-Valine, ester with ganciclovir</div>
<div>RO-1079070/194</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>RS-079070-194</div>
<div>Valcyt</div>
<div>Valcyte</div>
<div>VALGANCICLOVIR</div>
<div>Valganciclovir hydrochloride</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>42</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Active, not recruiting">Romidepsin</td>
<td>Approved, Investigational</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Romidepsin%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>128517-07-7</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/5352062" target="_blank">5352062</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>ANTIBIOTIC FR 901228</div>
<div>CHROMADAX</div>
<div>DEPSIPEPTIDE</div>
<div>FK228</div>
<div>FK-228</div>
<div>FR901228</div>
<div>FR-901228</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>ISTODAX</div>
<div>Istodax&amp;reg;</div>
<div>NSC-630176</div>
<div>ROMIDEPSIN</div>
<div>Romidepsina</div>
<div>Romidepsine</div>
<div>Romidepsinum</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>43</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Not yet recruiting">Dexamethasone</td>
<td>Approved, Investigational, Vet_approved</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Dexamethasone%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>50-02-2</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/3003" target="_blank">3003</a> <a href="https://pubchem.ncbi.nlm.nih.gov/compound/5743" target="_blank">5743</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>[&lt;sup&gt;3&lt;/sup&gt;H]-dexamethasone</div>
<div>16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol</div>
<div>16alpha -Methyl-9alpha -fluoroprednisolone</div>
<div>16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol</div>
<div>16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol</div>
<div>16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone</div>
<div>16alpha-Methyl-9alpha-fluoroprednisolone</div>
<div>16-alpha-Methyl-9-alpha-fluoroprednisolone</div>
<div>16a-Methyl-9a-fluoro-1-dehydrocortisol</div>
<div>16-methyl-9-fluoro-1-dehydrocortisol</div>
<div>1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone</div>
<div>1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone</div>
<div>1-Dehydro-16a-methyl-9a-fluorohydrocortisone</div>
<div>1-Dehydro-16-methyl-9-fluorohydrocortisone</div>
<div>9a-Fluoro-16a-methylprednisolone</div>
<div>9a-Fluoro-16BETA-methylprednisolone</div>
<div>9alpha -Fluoro-16alpha -methylprednisolone</div>
<div>9alpha-Fluoro-16alpha-methylprednisolone</div>
<div>9alpha-Fluoro-16alpha-methyl-prednisolone</div>
<div>9-alpha-Fluoro-16-alpha-methylprednisolone</div>
<div>9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione</div>
<div>9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione</div>
<div>9-Fluoro-16-methylprednisolone</div>
<div>9-fluoro-16-methylprednisolone</div>
<div>Adexone</div>
<div>Aeroseb-D</div>
<div>Aeroseb-dex</div>
<div>Ak dex OPH otic soln 0.1%</div>
<div>Alcon brand OF dexamethasone</div>
<div>alpha -Fluoro-16-alpha -methylcortisol</div>
<div>Anaflogistico</div>
<div>Aphtasolon</div>
<div>Aphthasolone</div>
<div>Apo-dexamethasone</div>
<div>Auxiron</div>
<div>Azimycin (veterinary)</div>
<div>Azium</div>
<div>Azium (veterinary)</div>
<div>Bisu DS</div>
<div>Calonat</div>
<div>Corson</div>
<div>Corsone</div>
<div>Cortisumman</div>
<div>DALALONE</div>
<div>Decacort</div>
<div>Decacortin</div>
<div>Decaderm</div>
<div>Decadron</div>
<div>Decadron Tablets</div>
<div>Decadron&amp;reg;</div>
<div>DECADRON-75</div>
<div>DECADRON-LA</div>
<div>Decagel</div>
<div>Decaject</div>
<div>Decaject l.a.</div>
<div>Decaject-l.a.</div>
<div>Decalix</div>
<div>Decameth</div>
<div>Decasone</div>
<div>Decaspray</div>
<div>Dectancyl</div>
<div>Dekacort</div>
<div>Delta1-9alpha-Fluoro-16alpha-methylcortisol</div>
<div>Deltafluorene</div>
<div>Dergramin</div>
<div>Deronil</div>
<div>Desadrene</div>
<div>Desametasone</div>
<div>Desametasone [Dcit]</div>
<div>Desamethasone</div>
<div>Desameton</div>
<div>Deseronil</div>
<div>DEX</div>
<div>DEXA</div>
<div>Dexa mamallet</div>
<div>DEXACEN-4</div>
<div>Dexacidin</div>
<div>Dexacort</div>
<div>Dexacortal</div>
<div>Dexa-cortidelt</div>
<div>Dexacortin</div>
<div>Dexa-cortisyl</div>
<div>DEXACORTISYL</div>
<div>Dexadeltone</div>
<div>Dexafarma</div>
<div>DEXAFREE</div>
<div>DEXAIR</div>
<div>Dexalona</div>
<div>Dexaltin</div>
<div>Dexa-Mamallet</div>
<div>Dexametasona</div>
<div>Dexametasona [INN-Spanish]</div>
<div>Dexametasone</div>
<div>Dexameth</div>
<div>Dexamethansone</div>
<div>DEXAMETHASONE</div>
<div>Dexam&#233;thasone</div>
<div>Dexamethasone acetate</div>
<div>Dexamethasone alcohol</div>
<div>Dexamethasone base</div>
<div>Dexamethasone intensol</div>
<div>DEXAMETHASONE METASULFOBENZOATE SODIUM</div>
<div>DEXAMETHASONE PALMITATE</div>
<div>Dexamethasone sodium phosphate</div>
<div>DEXAMETHASONE VALERATE</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Dexamethasone-omega</div>
<div>Dexamethasonum</div>
<div>Dexamethasonum [INN-Latin]</div>
<div>Dexamethazone</div>
<div>Dexamonozon</div>
<div>Dexapolcort</div>
<div>Dexapos</div>
<div>Dexaprol</div>
<div>Dexa-scheroson</div>
<div>Dexa-sine</div>
<div>Dexason</div>
<div>Dexasone</div>
<div>Dexasone 0.5MG</div>
<div>Dexasone 0.75MG</div>
<div>Dexasone 4MG</div>
<div>Dexasporin</div>
<div>Dex-ide</div>
<div>Dexinolon</div>
<div>Dexinoral</div>
<div>Dexone</div>
<div>DEXONE 0.5</div>
<div>DEXONE 0.75</div>
<div>DEXONE 1.5</div>
<div>DEXONE 4</div>
<div>Dexonium</div>
<div>Dexpak</div>
<div>DEXSOL</div>
<div>Dextelan</div>
<div>DEXTENZA</div>
<div>DEXYCU KIT</div>
<div>Dezone</div>
<div>Dinormon</div>
<div>DROPODEX</div>
<div>DXM</div>
<div>DXM833</div>
<div>DXMS</div>
<div>ECR brand OF dexamethasone</div>
<div>Elixir</div>
<div>Fluormethylprednisolone</div>
<div>Fluormone</div>
<div>Fluorocort</div>
<div>Fortecortin</div>
<div>Foy brand OF dexamethasone</div>
<div>Gammacorten</div>
<div>GPPE EAR SPY</div>
<div>Hexadecadrol</div>
<div>Hexadrol</div>
<div>Hexadrol elixir</div>
<div>Hexadrol Tablets</div>
<div>HL-Dex</div>
<div>ICN brand OF dexamethasone</div>
<div>IontoDex</div>
<div>Isopto-dex</div>
<div>ISV-305</div>
<div>KORTICO INJECTION</div>
<div>Lokalison F</div>
<div>Loverine</div>
<div>Luxazone</div>
<div>MARTAPAN</div>
<div>Maxidex</div>
<div>Maxidex ont 0.1%</div>
<div>Maxidex sus 0.1%</div>
<div>Maxitrol</div>
<div>Mediamethasone</div>
<div>Merck brand OF dexamethasone</div>
<div>Merz brand 1 OF dexamethasone</div>
<div>Merz brand 2 OF dexamethasone</div>
<div>Methylfluorprednisolone</div>
<div>Mexidex</div>
<div>Millicorten</div>
<div>Mymethasone</div>
<div>Naquasone (veterinary)</div>
<div>NEODECADRON</div>
<div>Neomycin and polymyxin b sulfates and dexamethasone</div>
<div>Neomycin and polymyxin b sulphates and dexamethasone</div>
<div>NSC 34521</div>
<div>NSC-34521</div>
<div>Ocu-trol</div>
<div>Oradexon</div>
<div>OTO-104</div>
<div>OTOMIZE</div>
<div>OZURDEX</div>
<div>Pet derm III</div>
<div>Pet-Derm Iii</div>
<div>PHL-Dexamethasone</div>
<div>PMS Dexamethasone elixir 0.5mg/5ML</div>
<div>PMS-Dexamethasone</div>
<div>Policort</div>
<div>Posurdex</div>
<div>Prednisolon F</div>
<div>Prednisolone F</div>
<div>Prodex</div>
<div>Sandoz dexamethasone</div>
<div>SK-Dexamethasone</div>
<div>SOFRADEX</div>
<div>SPERSADEX COMP</div>
<div>Spoloven</div>
<div>Sunia sol D</div>
<div>Superprednol</div>
<div>Tobradex</div>
<div>Tobramycin and dexamethasone</div>
<div>Tresaderm (veterinary)</div>
<div>Turbinaire</div>
<div>Visumetazone</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>44</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Not yet recruiting">Dexamethasone acetate</td>
<td>Approved, Investigational, Vet_approved</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Dexamethasone+acetate%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>1177-87-3</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/3680" target="_blank">3680</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>16alpha-Methyl-9alpha-fluoroprednisolone 21-acetate</div>
<div>2-{1-fluoro-14,17-dihydroxy-2,13,15-trimethyl-5-oxotetracyclo[8.7.0.0,.0,]heptadeca-3,6-dien-14-yl}-2-oxoethyl acetic acid</div>
<div>9alpha-Fluoro-16alpha-methylprednisolone acetate</div>
<div>DECADRON-LA</div>
<div>Dexamethasone 21-acetate</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>DEXAMETHASONE ACETATE</div>
<div>Dexamethasone acetate anhydrous</div>
<div>Dexamethasone acetate, anhydrous</div>
<div>Dexamethasone acetic acid</div>
<div>Dexamethasoni acetas</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>45</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Not yet recruiting">Pegaspargase</td>
<td>Approved, Investigational</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Pegaspargase%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>130167-69-0</td>
<td>
</td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>L-ASPARAGINE AMIDOHYDROLASE</div>
<div>ONCASPAR</div>
<div>Peg/L-asparaginase</div>
<div>Peg-asparaginase</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Pegaspargasa</div>
<div>PEGASPARGASE</div>
<div>PUTATIVE L-ASPARAGINASE PRECURSOR</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>46</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Not yet recruiting">Azacitidine</td>
<td>Approved, Investigational</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Azacitidine%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>320-67-2</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/9444" target="_blank">9444</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>4-Amino-1-b-D-ribofuranosyl-S-triazin-2(1H)-one</div>
<div>4-Amino-1-beta-D-ribofuranosyl-S-triazin-2(1H)-one</div>
<div>4-Amino-1--D-ribofuranosyl-S-triazin-2(1H)-one</div>
<div>5 Azacytidine</div>
<div>5 AZC</div>
<div>5-AZAC</div>
<div>5-azacytidine</div>
<div>Azacitidina</div>
<div>Azacitidina [INN-Spanish]</div>
<div>Azacitidine</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Azacitidinum</div>
<div>Azacitidinum [INN-Latin]</div>
<div>Azacytidine</div>
<div>LADAKAMYCIN</div>
<div>Mylosar</div>
<div>NSC-102816</div>
<div>Pharmion brand OF azacitidine</div>
<div>U-18496</div>
<div>Vidaza</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>47</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Not yet recruiting">Mitoxantrone</td>
<td>Approved, Investigational</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Mitoxantrone%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>70476-82-3, 65271-80-9</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/4212" target="_blank">4212</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone</div>
<div>1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione</div>
<div>Acetate, mitoxantrone</div>
<div>AHP brand OF mitoxantrone hydrochloride</div>
<div>Amgen brand OF mitoxantrone hydrochloride</div>
<div>ASTA medica brand OF mitoxantrone hydrochloride</div>
<div>Baxter oncology brand OF mitoxantrone hydrochloride</div>
<div>CL-232315</div>
<div>Columbia brand OF mitoxantrone hydrochloride</div>
<div>DHAD</div>
<div>DHAQ</div>
<div>DHAQ HCl</div>
<div>Dihydroxyanthraquinone</div>
<div>Hydrochloride, mitoxantrone</div>
<div>Inibsa brand OF mitoxantrone hydrochloride</div>
<div>Lederle brand OF mitoxantrone hydrochloride</div>
<div>Misostol</div>
<div>Mitox</div>
<div>Mitoxanthrone</div>
<div>Mitoxantron</div>
<div>Mitoxantrona</div>
<div>Mitoxantrona [INN-Spanish]</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>MITOXANTRONE</div>
<div>Mitoxantrone 2HCl</div>
<div>Mitoxantrone acetate</div>
<div>MITOXANTRONE DIHCL</div>
<div>MITOXANTRONE DIHYDROCHLORIDE</div>
<div>MITOXANTRONE HCL</div>
<div>Mitoxantrone hydrochloride</div>
<div>Mitoxantronum</div>
<div>Mitoxantronum [INN-Latin]</div>
<div>Mitozantrone</div>
<div>Mitozantrone hydrochloride</div>
<div>Mitroxone</div>
<div>Novantron</div>
<div>Novantrone</div>
<div>Novantrone&amp;reg;</div>
<div>NSC-279836</div>
<div>NSC-301739</div>
<div>Onkotrone</div>
<div>Pralifan</div>
<div>Ralenova</div>
<div>Wyeth brand OF mitoxantrone hydrochloride</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>48</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Terminated">Ifosfamide</td>
<td>Approved</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Ifosfamide%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>3778-73-2</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/3690" target="_blank">3690</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide</div>
<div>Asta Z 4942</div>
<div>Holoxan</div>
<div>Ifex</div>
<div>Ifosfamid</div>
<div>Ifosfamida</div>
<div>IFOSFAMIDE</div>
<div>Ifosfamide sterile</div>
<div>Ifosfamidum</div>
<div>Ifosphamide</div>
<div>Ifsofamide</div>
<div>Iphosphamid</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Iphosphamide</div>
<div>I-phosphamide</div>
<div>Iso endoxan</div>
<div>Iso-endoxan</div>
<div>Isofosfamide</div>
<div>Isophosphamide</div>
<div>Isosfamide</div>
<div>MITOXANA</div>
<div>MJF-9325</div>
<div>NSC-109724</div>
<div>Z-4942</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>49</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Terminated">Brentuximab vedotin</td>
<td>Approved, Investigational</td>
<td>Phase 1, Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Brentuximab+vedotin%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>914088-09-8</td>
<td>
</td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>124490327</div>
<div>ADCETRIS</div>
<div>Adcetris&amp;reg;</div>
<div>anti-CD30 ADC SGN-35</div>
<div>Brentuximab</div>
<div>BRENTUXIMAB VEDOTIN</div>
<div>Brentuximab vedotin brentuximab</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>Brentuximab vedotina</div>
<div>CAC10-VCMMAE</div>
<div>Moab, chimeric, SGN-30, to CD30 antigen</div>
<div>Monoclonal antibody SGN-30</div>
<div>SGN 35</div>
<div>SGN-35</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr class="collapsable">
<td>50</td>
<td>
<div class="unified_drug_open_icon" title="Expand to show the synonyms"></div>
</td>
<td title="Terminated">Lenalidomide</td>
<td>Approved</td>
<td>Phase 2</td>
<td>
<a href="https://clinicaltrials.gov/ct2/results?cond=%22Nasal+Type+Extranodal+Nk%2ft-Cell+Lymphoma%22&amp;intr=%22Lenalidomide%22" title="Clinical trials for this disease and drug" target="_blank" class="new_win_icon"></a>
</td>
<td>191732-72-6</td>
<td>
<a href="https://pubchem.ncbi.nlm.nih.gov/compound/216326" target="_blank">216326</a> </td>
</tr>
<tr class="unified_drugs hidden_minicard" style="display: none;">
<td colspan="8" style="word-wrap:break-word;">
<div class="main-name"><b>Synonyms:</b></div>
<table class="borderless aliases" style="table-layout:fixed;">
<tbody>
<tr>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline</div>
<div>3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione</div>
<div>CC-5013</div>
<div>CDC 501</div>
<div>CDC-501</div>
<div>Celgene brand OF lenalidomide</div>
<div>IMID-1</div>
<div>IMiD3</div>
</div>
</div>
</div>
</td>
<td width="390">
<div id="drug_table">
<div id="drug_table_row">
<div id>
<div>IMiD3 CPD</div>
<div>Lenalidomida</div>
<div>LENALIDOMIDE</div>
<div>Revimid</div>
<div>Revlimid</div>
<div>Revlimid&amp;reg;</div>
<div>SYP-1512</div>
</div>
</div>
</div>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
<h3>Interventional clinical trials:</h3>
<span class="showmore">
(<a id="ClinicalTrial-table_SeeMore" href="javascript:showMoreTable('ClinicalTrial-table','ClinicalTrial-table_SeeMore', 'show top 50', 'showing 50, show less','collapsable')">show top 50</a>)
</span>
<span class="showmore">
(<a href="#" class="showAll" onclick="javascript: return showAll('ClinicalTrial', '166', 'ClinicalTrial-table');">show all 166</a>)
</span>
<br/>
<table id="ClinicalTrial-table" style="table-layout: fixed;">
<thead>
<tr>
<th width="20">#</th>
<th width="400">Name</th>
<th width="80">Status</th>
<th width="90">NCT ID</th>
<th width="70">Phase</th>
<th>Drugs</th>
</tr>
</thead>
<tbody>
<tr>
<td>1</td>
<td>A Randomized Controlled Multi-center Clinical Trial on Treatment of Stage I/II NK/T Cell Lymphoma With DDGP Regiment (Gemcitabine,Pegaspargase,Cisplatin,Dexamethasone)</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT01501136" target="_blank">NCT01501136</a></td>
<td>Phase 4</td>
<td style="word-wrap: break-word;"></td>
</tr>
<tr>
<td>2</td>
<td>A Randomized Controlled Multi-center Clinical Trial on Treatment of Stage / NK/T Cell Lymphoma With DDGP Regiment (Gemcitabine,Pegaspargase,Cisplatin,Dexamethasone)</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT01501149" target="_blank">NCT01501149</a></td>
<td>Phase 4</td>
<td style="word-wrap: break-word;">DDGP(cisplatin,dexamethasone,gemcitabine,pegaspargase);Modified SMILE MTXDEXIFOL-ASPEtoposideMesna</td>
</tr>
<tr>
<td>3</td>
<td>Single-arm, Multi-center Clinical Study of PD-1 Antibody, Chidamide, Lenalidomide and Etoposide for Relapsed or Refractory Natural Killer/T Cell Lymphoma</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT04038411" target="_blank">NCT04038411</a></td>
<td>Phase 4</td>
<td style="word-wrap: break-word;">PD-1 Antibody, chidamide, lenalidomide and etoposide</td>
</tr>
<tr>
<td>4</td>
<td>A Clinical Trial of Chidamide Combined With Etoposide in Relapsed or Refractory NK/T-cell Lymphoma</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT04490590" target="_blank">NCT04490590</a></td>
<td>Phase 4</td>
<td style="word-wrap: break-word;">Chidamide+ Etoposide</td>
</tr>
<tr>
<td>5</td>
<td>PA-Gemox Regimen Followed by Thalidomide Versus AspaMetDex Regimen in NKTCL Patientsa Randomized, Open-label, Phase 3 Study</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT02085655" target="_blank">NCT02085655</a></td>
<td>Phase 3</td>
<td style="word-wrap: break-word;">pegaspargase;Gemcitabine;Oxaliplatin;Methotrexate;Dexamethasone;Thalidomide</td>
</tr>
<tr>
<td>6</td>
<td>Phase III Study of CHOP-14 Plus or Minus Alemtuzumab in Peripheral T-cell Lymphoma of the Elderly</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT00725231" target="_blank">NCT00725231</a></td>
<td>Phase 3</td>
<td style="word-wrap: break-word;">chemotherapy</td>
</tr>
<tr>
<td>7</td>
<td>A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy With or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL)</td>
<td>Recruiting</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT04365036" target="_blank">NCT04365036</a></td>
<td>Phase 3</td>
<td style="word-wrap: break-word;">Toripalimab;Pegaspargase;Gemcitabine;Oxaliplatin</td>
</tr>
<tr>
<td>8</td>
<td>The Efficacy and Safety of Etoposide, Dexamethasone, Peg-asparaginase or Plus Methotrexate With Sandwiched Radiotherapy in the Treatment of Stage I to II Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type</td>
<td>Active, not recruiting</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT02631239" target="_blank">NCT02631239</a></td>
<td>Phase 3</td>
<td style="word-wrap: break-word;">Methotrexate;Etoposide;Dexamethasone;Pegaspargase</td>
</tr>
<tr>
<td>9</td>
<td>A Phase III, Randomized, Double-Blind, Multicenter Study of Sugemalimab (CS1001) Plus PGemOx Regimen Versus Placebo Plus PGemOx for Subjects With Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (R/R ENKTL)</td>
<td>Not yet recruiting</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT05700448" target="_blank">NCT05700448</a></td>
<td>Phase 3</td>
<td style="word-wrap: break-word;">Placebo;Pegaspargase;Gemcitabine;Oxaliplatin</td>
</tr>
<tr>
<td>10</td>
<td>Phase II Study of Durvalumab in Combination With Lenalidomide in Relapsed/Refractory NK-T-cell Lymphoma</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT03054532" target="_blank">NCT03054532</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">Durvalumab;Lenali</td>
</tr>
<tr class="collapsable">
<td>11</td>
<td>Phase II Study of a Combination Chemotherapy of DICE in the Patients With NK/T Cell Lymphoma</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT00568607" target="_blank">NCT00568607</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">IFO, VP-16, DDP, DXM</td>
</tr>
<tr class="collapsable">
<td>12</td>
<td>Phase II Study of L-asparaginase Plus DICE Regimen in Patients With Stage I/II NK/T-cell Lymphoma</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT00933673" target="_blank">NCT00933673</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">L-asp, DXM, IFO, VP-16, DDP</td>
</tr>
<tr class="collapsable">
<td>13</td>
<td>A Multi-center, Prospective Study of the Efficacy and Safety of PD-1 Antibody (Sintilimab) in Combination With Pegaspargase and Erlotinib in the Treatment of Stage IV Extranodal NK/T-cell Lymphoma Unfit for High-intensity Chemotherapy</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT04004572" target="_blank">NCT04004572</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">LEAP regimen</td>
</tr>
<tr class="collapsable">
<td>14</td>
<td>An Open-lable, Single Arm, Single Center, Phase 2 Study of PD1 Combined With Apatinib in Patients With Relapsed or Refractory NK/T Cell</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT03701022" target="_blank">NCT03701022</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">SHR1210</td>
</tr>
<tr class="collapsable">
<td>15</td>
<td>Phase I/II Study of Safety and Efficacy of Tofacitinib Combined With Chidamide in Patients With Relapsed and Refractory Extranodal Natural Killer/T Cell Lymphoma</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT03598959" target="_blank">NCT03598959</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">tofacitinib;chidamide</td>
</tr>
<tr class="collapsable">
<td>16</td>
<td>Single-arm, Open and Multi-center Phase II Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral T-cell Lymphoma and NK/T-cell Lymphoma</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT03776279" target="_blank">NCT03776279</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">Mitoxantrone Hydrochloride Liposome Injection</td>
</tr>
<tr class="collapsable">
<td>17</td>
<td>A Phase II Study of Radiotherapy Followed by Chemotherapy With DICEP Regimen in Patients With NK/T-cell Lymphoma</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT01667302" target="_blank">NCT01667302</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">Radiotherapy followed by chemotherapy</td>
</tr>
<tr class="collapsable">
<td>18</td>
<td>Combination of Basiliximab and Pegaspargase in the Treatment of Relapsed/Refractory Extranodal NK/T-cell Lymphoma, Nasal Type: a Single Arm, Open Label, Phase 2 Trial</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT04337593" target="_blank">NCT04337593</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">Basiliximab;Pegaspargase</td>
</tr>
<tr class="collapsable">
<td>19</td>
<td>Maintenance Therapy With Anti-PD-1 Antibody for Patients With NK/T-cell Lymphoma: a Single Arm, Single Center, Open Label, Phase 2 Trial</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT04338282" target="_blank">NCT04338282</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">toripalimab</td>
</tr>
<tr class="collapsable">
<td>20</td>
<td>Gemcitabine, Pegaspargase, Etoposide, and Dexamethasone (GPED) for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma : a Single Arm,Open-lable,Phase II Study</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT04405375" target="_blank">NCT04405375</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">gemcitabin;Pegaspargase;Etoposide;Dexamethasone</td>
</tr>
<tr class="collapsable">
<td>21</td>
<td>Chimeric Antigen Receptor-Modified pNK Cells for CD7 Positive Relapsed or Refractory Leukemia and Lymphoma</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT02742727" target="_blank">NCT02742727</a></td>
<td>Phase 1, Phase 2</td>
<td style="word-wrap: break-word;"></td>
</tr>
<tr class="collapsable">
<td>22</td>
<td>Phase II Study of VIDL (VP-16, Ifosfamide, Dexamethasone, L-asparaginase) Chemotherapy Followed by High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Stage III/IV Extranodal NK-T-Cell Lymphoma</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT02544425" target="_blank">NCT02544425</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">Etoposide;Ifosfamide;Dexamethasone;L-asparaginase;Busulfan;Melphalan</td>
</tr>
<tr class="collapsable">
<td>23</td>
<td>Combination of Sintilimab and Decitabine for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma : a Single Arm,Open-lable,Phase II Study</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT04279379" target="_blank">NCT04279379</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">Sintilimab;Decitabine</td>
</tr>
<tr class="collapsable">
<td>24</td>
<td>Combination of Lenalidomide and Sintilimab for Patients With Relapsed/Refractory NK/T-cell Lymphoma Who Failed Pegaspargase-based Regimens: a Single Arm, Open, Phase II Study</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT04231370" target="_blank">NCT04231370</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">Sintilimab;Lenalidomide</td>
</tr>
<tr class="collapsable">
<td>25</td>
<td>A Multicentre, Open-label, Single-arm, Phase I/II Clinical Study to Evaluate the Safety, Efficacy and Pharmacokinetic Characteristics of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT04509466" target="_blank">NCT04509466</a></td>
<td>Phase 1, Phase 2</td>
<td style="word-wrap: break-word;">Part 1: Liposomal mitoxantrone hydrochloride and Pegaspargase;Part 2 (treatment-na&#239;ve patients): Liposomal mitoxantrone hydrochloride and Pegaspargase;Part 2 (relapsed or refractory patients): Liposomal mitoxantrone hydrochloride and Pegaspargase</td>
</tr>
<tr class="collapsable">
<td>26</td>
<td>Mild-dose Intensity-modulated Radiation Treatment for Stage IE/IIE Extranodal Nasal-type NK/T-cell Lymphoma With Complete Remission Tumor After Combination of Gemcitabine, Oxaliplatin, and Asparaginase (GELOX) Chemotherapy:a Phase II Study</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT02229682" target="_blank">NCT02229682</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;"></td>
</tr>
<tr class="collapsable">
<td>27</td>
<td>An Open-Label, Single Arm, Multi-Center, Phase 2 Study of PD-1 Antibody SHR-1210 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT03363555" target="_blank">NCT03363555</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">SHR-1210</td>
</tr>
<tr class="collapsable">
<td>28</td>
<td>An Open, Single-center, Phase II Clinical Trial for Treatment of Untreated Extranodal NK/T Cell Lymphoma With High Dose of Methotrexate in Combination With Gemcitabine, Pegaspargase and Dexamethasone (GAD-M Regimen)</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT01991158" target="_blank">NCT01991158</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">High dose of methotrexate;Gemcitabine;Pegaspargase;Dexamethasone</td>
</tr>
<tr class="collapsable">
<td>29</td>
<td>Gemcitabine, Pegaspargase, Etoposide, and Dexamethasone (GPED) for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma : a Single Arm,Open-lable,Phase II Study</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT04917250" target="_blank">NCT04917250</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">Gemcitabine;Pegaspargase;Etoposide;Dexamethasone</td>
</tr>
<tr class="collapsable">
<td>30</td>
<td>An Open-Label, Uncontrolled, Single Centered Phase  Study of Avastin Combined With Gemcitabine, Oxaliplatin, Pegaspargase and Dexamethasone (Avastin+ GemAOD) As First-Line Treatment in Patients With Untreated NK/T Cell Lymphoma</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT01921790" target="_blank">NCT01921790</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">Gemcitabine;Oxaliplatin;Pegaspargase;Dexamethasone</td>
</tr>
<tr class="collapsable">
<td>31</td>
<td>The Efficacy and Safety of Anti-PD-1 Antibody in Combination With Pegaspargase in the Treatment of Newly Diagnosed, Stage III to IV Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type</td>
<td>Unknown status</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT04096690" target="_blank">NCT04096690</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">Pegaspargase;Anti-PD-1 monoclonal antibody</td>
</tr>
<tr class="collapsable">
<td>32</td>
<td>Efficacy and Safety Evaluation of IBI308 in Patients With Relapsed/Refractory Extranodal NK/T Cell Lymphoma, Nasal Type: a Multicenter, Single Arm, Phase 2 Study (ORIENT-4)</td>
<td>Completed</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT03228836" target="_blank">NCT03228836</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">Sintilimab</td>
</tr>
<tr class="collapsable">
<td>33</td>
<td>Prospective, Multicenter, Open-labeled, Phase I/II Study of the Efficacy and Safety of Copanlisib (BAY 80-6946) and Gemcitabine Combination in Patients With Relapsed/Refractory Peripheral T-cell or NK/T-cell Lymphoma</td>
<td>Completed</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT03052933" target="_blank">NCT03052933</a></td>
<td>Phase 1, Phase 2</td>
<td style="word-wrap: break-word;">Copanlisib;Gemcitabine</td>
</tr>
<tr class="collapsable">
<td>34</td>
<td>A Phase II Study of Concurrent Chemoradiation Followed by VIPD (Etoposide/Ifosfamide/Cisplatin/Dexamethasone) in Stage I, II Nasal NK/T-cell Lymphoma</td>
<td>Completed</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT00418535" target="_blank">NCT00418535</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">Concurrent Radiotherapy (RT)/cisplatin, VIPD</td>
</tr>
<tr class="collapsable">
<td>35</td>
<td>Phase II Study of an Association of L-asparaginase-Methotrexate-Dexamethasone for Relapsing and/or Refractory Nasal and Nasal-type NK-T-cell Lymphoma</td>
<td>Completed</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT00283985" target="_blank">NCT00283985</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">Kidrolase;Methotrexate;Dexamethasone;Erwinase</td>
</tr>
<tr class="collapsable">
<td>36</td>
<td>A Phase II Study of Concurrent Chemoradiation for The Localized Nasal NK/T-cell Lymphoma</td>
<td>Completed</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT00292695" target="_blank">NCT00292695</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;"></td>
</tr>
<tr class="collapsable">
<td>37</td>
<td>An Open, Single-center, Phase II Study of Sintilimab, Peg-aspargase Plus Anlotinib &quot;Sandwich&quot;With Radiotherapy in Previously Untreated Stage I-II Extranodal NK/T Cell Lymphoma</td>
<td>Completed</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT03936452" target="_blank">NCT03936452</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">Sintilimab</td>
</tr>
<tr class="collapsable">
<td>38</td>
<td>Phase II Study of L-asparaginase Monotherapy as Salvage Treatment in Patients With NK/T Cell Lymphoma</td>
<td>Completed</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT00854425" target="_blank">NCT00854425</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">L-asparaginase</td>
</tr>
<tr class="collapsable">
<td>39</td>
<td>Radiotherapy Combined With GDP (Gemcitabine, Cisplatin, Dexamethasone) Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma Patients With Unfavorable Prognostic Factors: an Open-label, Single-arm, Phase II Clinical Trial</td>
<td>Completed</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT02276248" target="_blank">NCT02276248</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">GDP chemotherapy</td>
</tr>
<tr class="collapsable">
<td>40</td>
<td>An Open-label Phase 2 Study of Intravenous Bortezomib and Oral Panobinostat (LBH589) in Adult Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma After Failure of Conventional Chemotherapy</td>
<td>Completed</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT00901147" target="_blank">NCT00901147</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">panobinostat and bortezomib</td>
</tr>
<tr class="collapsable">
<td>41</td>
<td>Open-labeled, Multicenter Phase II Study of Concomitant Chemo-radiotherapy Followed by VIDL Chemotherapy With Risk-based Application of Autologous Stem Cell Transplantation in Stage I/II Extranodal NK/T-cell Lymphoma</td>
<td>Completed</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT01007526" target="_blank">NCT01007526</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;"></td>
</tr>
<tr class="collapsable">
<td>42</td>
<td>Open-labeled, Multicenter Phase II Study of Concomitant Chemo-radiotherapy Followed by MIDLE (Methotrexate, Ifosfamide, Dexamethasone, L-asparaginase, Etoposide) Chemotherapy in Stage I/II Extranodal NK/T-cell Lymphoma</td>
<td>Completed</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT01238159" target="_blank">NCT01238159</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;"></td>
</tr>
<tr class="collapsable">
<td>43</td>
<td>High-dose Busulfan, High-dose Cyclophosphamide, and Allogeneic Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndromes, Multiple Myeloma and Lymphoma</td>
<td>Completed</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT01177371" target="_blank">NCT01177371</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">busulfan;cyclophosphamide;methylprednisolone;methotrexate;cyclosporine</td>
</tr>
<tr class="collapsable">
<td>44</td>
<td>A Phase I/II Clinical Trial of the mTor Inhibitor RAD001 (Everolimus) in Combination With Lenalidomide (Revlimid) for Patients With Relapsed or Refractory Lymphoid Malignancy</td>
<td>Completed</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT01075321" target="_blank">NCT01075321</a></td>
<td>Phase 1, Phase 2</td>
<td style="word-wrap: break-word;">everolimus;lenalidomide</td>
</tr>
<tr class="collapsable">
<td>45</td>
<td>A Phase II Study of Bendamustine (B), Etoposide (E), Dexamethasone (D), and GCSF for Peripheral Blood Hematopoietic Stem Cell Mobilization (BED)</td>
<td>Completed</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT01110135" target="_blank">NCT01110135</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">bendamustine hydrochloride;dexamethasone;etoposide</td>
</tr>
<tr class="collapsable">
<td>46</td>
<td>Phase II Study of MK-2206 in Patients With Relapsed Lymphoma</td>
<td>Completed</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT01258998" target="_blank">NCT01258998</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">Akt inhibitor MK2206</td>
</tr>
<tr class="collapsable">
<td>47</td>
<td>Pegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell Lymphoma</td>
<td>Completed</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT02825147" target="_blank">NCT02825147</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">Pegaspargase;Methotrexate;Dexamethasone;Etoposide</td>
</tr>
<tr class="collapsable">
<td>48</td>
<td>A Phase 2, Open-Label Study of BGB-A317 in Patients With Relapsed or Refractory Mature T- and NK-cell Neoplasms</td>
<td>Completed</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT03493451" target="_blank">NCT03493451</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">Tislelizumab</td>
</tr>
<tr class="collapsable">
<td>49</td>
<td>A Phase I/II Study of the Histone Deacetylase (HDAC) Inhibitor LBH589 (Panobinostat) in Combination With mTOR Inhibitor RAD001 (Everolimus) in Patients With Relapsed Multiple Myeloma or Lymphoma</td>
<td>Completed</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT00918333" target="_blank">NCT00918333</a></td>
<td>Phase 1, Phase 2</td>
<td style="word-wrap: break-word;">panobinostat;everolimus</td>
</tr>
<tr class="collapsable">
<td>50</td>
<td>A Phase II Study of the Histone Deacetylase (HDAC) Inhibitor LBH589 (Panobinostat) in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma</td>
<td>Completed</td>
<td> <a href="https://clinicaltrials.gov/ct2/show/NCT01261247" target="_blank">NCT01261247</a></td>
<td>Phase 2</td>
<td style="word-wrap: break-word;">panobinostat</td>
</tr>
</tbody>
</table>
<div>
<p>
<text>Search</text>
<a href="https://clinicalstudies.info.nih.gov/htmlSearchedFile.aspx?Query=Nasal Type Extranodal Nk/t-Cell Lymphoma&amp;status=&amp;gender=Select%20One&amp;Inst=&amp;age=&amp;healthyVolunteer=0" target="_blank">NIH Clinical Center</a>
<text>for Nasal Type Extranodal Nk/t-Cell Lymphoma</text>
</p>
</div>
</div>
</td>
</tr>
</table>
</div>
<div class="section" id="genetic_testing">
<div class="section-header">
<div class="jump-to-section">
<select onchange="jumpToSection(this);">
<option selected="selected" value>Jump to section</option>
<option value="#aliases_descriptions">Aliases &amp; Classifications</option>
<option value="#anatomical_context">Anatomical Context</option>
<option value="#therapeutics">Drugs &amp; Therapeutics</option>
<option value="#expression_profiles">Expression</option>
<option value="#related_genes">Genes</option>
<option value="#genetic_testing">Genetic Tests</option>
<option value="#goterms">GO Terms</option>
<option value="#pathways">Pathways</option>
<option value="#publications">Publications</option>
<option value="#disorders">Related Diseases</option>
<option value="#sources">Sources</option>
<option value="#summaries">Summaries</option>
<option value="#clinical_features">Symptoms &amp; Phenotypes</option>
<option value="#genetic_variations">Variations</option>
<option value="#container">Top</option>
<option value="#footer">Bottom</option>
</select>
</div>
<div class="section-header-sources">
<a href="#sources">Sources</a>
</div>
<h2 class="title">
<span itemprop="aspect">Genetic Tests<small> for Nasal Type Extranodal Nk/t-Cell Lymphoma</small></span>
</h2>
<div class="about-section">
<a href="/pages/info#genetic_testing">
<img src="/img/menu/help_icon.png" alt="About this section" title="About this section" style="width:20px;margin:0px;" />
</a>
</div>
</div>
<table class="section-table">
<tr>
<td class="rhs">
</td>
</tr>
</table>
</div>
<div class="section" id="anatomical_context">
<div class="section-header">
<div class="jump-to-section">
<select onchange="jumpToSection(this);">
<option selected="selected" value>Jump to section</option>
<option value="#aliases_descriptions">Aliases &amp; Classifications</option>
<option value="#anatomical_context">Anatomical Context</option>
<option value="#therapeutics">Drugs &amp; Therapeutics</option>
<option value="#expression_profiles">Expression</option>
<option value="#related_genes">Genes</option>
<option value="#genetic_testing">Genetic Tests</option>
<option value="#goterms">GO Terms</option>
<option value="#pathways">Pathways</option>
<option value="#publications">Publications</option>
<option value="#disorders">Related Diseases</option>
<option value="#sources">Sources</option>
<option value="#summaries">Summaries</option>
<option value="#clinical_features">Symptoms &amp; Phenotypes</option>
<option value="#genetic_variations">Variations</option>
<option value="#container">Top</option>
<option value="#footer">Bottom</option>
</select>
</div>
<div class="section-header-sources">
<a href="#sources">Sources</a>
</div>
<h2 class="title">
<span itemprop="aspect">Anatomical Context<small> for Nasal Type Extranodal Nk/t-Cell Lymphoma</small></span>
</h2>
<div class="about-section">
<a href="/pages/info#anatomical_context">
<img src="/img/menu/help_icon.png" alt="About this section" title="About this section" style="width:20px;margin:0px;" />
</a>
</div>
</div>
<table class="section-table">
<tr>
<td class="rhs">
<h3>Organs/tissues related to Nasal Type Extranodal Nk/t-Cell Lymphoma: <sup title="MalaCards">39</sup>
</h3>
<span itemprop="associatedAnatomy" itemscope="itemscope" itemtype="http://schema.org/AnatomicalStructure">
<div class="tab">
<span itemprop="name">
<span title="6.056206">T Cells</span>
</span>
<sup title="MalaCards"><span title="MalaCards">39</span> </sup>
, <span itemprop="name">
<span title="3.954668">Skin</span>
</span>
<sup title="MalaCards"><span title="MalaCards">39</span> </sup>
, <span itemprop="name">
<span title="0.9571577">Bone Marrow</span>
</span>
<sup title="MalaCards"><span title="MalaCards">39</span> </sup>
, <span itemprop="name">
<span title="0.8075421">Liver</span>
</span>
<sup title="MalaCards"><span title="MalaCards">39</span> </sup>
, <span itemprop="name">
<span title="0.4623323">Bone</span>
</span>
<sup title="MalaCards"><span title="MalaCards">39</span> </sup>
, <span itemprop="name">
<span title="0.2599178">Small Intestine</span>
</span>
<sup title="MalaCards"><span title="MalaCards">39</span> </sup>
, <span itemprop="name">
<span title="0.2310213">Nk Cells</span>
</span>
<sup title="MalaCards"><span title="MalaCards">39</span> </sup>
</div>
</span>
</td>
</tr>
</table>
</div>
<div class="section" id="publications">
<div class="section-header">
<div class="jump-to-section">
<select onchange="jumpToSection(this);">
<option selected="selected" value>Jump to section</option>
<option value="#aliases_descriptions">Aliases &amp; Classifications</option>
<option value="#anatomical_context">Anatomical Context</option>
<option value="#therapeutics">Drugs &amp; Therapeutics</option>
<option value="#expression_profiles">Expression</option>
<option value="#related_genes">Genes</option>
<option value="#genetic_testing">Genetic Tests</option>
<option value="#goterms">GO Terms</option>
<option value="#pathways">Pathways</option>
<option value="#publications">Publications</option>
<option value="#disorders">Related Diseases</option>
<option value="#sources">Sources</option>
<option value="#summaries">Summaries</option>
<option value="#clinical_features">Symptoms &amp; Phenotypes</option>
<option value="#genetic_variations">Variations</option>
<option value="#container">Top</option>
<option value="#footer">Bottom</option>
</select>
</div>
<div class="section-header-sources">
<a href="#sources">Sources</a>
</div>
<h2 class="title">
<span itemprop="aspect">Publications<small> for Nasal Type Extranodal Nk/t-Cell Lymphoma</small></span>
</h2>
<div class="about-section">
<a href="/pages/info#publications">
<img src="/img/menu/help_icon.png" alt="About this section" title="About this section" style="width:20px;margin:0px;" />
</a>
</div>
</div>
<table class="section-table">
<tr>
<td class="rhs">
<div class="section-data">
<h3>Text-mined articles related to Nasal Type Extranodal Nk/t-Cell Lymphoma according to PubMed:</h3> <div class="badge badge-improved">
<a href="/pages/whatsnew" target="_blank">IMPROVED</a>
</div>
<span class="showmore">
(<a id="InferredPublications-table_SeeMore" href="javascript:showMoreTable('InferredPublications-table','InferredPublications-table_SeeMore', 'show top 50', 'showing 50, show less','collapsable')">show top 50</a>)
</span>
<span class="showmore">
(<a href="#" class="showAll" onclick="javascript: return showAll('InferredPublications', '2137', 'InferredPublications-table');">show all 2137</a>)
</span>
<table id="InferredPublications-table">
<thead>
<tr>
<th width="12">#</th>
<th>Title</th>
<th>Authors</th>
<th>PMID</th>
<th>Year</th>
</tr>
</thead>
<tbody>
<tr>
<td>1</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
A nuclear NKRF interacting long noncoding RNA controls EBV eradication and suppresses tumor progression in natural killer/T-cell lymphoma.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Wang WF...Zhao WL</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37084822" target="_blank">37084822</a></td>
<td>2023</td>
</tr>
<tr>
<td>2</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
First-line immunotherapy with anti-PD-1 antibody for extranodal NK/T-cell lymphoma: A retrospective study.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Wang X...Huang H</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37394245" target="_blank">37394245</a></td>
<td>2023</td>
</tr>
<tr>
<td>3</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
[Primary adrenal NK/T cell lymphoma: a clinicopathologic analysis of six cases].
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Zhou SL...Kong LF</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37408402" target="_blank">37408402</a></td>
<td>2023</td>
</tr>
<tr>
<td>4</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
NK/T-cell Lymphoma With Orbital Involvement: A Case Report and Systematic Review of the Literature.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Dhodapkar RM...Pointdujour-Lim R</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/36692957" target="_blank">36692957</a></td>
<td>2023</td>
</tr>
<tr>
<td>5</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma Recurrence at Penile Glans Masquerading Urinary Contamination on 18F-FDG PET/CT.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Zhang Y...Su M</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37418289" target="_blank">37418289</a></td>
<td>2023</td>
</tr>
<tr>
<td>6</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Berning P...Glass B</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37157017" target="_blank">37157017</a></td>
<td>2023</td>
</tr>
<tr>
<td>7</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Long-term survival by surgery and adjuvant chemotherapy in a patient with perforated extranodal NK/T-cell lymphoma of the small intestine: a retrospective case study.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Funaki H...Masaki Y</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37306807" target="_blank">37306807</a></td>
<td>2023</td>
</tr>
<tr>
<td>8</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Disseminated Extranodal NK/T-Cell lymphoma, Presenting as an Orbital Mass.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Gonzalez Martinez OG...Milman T</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37351864" target="_blank">37351864</a></td>
<td>2023</td>
</tr>
<tr>
<td>9</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Comparative analysis of upper aerodigestive tract and non-upper aerodigestive tract in NK/T-cell lymphoma.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Liu X...Xu X</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37351807" target="_blank">37351807</a></td>
<td>2023</td>
</tr>
<tr>
<td>10</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
[Influence of Pre-treatment Lymphocyte/Monocyte Ratio and Neutrophil/Lymphocyte Ratio on the Prognosis of Patients with Extranodal NK/T-Cell Lymphoma].
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Deng XY...Yang DK</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37356930" target="_blank">37356930</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>11</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
[Regulation of Baicalin on Growth of Extranodal NK/T Cell Lymphoma Cells through FOXO3/CCL22 Signaling Pathway].
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Duan XH...Liang R</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37356933" target="_blank">37356933</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>12</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Methyltransferase-like 3 enhances cell proliferation and cisplatin resistance in natural killer/T-cell lymphoma through promoting N6-methyladenosine modification and the stability of staphylococcal nuclease and Tudor domain-containing protein 1 mRNA.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Li N...Liu B</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/36730541" target="_blank">36730541</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>13</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Li JY...Li YX</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37306711" target="_blank">37306711</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>14</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Up-front autologous hematopoietic stem cell transplantation after first complete remission improved prognosis of advanced extra-nodal NKT cell lymphoma: A multicenter real-world study in China.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Gao H...Gao C</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/36825748" target="_blank">36825748</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>15</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Clinical characteristics analysis of sinonasal diffuse large B-cell lymphoma and extranodal NK/T-cell lymphoma.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Jang HB...Lim SC</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37329243" target="_blank">37329243</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>16</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Expression of Tryptophan Metabolism Enzymes in Patients with Diffuse Large B-cell Lymphoma and NK/T-cell Lymphoma.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Guo D...Zhang Y</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37148546" target="_blank">37148546</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>17</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Prognostic value of soluble programmed cell death ligand-1 (sPD-L1) in lymphoma: a systematic review and meta-analysis.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Ding Y...Zhai Z</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37382610" target="_blank">37382610</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>18</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
[Clinical Analysis of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm].
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Cheng P...Zou L</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37356957" target="_blank">37356957</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>19</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
An update on viral-induced cutaneous lymphoproliferative disorders. CME Part I.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Plaza JA...Sangueza MJ</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/36041557" target="_blank">36041557</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>20</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Epstein-Barr virus: the molecular virology and the associated diseases.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Murata T</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37234394" target="_blank">37234394</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>21</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Argirion I...Liu Z</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/36788424" target="_blank">36788424</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>22</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Salvage camrelizumab for an intractable NK/T cell lymphoma patient with two instances of intestinal perforation: a case report and literature review.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Xia Y...Zhu F</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37259738" target="_blank">37259738</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>23</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
FDG PET/CT in a Case of Esophageal Extranodal NK/T-Cell Lymphoma, Nasal Type.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Zhang J...Wang Y</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/36727864" target="_blank">36727864</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>24</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">He Y...Huang H</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/35809114" target="_blank">35809114</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>25</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Inhibition of extranodal NK/T-cell lymphoma by Chiauranib through an AIF-dependent pathway and its synergy with L-asparaginase.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Gao T...Li Z</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37160920" target="_blank">37160920</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>26</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L-asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T-cell lymphoma: A French retrospective study.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Chaubard S...Jaccard A</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/36799516" target="_blank">36799516</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>27</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Extranodal NK/T-cell lymphoma with isolated central nervous system relapse: A defiant disease and the role of flow cytometry in monitoring.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Panda D...Mehta A</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37139678" target="_blank">37139678</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>28</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
A Case Report of Extranodal NK/T-Cell Lymphoma Misdiagnosed as Meibomitis.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Wu C...Zhang Y</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37186811" target="_blank">37186811</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>29</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Etoposide, dexamethasone, and pegaspargase with sandwiched radiotherapy in early-stage natural killer/T-cell lymphoma: A randomized phase III study.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Zhong H...Zhao W</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37181228" target="_blank">37181228</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>30</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
CD4-positive extranodal NK/T-cell lymphoma with T-cell receptor  phenotype.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Hisamoto T...Sato S</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37208849" target="_blank">37208849</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>31</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Extranodal NK/T-cell lymphoma manifesting as cutaneous lesions and intestinal perforation: A case report.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Shi J...Kang X</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37317724" target="_blank">37317724</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>32</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
A novel prognostic model based on ferritin and nomogram-revised risk index could better stratify patients with extranodal natural killer/T-cell lymphoma.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Liu X...Wang L</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/36924334" target="_blank">36924334</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>33</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Comparison of the clinical efficacies of two L-asparaginase-based chemotherapy regimens for newly diagnosed nasal-type extranodal NK/T-cell lymphoma.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Wu W...Zou L</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37000008" target="_blank">37000008</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>34</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Clinical analysis of patients with primary and secondary extranodal natural killer/T-cell lymphoma of central nervous system.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Li X...Zhang M</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/34061378" target="_blank">34061378</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>35</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
A controlling nutritional status score is an independent predictor for patients with newly diagnosed nasal-type extranodal NK/T-cell lymphoma based on asparaginase-containing regimens.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Wu W...Zou L</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/36866811" target="_blank">36866811</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>36</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Review on natural killer/T-cell lymphoma.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">He X...Huang H</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/34731509" target="_blank">34731509</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>37</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Synergistic anticancer effect of a combination of chidamide and etoposide against NK/T cell lymphoma.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Song W...Zhang M</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/34854108" target="_blank">34854108</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>38</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Central nervous system involvement at initial diagnosis of extranodal NK/T-cell lymphoma: a retrospective study of a consecutive 12-year case series.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Wu W...Zou L</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/36729147" target="_blank">36729147</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>39</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Primary spinal extranodal NK/T-cell lymphoma diagnosed by fine-needle aspiration and core biopsy.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Tefft J...Zhang X</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/36585874" target="_blank">36585874</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>40</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
A neutrophil/lymphocyte Ratio as a Significant Predictor for Patients with low-risk and early-stage Extranodal NK-T-cell Lymphoma.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Wu W...Zou L</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37006977" target="_blank">37006977</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>41</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent anti-lymphoma activity in preclinical models.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Ke H...Li QX</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37012357" target="_blank">37012357</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>42</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
[Clinical Anslysis of Primary Adrenal NK/T-Cell Lymphoma].
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Ji XY...He HS</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37096511" target="_blank">37096511</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>43</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Newly diagnosed extranodal NK/T-cell lymphoma, nasal type, at the injected left arm after BNT162b2 mRNA COVID-19 vaccination.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Tachita T...Sakuraba H</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37093551" target="_blank">37093551</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>44</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Primary Non-Hodgkin's Lymphoma of the Nose: A Rare Case Report.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Biradar K...Paramasivam PK</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37206787" target="_blank">37206787</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>45</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Radiological aspects of lymphomas and leukaemias affecting the jaws: A systematic review.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Gomes NR...Fonseca FP</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/36852531" target="_blank">36852531</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>46</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
EBV and Lymphomagenesis.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Sausen DG...Muqeemuddin S</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37046794" target="_blank">37046794</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>47</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Intermittent fever and cough in a 56-year-old patient: Relapsing polychondritis and extranodal NK/T-cell lymphoma.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Huang Q...Yang M</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37138649" target="_blank">37138649</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>48</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
[Clinical analysis of 7 cases of pregnancy with non-Hodgkin lymphoma].
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Liu H...Dai YM</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/36935198" target="_blank">36935198</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>49</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Establishment and comprehensive analysis of a new human cell line (NK-NJ) with NK-cell characteristics established from extranodal natural killer cell lymphoma/leukemia.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Liang JH...Xu W</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/36520345" target="_blank">36520345</a></td>
<td>2023</td>
</tr>
<tr class="collapsable">
<td>50</td>
<td>
<div itemscope="itemscope" itemtype="http://schema.org/MedicalScholarlyArticle">
<span itemprop="name">
Diagnostic value of IL-22, IL-23, and IL-17 for NK/T cell lymphoma.
<sup title="PubMed">62</sup>
</span>
</div>
</td>
<td>
<div itemprop="author" itemscope="itemscope" itemtype="http://schema.org/Person">
<span itemprop="name">Qi Y...Xie B</span>
</div>
</td>
<td> <a href="https://pubmed.ncbi.nlm.nih.gov/37300674" target="_blank">37300674</a></td>
<td>2023</td>
</tr>
</tbody>
</table>
</div>
</td>
</tr>
</table>
</div>
<div class="section" id="related_genes">
<div class="section-header">
<div class="jump-to-section">
<select onchange="jumpToSection(this);">
<option selected="selected" value>Jump to section</option>
<option value="#aliases_descriptions">Aliases &amp; Classifications</option>
<option value="#anatomical_context">Anatomical Context</option>
<option value="#therapeutics">Drugs &amp; Therapeutics</option>
<option value="#expression_profiles">Expression</option>
<option value="#related_genes">Genes</option>
<option value="#genetic_testing">Genetic Tests</option>
<option value="#goterms">GO Terms</option>
<option value="#pathways">Pathways</option>
<option value="#publications">Publications</option>
<option value="#disorders">Related Diseases</option>
<option value="#sources">Sources</option>
<option value="#summaries">Summaries</option>
<option value="#clinical_features">Symptoms &amp; Phenotypes</option>
<option value="#genetic_variations">Variations</option>
<option value="#container">Top</option>
<option value="#footer">Bottom</option>
</select>
</div>
<div class="section-header-sources">
<a href="#sources">Sources</a>
</div>
<h2 class="title">
<span itemprop="aspect">Genes<small> for Nasal Type Extranodal Nk/t-Cell Lymphoma</small></span>
</h2>
<div class="about-section">
<a href="/pages/info#related_genes">
<img src="/img/menu/help_icon.png" alt="About this section" title="About this section" style="width:20px;margin:0px;" />
</a>
</div>
</div>
<table class="section-table">
<tr>
<td class="rhs">
<div class="section-data">
<div class="no_wrap">
<h3>Genes related to Nasal Type Extranodal Nk/t-Cell Lymphoma (0 elite genes):</h3>
</div>
<div class="no_wrap" style="margin-top:7px;">
<div class="asterisk_icon" style="margin-top:5px;"></div>
<div style="float:left;">&nbsp;- Elite gene</div>
<div style="margin-top:3px;float:left;margin-top: -4px;margin-bottom: 6px;margin-left: 5px;">
<a href="/pages/info#elite_genes">
<img src="/img/menu/help_icon.png" alt="About elite gene" title="About elite gene" style="width:20px;margin:0px;">
</a>
</div>
<div class="cc_icon" style="margin-left:35px;"></div>
<div>&nbsp;- Cancer Census gene in COSMIC</div>
<div style="margin-top: -6px;margin-bottom: 6px;margin-left: 5px;">
<a href="/pages/info#census_genes"><img src="/img/menu/help_icon.png" alt="About Cancer Census gene" title="About Cancer Census gene" style="width:20px;margin:0px;"></a>
</div>
</div>
<table id="RelatedGenes-table" style="table-layout:fixed;">
<thead>
<tr>
<th width="12">#</th>
<th width="135"><div class="no_wrap"><div>Symbol</div></div></th>
<th width="225">Description</th>
<th width="70">Category</th>
<th width="42" title="Solr Relevance Score">Score</th>
<th width="180">Evidence</th>
<th width="120" style="white-space:nowrap">PubMed IDs</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="1">1</td>
<td>
<div class="no_wrap">
<div> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDM4C" title="KDM4C gene information at GeneCards" target="_blank">KDM4C</a></div>
</div>
</td>
<td>Lysine Demethylase 4C</td>
<td>Protein Coding</td>
<td>5.82</td>
<td>
<div>
DISEASES inferred
<sup title="The University of Copenhagen DISEASES"> <a href="http://diseases.jensenlab.org/Entity?documents=10&amp;type1=9606&amp;id1=ENSP00000370710&amp;type2=-26&amp;id2=DOID:0080797" title="The University of Copenhagen DISEASES" target="_blank">14</a></sup>
<sup title="The University of Copenhagen DISEASES"> <a href="http://diseases.jensenlab.org/Entity?documents=10&amp;type1=9606&amp;id1=ENSP00000442382&amp;type2=-26&amp;id2=DOID:0080797" title="The University of Copenhagen DISEASES" target="_blank">14</a></sup>
</div>
</td>
<td>
<div id="pubmedids_item_1">
<span>
</span>
</div>
</td>
</tr>
<tr>
<td rowspan="1">2</td>
<td>
<div class="no_wrap">
<div> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a></div>
</div>
</td>
<td>Neural Cell Adhesion Molecule 1</td>
<td>Protein Coding</td>
<td>5.66</td>
<td>
<div>
DISEASES inferred
<sup title="The University of Copenhagen DISEASES"> <a href="http://diseases.jensenlab.org/Entity?documents=10&amp;type1=9606&amp;id1=ENSP00000480132&amp;type2=-26&amp;id2=DOID:0080797" title="The University of Copenhagen DISEASES" target="_blank">14</a></sup>
</div>
</td>
<td>
<div id="pubmedids_item_2">
<span>
</span>
</div>
</td>
</tr>
<tr>
<td rowspan="1">3</td>
<td>
<div class="no_wrap">
<div> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TIA1" title="TIA1 gene information at GeneCards" target="_blank">TIA1</a></div>
</div>
</td>
<td>TIA1 Cytotoxic Granule Associated RNA Binding Protein</td>
<td>Protein Coding</td>
<td>5.53</td>
<td>
<div>
DISEASES inferred
<sup title="The University of Copenhagen DISEASES"> <a href="http://diseases.jensenlab.org/Entity?documents=10&amp;type1=9606&amp;id1=ENSP00000401371&amp;type2=-26&amp;id2=DOID:0080797" title="The University of Copenhagen DISEASES" target="_blank">14</a></sup>
</div>
</td>
<td>
<div id="pubmedids_item_3">
<span>
</span>
</div>
</td>
</tr>
<tr>
<td rowspan="1">4</td>
<td>
<div class="no_wrap">
<div> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KLRC3" title="KLRC3 gene information at GeneCards" target="_blank">KLRC3</a></div>
</div>
</td>
<td>Killer Cell Lectin Like Receptor C3</td>
<td>Protein Coding</td>
<td>5.35</td>
<td>
<div>
DISEASES inferred
<sup title="The University of Copenhagen DISEASES"> <a href="http://diseases.jensenlab.org/Entity?documents=10&amp;type1=9606&amp;id1=ENSP00000371328&amp;type2=-26&amp;id2=DOID:0080797" title="The University of Copenhagen DISEASES" target="_blank">14</a></sup>
</div>
</td>
<td>
<div id="pubmedids_item_4">
<span>
</span>
</div>
</td>
</tr>
<tr>
<td rowspan="1">5</td>
<td>
<div class="no_wrap">
<div> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a></div>
</div>
</td>
<td>TNF Receptor Superfamily Member 8</td>
<td>Protein Coding</td>
<td>5.27</td>
<td>
<div>
DISEASES inferred
<sup title="The University of Copenhagen DISEASES"> <a href="http://diseases.jensenlab.org/Entity?documents=10&amp;type1=9606&amp;id1=ENSP00000263932&amp;type2=-26&amp;id2=DOID:0080797" title="The University of Copenhagen DISEASES" target="_blank">14</a></sup>
</div>
</td>
<td>
<div id="pubmedids_item_5">
<span>
</span>
</div>
</td>
</tr>
<tr>
<td rowspan="1">6</td>
<td>
<div class="no_wrap">
<div> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD2" title="CD2 gene information at GeneCards" target="_blank">CD2</a></div>
</div>
</td>
<td>CD2 Molecule</td>
<td>Protein Coding</td>
<td>4.94</td>
<td>
<div>
DISEASES inferred
<sup title="The University of Copenhagen DISEASES"> <a href="http://diseases.jensenlab.org/Entity?documents=10&amp;type1=9606&amp;id1=ENSP00000358490&amp;type2=-26&amp;id2=DOID:0080797" title="The University of Copenhagen DISEASES" target="_blank">14</a></sup>
</div>
</td>
<td>
<div id="pubmedids_item_6">
<span>
</span>
</div>
</td>
</tr>
<tr>
<td rowspan="1">7</td>
<td>
<div class="no_wrap">
<div> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=ASPG" title="ASPG gene information at GeneCards" target="_blank">ASPG</a></div>
</div>
</td>
<td>Asparaginase</td>
<td>Protein Coding</td>
<td>4.92</td>
<td>
<div>
DISEASES inferred
<sup title="The University of Copenhagen DISEASES"> <a href="http://diseases.jensenlab.org/Entity?documents=10&amp;type1=9606&amp;id1=ENSP00000450040&amp;type2=-26&amp;id2=DOID:0080797" title="The University of Copenhagen DISEASES" target="_blank">14</a></sup>
</div>
</td>
<td>
<div id="pubmedids_item_7">
<span>
</span>
</div>
</td>
</tr>
<tr>
<td rowspan="1">8</td>
<td>
<div class="no_wrap">
<div> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB" title="GZMB gene information at GeneCards" target="_blank">GZMB</a></div>
</div>
</td>
<td>Granzyme B</td>
<td>Protein Coding</td>
<td>4.71</td>
<td>
<div>
DISEASES inferred
<sup title="The University of Copenhagen DISEASES"> <a href="http://diseases.jensenlab.org/Entity?documents=10&amp;type1=9606&amp;id1=ENSP00000216341&amp;type2=-26&amp;id2=DOID:0080797" title="The University of Copenhagen DISEASES" target="_blank">14</a></sup>
</div>
</td>
<td>
<div id="pubmedids_item_8">
<span>
</span>
</div>
</td>
</tr>
</tbody>
</table>
</div>
</td>
</tr>
</table>
</div>
<div class="section" id="genetic_variations">
<div class="section-header">
<div class="jump-to-section">
<select onchange="jumpToSection(this);">
<option selected="selected" value>Jump to section</option>
<option value="#aliases_descriptions">Aliases &amp; Classifications</option>
<option value="#anatomical_context">Anatomical Context</option>
<option value="#therapeutics">Drugs &amp; Therapeutics</option>
<option value="#expression_profiles">Expression</option>
<option value="#related_genes">Genes</option>
<option value="#genetic_testing">Genetic Tests</option>
<option value="#goterms">GO Terms</option>
<option value="#pathways">Pathways</option>
<option value="#publications">Publications</option>
<option value="#disorders">Related Diseases</option>
<option value="#sources">Sources</option>
<option value="#summaries">Summaries</option>
<option value="#clinical_features">Symptoms &amp; Phenotypes</option>
<option value="#genetic_variations">Variations</option>
<option value="#container">Top</option>
<option value="#footer">Bottom</option>
</select>
</div>
<div class="section-header-sources">
<a href="#sources">Sources</a>
</div>
<h2 class="title">
<span itemprop="aspect">Variations<small> for Nasal Type Extranodal Nk/t-Cell Lymphoma</small></span>
</h2>
<div class="about-section">
<a href="/pages/info#genetic_variations">
<img src="/img/menu/help_icon.png" alt="About this section" title="About this section" style="width:20px;margin:0px;" />
</a>
</div>
</div>
<table class="section-table">
<tr>
<td class="rhs">
<div class="section-data">
</div>
</td>
</tr>
</table>
</div>
<div class="section" id="expression_profiles">
<div class="section-header">
<div class="jump-to-section">
<select onchange="jumpToSection(this);">
<option selected="selected" value>Jump to section</option>
<option value="#aliases_descriptions">Aliases &amp; Classifications</option>
<option value="#anatomical_context">Anatomical Context</option>
<option value="#therapeutics">Drugs &amp; Therapeutics</option>
<option value="#expression_profiles">Expression</option>
<option value="#related_genes">Genes</option>
<option value="#genetic_testing">Genetic Tests</option>
<option value="#goterms">GO Terms</option>
<option value="#pathways">Pathways</option>
<option value="#publications">Publications</option>
<option value="#disorders">Related Diseases</option>
<option value="#sources">Sources</option>
<option value="#summaries">Summaries</option>
<option value="#clinical_features">Symptoms &amp; Phenotypes</option>
<option value="#genetic_variations">Variations</option>
<option value="#container">Top</option>
<option value="#footer">Bottom</option>
</select>
</div>
<div class="section-header-sources">
<a href="#sources">Sources</a>
</div>
<h2 class="title">
<span itemprop="aspect">Expression<small> for Nasal Type Extranodal Nk/t-Cell Lymphoma</small></span>
</h2>
<div class="about-section">
<a href="/pages/info#expression_profiles">
<img src="/img/menu/help_icon.png" alt="About this section" title="About this section" style="width:20px;margin:0px;" />
</a>
</div>
</div>
<table class="section-table">
<tr>
<td class="rhs">
<div class="section-data">
<div class="expression-images">
</div>
<div>
Search
<a href="http://www.ncbi.nlm.nih.gov/gds/?term=%22disease%20state%22%5BAll%20Fields%5D%20AND%20%22Homo%20Sapiens%22%5Bporgn%5D%20AND%20%28%22Nasal%20Type%20Extranodal%20Nk%2Ft-Cell%20Lymphoma%22%5BMeSH%20Terms%5D%20OR%20%22Nasal%20Type%20Extranodal%20Nk%2Ft-Cell%20Lymphoma%22%5BAll%20Fields%5D%29%20AND%20%28%22gds%22%5BFilter%5D%20OR%20%22gse%22%5BFilter%5D%20OR%20%22gsm%22%5BFilter%5D%29%20AND%20%28%22Expression%20profiling%20by%20array%22%5BFilter%5D%20OR%20Expression%20profiling%20by%20high%20throughput%20sequencing%5BFilter%5D%29" target="_blank" title="Gene Expression Omnibus">GEO</a>
for disease gene expression data for Nasal Type Extranodal Nk/t-Cell Lymphoma.
</div>
</div>
</td>
</tr>
</table>
</div>
<div class="section" id="pathways">
<div class="section-header">
<div class="jump-to-section">
<select onchange="jumpToSection(this);">
<option selected="selected" value>Jump to section</option>
<option value="#aliases_descriptions">Aliases &amp; Classifications</option>
<option value="#anatomical_context">Anatomical Context</option>
<option value="#therapeutics">Drugs &amp; Therapeutics</option>
<option value="#expression_profiles">Expression</option>
<option value="#related_genes">Genes</option>
<option value="#genetic_testing">Genetic Tests</option>
<option value="#goterms">GO Terms</option>
<option value="#pathways">Pathways</option>
<option value="#publications">Publications</option>
<option value="#disorders">Related Diseases</option>
<option value="#sources">Sources</option>
<option value="#summaries">Summaries</option>
<option value="#clinical_features">Symptoms &amp; Phenotypes</option>
<option value="#genetic_variations">Variations</option>
<option value="#container">Top</option>
<option value="#footer">Bottom</option>
</select>
</div>
<div class="section-header-sources">
<a href="#sources">Sources</a>
</div>
<h2 class="title">
<span itemprop="aspect">Pathways<small> for Nasal Type Extranodal Nk/t-Cell Lymphoma</small></span>
</h2>
<div class="about-section">
<a href="/pages/info#pathways">
<img src="/img/menu/help_icon.png" alt="About this section" title="About this section" style="width:20px;margin:0px;" />
</a>
</div>
</div>
<table class="section-table">
<tr>
<td class="rhs">
<div class="section-data">
<h3>Pathways related to Nasal Type Extranodal Nk/t-Cell Lymphoma according to GeneCards Suite gene sharing:</h3>
<table id="Pathway-table">
<thead>
<tr>
<th width="12">#</th>
<th>Super pathways</th>
<th width="40" title="Solr Relevance Score">Score</th>
<th width="220">Top Affiliating Genes</th>
</tr>
</thead>
<tbody>
<tr id="NF-kappaB_Signaling_1">
<td>1</td>
<td>
<div class="super_pathway">
<a href="https://pathcards.genecards.org/card/nf-kappab_signaling" target="_blank">NF-kappaB Signaling</a>
<sup title="Cell Signaling Technology"> <a href="https://www.cellsignal.com/pathways/by-research-area" target="_blank">3</a></sup>
</div>
</td>
<td>11.44</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=NF-kappaB+Signaling&amp;prefilter=pathways_interactions#pathways_interactions" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD2&amp;keywords=NF-kappaB+Signaling&amp;prefilter=pathways_interactions#pathways_interactions" title="CD2 gene information at GeneCards" target="_blank">CD2</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF8&amp;keywords=NF-kappaB+Signaling&amp;prefilter=pathways_interactions#pathways_interactions" title="TNFRSF8 gene information at GeneCards" target="_blank">TNFRSF8</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=NF-kappaB+Signaling&amp;prefilter=pathways_interactions#pathways_interactions" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> </td>
</tr>
<tr id="Innate_Lymphoid_Cells_Differentiation_2">
<td>2</td>
<td>
<div class="super_pathway">
<a href="https://pathcards.genecards.org/card/innate_lymphoid_cells_differentiation" target="_blank">Innate Lymphoid Cells Differentiation</a>
<sup title="R&amp;D Systems"> <a href="https://www.rndsystems.com/pathways/innate-lymphoid-cells-differentiation?utm_source=genecards&amp;utm_medium=referral&amp;utm_campaign=product&amp;utm_content=pathway" target="_blank">65</a></sup>
</div>
</td>
<td>11.06</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=Innate+Lymphoid+Cells+Differentiation&amp;prefilter=pathways_interactions#pathways_interactions" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=Innate+Lymphoid+Cells+Differentiation&amp;prefilter=pathways_interactions#pathways_interactions" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> </td>
</tr>
<tr id="FGF_signaling_pathway_3">
<td>3</td>
<td>
<div class="super_pathway">
<a href="https://pathcards.genecards.org/card/fgf_signaling_pathway" target="_blank">FGF signaling pathway</a>
<sup title="PubChem"> <a href="https://pubchem.ncbi.nlm.nih.gov/pathway/Pathway Interaction Database:fgf_pathway#section=Diagram" target="_blank">61</a></sup>
</div>
</td>
<td>10.69</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=FGF+signaling+pathway&amp;prefilter=pathways_interactions#pathways_interactions" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&amp;keywords=FGF+signaling+pathway&amp;prefilter=pathways_interactions#pathways_interactions" title="NCAM1 gene information at GeneCards" target="_blank">NCAM1</a> </td>
</tr>
</tbody>
</table>
</div>
</td>
</tr>
</table>
</div>
<div class="section" id="goterms">
<div class="section-header">
<div class="jump-to-section">
<select onchange="jumpToSection(this);">
<option selected="selected" value>Jump to section</option>
<option value="#aliases_descriptions">Aliases &amp; Classifications</option>
<option value="#anatomical_context">Anatomical Context</option>
<option value="#therapeutics">Drugs &amp; Therapeutics</option>
<option value="#expression_profiles">Expression</option>
<option value="#related_genes">Genes</option>
<option value="#genetic_testing">Genetic Tests</option>
<option value="#goterms">GO Terms</option>
<option value="#pathways">Pathways</option>
<option value="#publications">Publications</option>
<option value="#disorders">Related Diseases</option>
<option value="#sources">Sources</option>
<option value="#summaries">Summaries</option>
<option value="#clinical_features">Symptoms &amp; Phenotypes</option>
<option value="#genetic_variations">Variations</option>
<option value="#container">Top</option>
<option value="#footer">Bottom</option>
</select>
</div>
<div class="section-header-sources">
<a href="#sources">Sources</a>
</div>
<h2 class="title">
<span itemprop="aspect">GO Terms<small> for Nasal Type Extranodal Nk/t-Cell Lymphoma</small></span>
</h2>
<div class="about-section">
<a href="/pages/info#goterms">
<img src="/img/menu/help_icon.png" alt="About this section" title="About this section" style="width:20px;margin:0px;" />
</a>
</div>
</div>
<table class="section-table">
<tr>
<td class="rhs">
<div class="section-data">
<div class="section-data">
<h3>Biological processes related to Nasal Type Extranodal Nk/t-Cell Lymphoma according to GeneCards Suite gene sharing:</h3>
<table id="go_proc-table">
<thead>
<tr>
<th width="12">#</th>
<th>Name</th>
<th>GO ID</th>
<th width="40" title="Solr Relevance Score">Score</th>
<th>Top Affiliating Genes</th>
</tr>
</thead>
<tbody>
<tr>
<td>1</td>
<td>natural killer cell mediated cytotoxicity</td>
<td> <a href="http://amigo.geneontology.org/amigo/term/GO:0042267" target="_blank">GO:0042267</a></td>
<td>8.92</td>
<td>
<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMB&amp;keywords=natural+killer+cell+mediated+cytotoxicity&amp;prefilter=go_proc#go_proc" title="GZMB gene information at GeneCards" target="_blank">GZMB</a> <a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD2&amp;keywords=natural+killer+cell+mediated+cytotoxicity&amp;prefilter=go_proc#go_proc" title="CD2 gene information at GeneCards" target="_blank">CD2</a> </td>
</tr>
</tbody>
</table>
</div>
</div>
</td>
</tr>
</table>
</div>
<div class="section" id="sources">
<div class="section-header">
<div class="jump-to-section">
<select onchange="jumpToSection(this);">
<option selected="selected" value>Jump to section</option>
<option value="#aliases_descriptions">Aliases &amp; Classifications</option>
<option value="#anatomical_context">Anatomical Context</option>
<option value="#therapeutics">Drugs &amp; Therapeutics</option>
<option value="#expression_profiles">Expression</option>
<option value="#related_genes">Genes</option>
<option value="#genetic_testing">Genetic Tests</option>
<option value="#goterms">GO Terms</option>
<option value="#pathways">Pathways</option>
<option value="#publications">Publications</option>
<option value="#disorders">Related Diseases</option>
<option value="#sources">Sources</option>
<option value="#summaries">Summaries</option>
<option value="#clinical_features">Symptoms &amp; Phenotypes</option>
<option value="#genetic_variations">Variations</option>
<option value="#container">Top</option>
<option value="#footer">Bottom</option>
</select>
</div>
<div class="section-header-sources">
<a href="#sources">Sources</a>
</div>
<h2 class="title">
<span itemprop="aspect">Sources<small> for Nasal Type Extranodal Nk/t-Cell Lymphoma</small></span>
</h2>
<div class="about-section">
<a href="/pages/info#sources">
<img src="/img/menu/help_icon.png" alt="About this section" title="About this section" style="width:20px;margin:0px;" />
</a>
</div>
</div>
<table class="section-table">
<tr>
<td class="rhs">
<table class="section-table sources-section-table">
<tr>
<td>
<div title="BitterDB">
<sup>1</sup>
<a href="http://bitterdb.agri.huji.ac.il/bitterdb/" title="BitterDB" target="_blank">BitterDB</a>
</div>
<div title="Centers for Disease Control and Prevention">
<sup>2</sup>
<a href="https://www.cdc.gov/" title="Centers for Disease Control and Prevention" target="_blank">CDC</a>
</div>
<div title="Cell Signaling Technology">
<sup>3</sup>
<a href="http://www.cellsignal.com/" title="Cell Signaling Technology" target="_blank">Cell Signaling Technology</a>
</div>
<div title="ClinicalTrials.gov">
<sup>4</sup>
<a href="https://clinicaltrials.gov/" title="ClinicalTrials.gov" target="_blank">ClinicalTrials</a>
</div>
<div title="ClinVar">
<sup>5</sup>
<a href="http://www.ncbi.nlm.nih.gov/clinvar/" title="ClinVar" target="_blank">ClinVar</a>
</div>
<div title="Copy Number Variation in Disease">
<sup>6</sup>
<span title="No website currently available for Copy Number Variation in Disease">CNVD</span>
</div>
<div title="Cochrane Library">
<sup>7</sup>
<a href="http://www.cochranelibrary.com/" title="Cochrane Library" target="_blank">Cochrane Library</a>
</div>
<div title="Cosmic">
<sup>8</sup>
<a href="http://cancer.sanger.ac.uk/cosmic" title="Cosmic" target="_blank">Cosmic</a>
</div>
<div title="The Single Nucleotide Polymorphism Database">
<sup>9</sup>
<a href="http://www.ncbi.nlm.nih.gov/SNP/" title="The Single Nucleotide Polymorphism Database" target="_blank">dbSNP</a>
</div>
<div title="The Drug-Gene Interaction database">
<sup>10</sup>
<a href="https://www.dgidb.org/" title="The Drug-Gene Interaction database" target="_blank">DGIdb</a>
</div>
<div title="Disease Ontology">
<sup>11</sup>
<a href="http://disease-ontology.org/" title="Disease Ontology" target="_blank">Disease Ontology</a>
</div>
<div title="diseasecard">
<sup>12</sup>
<a href="http://bioinformatics.ua.pt/diseasecard/" title="diseasecard" target="_blank">diseasecard</a>
</div>
<div title="DiseaseEnhancer">
<sup>13</sup>
<a href="http://biocc.hrbmu.edu.cn/DiseaseEnhancer" title="DiseaseEnhancer" target="_blank">DiseaseEnhancer</a>
</div>
<div title="The University of Copenhagen DISEASES">
<sup>14</sup>
<a href="http://diseases.jensenlab.org/" title="The University of Copenhagen DISEASES" target="_blank">DISEASES</a>
</div>
<div title="DrugBank">
<sup>15</sup>
<a href="http://www.drugbank.ca/" title="DrugBank" target="_blank">DrugBank</a>
</div>
<div title="Experimental Factor Ontology">
<sup>16</sup>
<a href="https://www.ebi.ac.uk/efo/" title="Experimental Factor Ontology" target="_blank">EFO</a>
</div>
<div title="ExPASy">
<sup>17</sup>
<a href="http://web.expasy.org/" title="ExPASy" target="_blank">ExPASy</a>
</div>
<div title="The Foundational Model of Anatomy Ontology">
<sup>18</sup>
<a href="http://sig.biostr.washington.edu/projects/fm/AboutFM.html" title="The Foundational Model of Anatomy Ontology" target="_blank">FMA</a>
</div>
<div title="Genetic and Rare Diseases Information Center">
<sup>19</sup>
<a href="http://rarediseases.info.nih.gov" title="Genetic and Rare Diseases Information Center" target="_blank">GARD</a>
</div>
</td>
<td>
<div title="GeneAnalytics">
<sup>20</sup>
<a href="http://geneanalytics.genecards.org/" title="GeneAnalytics" target="_blank">GeneAnalytics</a>
</div>
<div title="GeneCards">
<sup>21</sup>
<a href="http://www.genecards.org/" title="GeneCards" target="_blank">GeneCards</a>
</div>
<div title="GeneGo (Thomson Reuters Life Sciences Research)">
<sup>22</sup>
<a href="http://pathwaymaps.com/maps/" title="GeneGo (Thomson Reuters Life Sciences Research)" target="_blank">GeneGo (Thomson Reuters)</a>
</div>
<div title="GeneHancer via GeneCards">
<sup>23</sup>
<a href="http://www.genecards.org/Guide/GeneCard#enhancers" title="GeneHancer via GeneCards" target="_blank">GeneHancer via GeneCards</a>
</div>
<div title="GeneReviews">
<sup>24</sup>
<a href="http://www.genereviews.org/" title="GeneReviews" target="_blank">GeneReviews</a>
</div>
<div title="GenomeRNAi">
<sup>25</sup>
<a href="http://www.genomernai.org/" title="GenomeRNAi" target="_blank">GenomeRNAi</a>
</div>
<div title="Gene Expression Omnibus DataSets">
<sup>26</sup>
<a href="http://www.ncbi.nlm.nih.gov/gds/" title="Gene Expression Omnibus DataSets" target="_blank">GEO DataSets</a>
</div>
<div title="Gene Ontology">
<sup>27</sup>
<a href="http://www.geneontology.org/" title="Gene Ontology" target="_blank">GO</a>
</div>
<div title="Genetic Testing Registry">
<sup>28</sup>
<a href="http://www.ncbi.nlm.nih.gov/gtr/" title="Genetic Testing Registry" target="_blank">GTR</a>
</div>
<div title="Human Metabolome Database">
<sup>29</sup>
<a href="http://www.hmdb.ca/" title="Human Metabolome Database" target="_blank">HMDB</a>
</div>
<div title="The Human Phenotype Ontology">
<sup>30</sup>
<a href=" http://www.human-phenotype-ontology.org/" title="The Human Phenotype Ontology" target="_blank">HPO</a>
</div>
<div title="International Classification of Diseases, 10th Revision">
<sup>31</sup>
<a href="http://apps.who.int/classifications/icd10/browse/2010/en#/" title="International Classification of Diseases, 10th Revision" target="_blank">ICD10</a>
</div>
<div title="ICD10 via Orphanet">
<sup>32</sup>
<span title="No website currently available for ICD10 via Orphanet">ICD10 via Orphanet</span>
</div>
<div title="International Classification of Diseases, 11th Revision">
<sup>33</sup>
<a href="https://icd.who.int/browse11/l-m/en" title="International Classification of Diseases, 11th Revision" target="_blank">ICD11</a>
</div>
<div title="International Classification of Diseases, 9th Revision, Clinical Modification">
<sup>34</sup>
<a href="http://icd9cm.chrisendres.com/index.php" title="International Classification of Diseases, 9th Revision, Clinical Modification" target="_blank">ICD9CM</a>
</div>
<div title="International Union of Basic and Clinical Pharmacology">
<sup>35</sup>
<a href="http://www.guidetopharmacology.org/" title="International Union of Basic and Clinical Pharmacology" target="_blank">IUPHAR</a>
</div>
<div title="LifeMap Discovery&#174;">
<sup>36</sup>
<a href="https://discovery.lifemapsc.com" title="LifeMap Discovery&#174;" target="_blank">LifeMap</a>
</div>
<div title="The LncRNADisease database">
<sup>37</sup>
<a href="http://www.rnanut.net/lncrnadisease" title="The LncRNADisease database" target="_blank">LncRNADisease</a>
</div>
<div title="Leiden Open Variation Database">
<sup>38</sup>
<a href="https://www.lovd.nl" title="Leiden Open Variation Database" target="_blank">LOVD</a>
</div>
</td>
<td>
<div title="MalaCards">
<sup>39</sup>
<a href="https://www.malacards.org/" title="MalaCards" target="_blank">MalaCards</a>
</div>
<div title="MedGen">
<sup>40</sup>
<a href="http://www.ncbi.nlm.nih.gov/medgen/" title="MedGen" target="_blank">MedGen</a>
</div>
<div title="MedlinePlus">
<sup>41</sup>
<a href="http://www.nlm.nih.gov/medlineplus/" title="MedlinePlus" target="_blank">MedlinePlus</a>
</div>
<div title="MedlinePlus Genetics">
<sup>42</sup>
<a href="https://medlineplus.gov/genetics/ " title="MedlinePlus Genetics" target="_blank">MedlinePlus Genetics</a>
</div>
<div title="Medical Subject Headings">
<sup>43</sup>
<a href="https://meshb.nlm.nih.gov/" title="Medical Subject Headings" target="_blank">MeSH</a>
</div>
<div title="MESH via Orphanet">
<sup>44</sup>
<span title="No website currently available for MESH via Orphanet">MESH via Orphanet</span>
</div>
<div title="Mouse Genome Informatics">
<sup>45</sup>
<a href="http://www.informatics.jax.org/" title="Mouse Genome Informatics" target="_blank">MGI</a>
</div>
<div title="miR2Disease">
<sup>46</sup>
<a href="http://watson.compbio.iupui.edu:8080/miR2Disease/index.jsp" title="miR2Disease" target="_blank">miR2Disease</a>
</div>
<div title="NCBI Bookshelf">
<sup>47</sup>
<a href="http://www.ncbi.nlm.nih.gov/books/" title="NCBI Bookshelf" target="_blank">NCBI Bookshelf</a>
</div>
<div title="National Cancer Institute">
<sup>48</sup>
<a href="http://www.cancer.gov/" title="National Cancer Institute" target="_blank">NCI</a>
</div>
<div title="National Cancer Institute Thesaurus">
<sup>49</sup>
<a href="http://ncit.nci.nih.gov/ncitbrowser/" title="National Cancer Institute Thesaurus" target="_blank">NCIt</a>
</div>
<div title="The National Drug File - Reference Terminology">
<sup>50</sup>
<span title="No website currently available for The National Drug File - Reference Terminology">NDF-RT</span>
</div>
<div title="NIH Clinical Center">
<sup>51</sup>
<a href="http://clinicalstudies.info.nih.gov/" title="NIH Clinical Center" target="_blank">NIH Clinical Center</a>
</div>
<div title="National Institute of Neurological Disorders and Stroke">
<sup>52</sup>
<a href="http://www.ninds.nih.gov" title="National Institute of Neurological Disorders and Stroke" target="_blank">NINDS</a>
</div>
<div title="Novoseek">
<sup>53</sup>
<span title="No website currently available for Novoseek">Novoseek</span>
</div>
<div title="Novus Biologicals">
<sup>54</sup>
<a href="http://www.novusbio.com/" title="Novus Biologicals" target="_blank">Novus Biologicals</a>
</div>
<div title="The Organ-Disease Annotation database of tissue-selective hereditary diseases">
<sup>55</sup>
<a href="https://netbio.bgu.ac.il/odisea/" title="The Organ-Disease Annotation database of tissue-selective hereditary diseases" target="_blank">ODiseA</a>
</div>
<div title="OMIM via Orphanet">
<sup>56</sup>
<span title="No website currently available for OMIM via Orphanet">OMIM via Orphanet</span>
</div>
<div title="Online Mendelian Inheritance in Man&#174;">
<sup>57</sup>
<a href="http://omim.org/" title="Online Mendelian Inheritance in Man&#174;" target="_blank">OMIM&#174;</a>
<span class="sourceUpdateDate">(Updated 09-Jul-2023)</span>
</div>
</td>
<td>
<div title="Orphanet">
<sup>58</sup>
<a href="http://www.orpha.net/" title="Orphanet" target="_blank">Orphanet</a>
</div>
<div title="PathCards">
<sup>59</sup>
<a href="http://pathcards.genecards.org/" title="PathCards" target="_blank">PathCards</a>
</div>
<div title="Pharmacogenomics Knowledge Base">
<sup>60</sup>
<a href="http://www.pharmgkb.org/" title="Pharmacogenomics Knowledge Base" target="_blank">PharmGKB</a>
</div>
<div title="PubChem">
<sup>61</sup>
<a href="https://pubchemdocs.ncbi.nlm.nih.gov/" title="PubChem" target="_blank">PubChem</a>
</div>
<div title="NCBI-PubMed">
<sup>62</sup>
<a href="https://www.ncbi.nlm.nih.gov/pubmed/" title="NCBI-PubMed" target="_blank">PubMed</a>
</div>
<div title="PubMed HealthMedical encyclopedia">
<sup>63</sup>
<a href="https://www.ncbi.nlm.nih.gov/pubmedhealth/" title="PubMed HealthMedical encyclopedia" target="_blank">PubMed Health</a>
</div>
<div title="QIAGEN">
<sup>64</sup>
<a href="http://www.qiagen.com" title="QIAGEN" target="_blank">QIAGEN</a>
</div>
<div title="R&amp;D Systems">
<sup>65</sup>
<a href="http://www.rndsystems.com" title="R&amp;D Systems" target="_blank">R&amp;D Systems</a>
</div>
<div title="Reactome">
<sup>66</sup>
<a href="http://www.reactome.org/" title="Reactome" target="_blank">Reactome</a>
</div>
<div title="Sino Biological">
<sup>67</sup>
<a href="https://www.sinobiological.com/" title="Sino Biological" target="_blank">Sino Biological</a>
</div>
<div title="Systematized Nomenclature of Medicine Clinical Terms">
<sup>68</sup>
<a href="http://www.ihtsdo.org/snomed-ct/" title="Systematized Nomenclature of Medicine Clinical Terms" target="_blank">SNOMED-CT</a>
</div>
<div title="SNOMED-CT via HPO">
<sup>69</sup>
<span title="No website currently available for SNOMED-CT via HPO">SNOMED-CT via HPO</span>
</div>
<div title="Tocris Bioscience">
<sup>70</sup>
<a href="http://www.tocris.com/" title="Tocris Bioscience" target="_blank">Tocris</a>
</div>
<div title="Unified Medical Language System">
<sup>71</sup>
<a href="http://www.nlm.nih.gov/research/umls/" title="Unified Medical Language System" target="_blank">UMLS</a>
</div>
<div title="UMLS via Orphanet">
<sup>72</sup>
<span title="No website currently available for UMLS via Orphanet">UMLS via Orphanet</span>
</div>
<div title="UniProtKB/Swiss-Prot">
<sup>73</sup>
<a href="http://www.uniprot.org/" title="UniProtKB/Swiss-Prot" target="_blank">UniProtKB/Swiss-Prot</a>
</div>
<div title="WikiPathways">
<sup>74</sup>
<a href="https://wikipathways.org" title="WikiPathways" target="_blank">WikiPathways</a>
</div>
<div title="Wikipedia">
<sup>75</sup>
<a href="https://en.wikipedia.org/wiki/" title="Wikipedia" target="_blank">Wikipedia</a>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</div>
</div>
</div>
<div class="footer_letters">
<span>The MalaCards human disease database index:</span>
<a href="/malalist/1-9">1-9</a>
<a href="/malalist/A">A</a>
<a href="/malalist/B">B</a>
<a href="/malalist/C">C</a>
<a href="/malalist/D">D</a>
<a href="/malalist/E">E</a>
<a href="/malalist/F">F</a>
<a href="/malalist/G">G</a>
<a href="/malalist/H">H</a>
<a href="/malalist/I">I</a>
<a href="/malalist/J">J</a>
<a href="/malalist/K">K</a>
<a href="/malalist/L">L</a>
<a href="/malalist/M">M</a>
<a href="/malalist/N">N</a>
<a href="/malalist/O">O</a>
<a href="/malalist/P">P</a>
<a href="/malalist/Q">Q</a>
<a href="/malalist/R">R</a>
<a href="/malalist/S">S</a>
<a href="/malalist/T">T</a>
<a href="/malalist/U">U</a>
<a href="/malalist/V">V</a>
<a href="/malalist/W">W</a>
<a href="/malalist/X">X</a>
<a href="/malalist/Y">Y</a>
<a href="/malalist/Z">Z</a>
</div>
<div id="footer">
<div>
<div style="float:left;">
<a href="https://auth.lifemapsc.com/TermsOfUse" target="_blank" class="link">Terms and Conditions</a> &bull;
<a href="#" class="link contact-dialog" rel="nofollow">User Feedback</a>
</div>
<div style="float:right;">
Copyright &copy; 1996-2023 , Weizmann Institute of Science. All Rights Reserved.
<span>Version 5.17.0.1037</span>
<span>2023 August 03</span>
</div>
<br/>
<div style="padding-top: 5px; font-weight: bold">GENECARDS SUITE PRODUCTS ARE FOR RESEARCH USE ONLY, DO NOT PROVIDE MEDICAL ADVICE AND ARE NOT FOR USE IN DIAGNOSTIC PROCEDURES.</div>
</div>
</div>
</div>
</div>
<div id="contactUs" class="slide-out-div hidden-print hide">
<a class="handle" href="/cdn-cgi/l/email-protection#53202623233c2127133f3a35363e322320307d303c3e">Content</a>
<button type="button" class="close" data-dismiss="modal" aria-hidden="true">&times;</button>
<div data-role="form">Loading form....</div>
</div>
<script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script src="/scripts/main?v=6X7ka5ngWa86w75AOGLnGMzosimrOYgwg5_yA4yQgNw1"></script>
<script type="text/javascript" src="https://auth.lifemapsc.com/bundle/gc-suite.js?ver=5.17.0.1037" data-container="#suiteBar" data-app="malacards" data-cdn="https://auth.lifemapsc.com" data-li></script>
<script>(function (d, a) { function c() { var b = d.createElement("script"); b.async = !0; b.type = "text/javascript"; b.src = a._settings.messengerUrl; b.crossOrigin = "anonymous"; var c = d.getElementsByTagName("script")[0]; c.parentNode.insertBefore(b, c) } window.kayako = a; a.readyQueue = []; a.newEmbedCode = !0; a.ready = function (b) { a.readyQueue.push(b) }; a._settings = { apiUrl: "https://genecards.kayako.com/api/v1", messengerUrl: "https://genecards.kayakocdn.com/messenger", realtimeUrl: "wss://kre.kayako.net/socket" }; window.attachEvent ? window.attachEvent("onload", c) : window.addEventListener("load", c, !1) })(document, window.kayako || {});</script>
<script>(function(){var js = "window['__CF$cv$params']={r:'809ed8e22b2c1660',t:'MTY5NTI2MzAxNy41MTEwMDA='};_cpo=document.createElement('script');_cpo.nonce='',_cpo.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js',document.getElementsByTagName('head')[0].appendChild(_cpo);";var _0xh = document.createElement('iframe');_0xh.height = 1;_0xh.width = 1;_0xh.style.position = 'absolute';_0xh.style.top = 0;_0xh.style.left = 0;_0xh.style.border = 'none';_0xh.style.visibility = 'hidden';document.body.appendChild(_0xh);function handler() {var _0xi = _0xh.contentDocument || _0xh.contentWindow.document;if (_0xi) {var _0xj = _0xi.createElement('script');_0xj.innerHTML = js;_0xi.getElementsByTagName('head')[0].appendChild(_0xj);}}if (document.readyState !== 'loading') {handler();} else if (window.addEventListener) {document.addEventListener('DOMContentLoaded', handler);} else {var prev = document.onreadystatechange || function () {};document.onreadystatechange = function (e) {prev(e);if (document.readyState !== 'loading') {document.onreadystatechange = prev;handler();}};}})();</script></body>
</html>
